assay_description
In vitro antibacterial activity of compound against Mycobacterium tuberculosis H37Rv ATCC 9660
Compound was tested for inhibitory activity against Mycobacterium tuberculosis H37Rv ATCC 27294 and the activity is expressed as minimum inhibitory concentration (MIC).
In vitro antibacterial activity against Mycobacterium tuberculosis 103471
The compound was tested for its ability to inhibit the growth of Mycobacterium tuberculosis strain H37Rv
The compound was tested for its ability to inhibit the growth of Mycobacterium tuberculosis strain H6/99
Compound was tested in vitro for growth inhibition activity against Mycobacterium tuberculosis H37Rv in Bactec 6A media.
Compound was tested in vitro for growth inhibition activity against Mycobacterium tuberculosis H37Rv in Bactec 12B media.
Inhibitory activity against Mycobacterium tuberculosis H37Ra
In vitro minimum inhibitory concentration against Mycobacterium tuberculosis CIP 103471 was determined
Antibacterial activity against human Mycobacterium tuberculosis H37Rv
Antibacterial activity against Mycobacterium tuberculosis H331
Antibacterial activity against Mycobacterium tuberculosis H242
Antibacterial activity against Mycobacterium tuberculosis H172
Minimum inhibitory concentration against Mycobacterium tuberculosis H37Rv (ATCC 27294) in BACTEC 6A medium
In vitro minimum inhibitory concentration (MIC) towardsMtb H37Ra was determined using a colorimetric (Alamar blue) microdilution broth assay
Minimum inhibitory concentration against Mycobacterium tuberculosis H37Ra; value ranges from 32-64 ug/mL
Minimum inhibitory concentration against Mycobacterium tuberculosis H37Ra; value ranges from 16-64 ug/mL
Minimum inhibitory concentration against Mycobacterium tuberculosis H37Ra; value ranges from 32-128 ug/mL
Minimum inhibitory concentration against Mycobacterium tuberculosis H37Ra; value ranges from 16-32 ug/mL
Minimum inhibitory concentration against Mycobacterium tuberculosis H37Ra; value ranges from 68->128 ug/mL
Antitubercular activity against Mycobacterium tuberculosis
Minimum inhibitory concentration (MIC) against Mycobacterium tuberculosis H 37 Ra
Compound was evaluated for antituberculosis activity against Mycobacterium tuberculosis in level 2 assay (performed using BACTEC in which MIC of RMP was found as 0.125 mg/mL)
Minimum inhibitory concentration (MIC) of compound against Mycobacterium tuberculosis H 37 Rv
In vitro antibacterial effect against Mycobacterium tuberculosis H37Rv by using gradient plate test
In vitro antituberculosis activity against Mycobacterium tuberculosis H37Rv using the BACTEC 12B medium using a micro dilution assay( MABA)
In vitro antibacterial effect against M. t. H37Rv by using gradient plate test
Compound was evaluated for the minimum inhibitory concentration (MIC) against Mycobacterium tuberculosis H 37 Rv
Compounds were evaluated for the minimum inhibitory concentration (MIC) Mycobacterium tuberculosis H 37 Rv (INH resistant)
Compounds were evaluated for the minimum inhibitory concentration (MIC) Mycobacterium tuberculosis H 37 Rv (thiosemicarbazone resistant)
"Compound was evaluated for the synergistic effect in combination with isoniazid for the inhibition of Mycobacterium tuberculosis H 37 Ra, using Lowenstein-Jensen medium (solid)"
"Compound was evaluated for the synergistic effect in combination with tetracycline hydrochloride for the inhibition of Mycobacterium tuberculosis H 37 Ra, using Lowenstein-Jensen medium (solid)"
"Compound was evaluated for the synergistic effect in combination with ethionamide for the inhibition of Mycobacterium tuberculosis H 37 Ra, using Lowenstein-Jensen medium (solid)"
"Compound was evaluated for the synergistic effect in combination with capreomycin for the inhibition of Mycobacterium tuberculosis H 37 Ra, using Lowenstein-Jensen medium (solid)"
"Compound was evaluated for the synergistic effect in combination with streptomycin sulfate for the inhibition of Mycobacterium tuberculosis H 37 Ra, using Lowenstein-Jensen medium (solid)"
"Compound was evaluated for the synergistic effect in combination with ethambutol for the inhibition of Mycobacterium tuberculosis H 37 Ra, using Lowenstein-Jensen medium (solid)"
"Compound was evaluated for the synergistic effect in combination with aminosalicylic acid for the inhibition of Mycobacterium tuberculosis H 37 Ra, using Lowenstein-Jensen medium (solid)"
"Compound was evaluated for the synergistic effect in combination with rifampicin for the inhibition of Mycobacterium tuberculosis H 37 Ra, using Lowenstein-Jensen medium (solid)"
"Compound was evaluated for the synergistic effect in combination with cycloserine for the inhibition of Mycobacterium tuberculosis H 37 Ra, using Lowenstein-Jensen medium (solid)"
"Compound was evaluated for the synergistic effect in combination with benzaldehyde thiosemicarbazone for the inhibition of Mycobacterium tuberculosis H 37 Ra, using Lowenstein-Jensen medium (solid)"
"Compound was evaluated for the synergistic effect in combination with dapsone for the inhibition of Mycobacterium tuberculosis H 37 Ra, using Lowenstein-Jensen medium (solid)"
"Compound was evaluated for the synergistic effect in combination with trimethoprim for the inhibition of Mycobacterium tuberculosis H 37 Ra, using Lowenstein-Jensen medium (solid)"
"Compound was evaluated for the synergistic effect in combination with isoniazid for the inhibition of Mycobacterium tuberculosis H 37 Ra, using middlebrook 7H9 medium (liquid)"
"Compound was evaluated for the synergistic effect in combination with tetracycline hydrochloride for the inhibition of Mycobacterium tuberculosis H 37 Ra, using middlebrook 7H9 medium (liquid)"
"Compound was evaluated for the synergistic effect in combination with ethionamide for the inhibition of Mycobacterium tuberculosis H 37 Ra, using middlebrook 7H9 medium (liquid)"
"Compound was evaluated for the synergistic effect in combination with capreomycin for the inhibition of Mycobacterium tuberculosis H 37 Ra, using middlebrook 7H9 medium (liquid)"
"Compound was evaluated for the synergistic effect in combination with streptomycin sulfate for the inhibition of Mycobacterium tuberculosis H 37 Ra, using middlebrook 7H9 medium (liquid)"
"Compound was evaluated for the synergistic effect in combination with ethambutol for the inhibition of Mycobacterium tuberculosis H 37 Ra, using middlebrook 7H9 medium (liquid)"
"Compound was evaluated for the synergistic effect in combination with aminosalicylic acid for the inhibition of Mycobacterium tuberculosis H 37 Ra, using middlebrook 7H9 medium (liquid)"
"Compound was evaluated for the synergistic effect in combination with rifampicin for the inhibition of Mycobacterium tuberculosis H 37 Ra, using middlebrook 7H9 medium (liquid)"
"Compound was evaluated for the synergistic effect in combination with cycloserine for the inhibition of Mycobacterium tuberculosis H 37 Ra, using middlebrook 7H9 medium (liquid)"
"Compound was evaluated for the synergistic effect in combination with benzaldehyde thiosemicarbazone for the inhibition of Mycobacterium tuberculosis H 37 Ra, using middlebrook 7H9 medium (liquid)"
"Compound was evaluated for the synergistic effect in combination with dapsone for the inhibition of Mycobacterium tuberculosis H 37 Ra, using middlebrook 7H9 medium (liquid)"
"Compound was evaluated for the synergistic effect in combination with trimethoprim for the inhibition of Mycobacterium tuberculosis H 37 Ra, using middlebrook 7H9 medium (liquid)"
Minimum inhibitory concentration against Mycobacterium tuberculosis
Compound was evaluated for in vitro anti-mycobacterial activity against Mycobacterium tuberculosis
Antibacterial activity was evaluated against Mycobacterium tuberculosis (ATCC)
Antibacterial activity was evaluated against Mycobacterium tuberculosis (clinical isolate 1104)
Antibacterial activity was evaluated against Mycobacterium tuberculosis
Tested for antibacterial activity against Mycobacterium tuberculosis
In vitro anti-mycobacterial activity against Mycobacterium tuberculosis strain H37Rv
Minimum Inhibitory Concentration against Mycobacterium tuberculosis ATCC 35801
Minimum Inhibitory Concentration against Mycobacterium tuberculosis ATCC 35828 PZA resistant form
Minimum Inhibitory Concentration against Mycobacterium tuberculosis ATCC 27294
Minimum Inhibitory Concentration for PZA resistant forms against Mycobacterium tuberculosis ATCC 35828
Inhibition against Mycobacterium tuberculosis
Minimum Inhibitory Concentration against Mycobacterium tuberculosis ATCC 35828 for PZA resistant form
In vitro minimum inhibitory concentration required to inhibit Mycobacterium tuberculosis
Activity against Mycobacterium tuberculosis (H37Rv) using the standard BACTEC radiometric growth assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv using Microplate Alamar Blue Assay (MABA) assay
"Antimycobacterial activity against Mycobacterium tuberculosis wild type (WT, H37Rv)"
Antimycobacterial activity against Mycobacterium tuberculosis strain resistant to isoniazid (INH)
Antimycobacterial activity against Mycobacterium tuberculosis strain resistant to rifampin (RMP)
Antimycobacterial activity against Mycobacterium tuberculosis strain resistant to pyrazinamide (PZA)
Antimycobacterial activity against Mycobacterium tuberculosis strain resistant to ethambutol (EMB)
Antimycobacterial activity against Mycobacterium tuberculosis strain resistant to kanamycin (KM)
Antimycobacterial activity against Mycobacterium tuberculosis strain resistant to ethionamide (ETA)
Antimycobacterial activity against Mycobacterium tuberculosis strain resistant to para-aminosalicilyc acid (PAS)
Antimycobacterial activity against Mycobacterium tuberculosis strain resistant to thiacetazone (TAC)
Antimycobacterial activity against Mycobacterium tuberculosis strain resistant to cycloserine (CS)
Antimycobacterial activity was assessed against Mycobacterium tuberculosis H37Ra using theMicroplate Alamar Blue Assay (MABA)
Antimycobacterial activity against Mycobacterium tuberculosis Erdman using Microplate Alamar Blue Assay (MABA) assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv.
Tested for antibacterial activity against Mycobacterium tuberculosis H37Rv streptomycin resistant strain
Tested for antibacterial activity against Mycobacterium tuberculosis H37Rv kanamycin resistant strain
Tested for antibacterial activity against Mycobacterium tuberculosis H37Rv isonicotinic acid hydrazide-resistant strain
"In vitro antimicrobacterial activity to inhibit 90% of Mycobacterium tuberculosis H37Rv (Rifampin and Isoniazid susceptible ATCC 27294 strain), relative to that of controls"
In vitro antibacterial activity against Mycobacterium tuberculosis H37Rv.
Antibacterial activity against Mycobacterium tuberculosis H37Rv
Antibacterial activity against Mycobacterium tuberculosis TN913
Antibacterial activity against Mycobacterium tuberculosis TN565 (W)
Antibacterial activity against Mycobacterium tuberculosis TN1618 (P)
Minimum inhibitory concentration against Mycobacterium tuberculosis H37Rv in BACTEC 12B medium using the Microplate Alamar Blue Assay
The compound was tested for its minimum inhibitory activity against Mycobacterium tuberculosis H37Rv in BACTEC 12B medium using the Microplate Alamar Blue Assay
Lowest concentration of compound against Mtb H37Ra strain required to inhibit the growth completely
In Vitro antimicrobial activity against the Mycobacterium tuberculosis (MT) strain H-37-Rv ATCC
In Vitro antimicrobial activity against the Mycobacterium tuberculosis (MT) Wild type strain MT-1
In Vitro antimicrobial activity against the Mycobacterium tuberculosis (MT) Wild type strain MT-2
Inhibitory activity against growth of Mycobacterium tuberculosis (Mtb) H37Ra Strain
Lowest concentration of compound against Mtb H37Ra strain required to inhibit the growth completely; activity range is 2-4
Minimum inhibitory concentration required to inhibit 90% of the inoculum of tuberculosis H37Rv
"Minimum inhibitory concentration against Mycobacterium tuberculosis strain, Erdman"
"Minimum inhibitory concentration against Mycobacterium tuberculosis strain, EMB-R"
"Minimum inhibitory concentration against Mycobacterium tuberculosis strain, RMP-R"
"Minimum inhibitory concentration against Mycobacterium tuberculosis strain, CIP-R"
"Minimum inhibitory concentration against Mycobacterium tuberculosis strain, KM-R"
"Minimum inhibitory concentration against Mycobacterium tuberculosis strain, INH-R"
"Minimum inhibitory concentration against Mycobacterium tuberculosis strain H37Rv, using Alamar assay"
Minimum inhibitory concentration required for antibacterial activity against Mycobacterium tuberculosis
In vitro antibacterial activity against Mycobacterium tuberculosis MT ATCC H37Rv strain
In vitro antibacterial activity against Mycobacterium tuberculosis MT-1 (wild type strain) isolated from infected patients.
In vitro antibacterial activity against Mycobacterium tuberculosis MT-2 (wild type strain) isolated from infected patients.
Minimum inhibitory concentration against Mycobacterium tuberculosis using microplate alamar blue assay
Growth inhibitory activity against Mycobacterium tuberculosis H37R
Minimum inhibitory concentration against (MDR-TB) Mycobacterium tuberculosis using microplate alamar blue assay
In vitro antibacterial activity of compound was measured against gram positive Mycobacterium tuberculosis H37Rv (human)
In vitro antibacterial activity of compound was measured against gram positive Mycobacterium tuberculosis Ravenel(bovin)
Antimycobacterial activity against Mycobacterium tuberculosis CIP 103471
Antibacterial activity against Mycobacterium tuberculosis H37Rv in BACTEC 12B medium using microplate alamar blue assay
Compound was tested for anti-mycobacterial activity against Mycobacterium tuberculosis CIP 103471
Minimum Inhibitory Concentration against drug-resistant strain of Mycobacterium tuberculosis Erdman
Minimum Inhibitory Concentration against drug-resistant strain resistant to Isoniazid
Minimum Inhibitory Concentration against drug-resistant strain resistant to Rifampin
Minimum Inhibitory Concentration against drug-resistant strain resistant to Kanamycin
In vitro activity against Mycobacterium. tuberculosis (strain type-BUR)at pH 5.8
In vitro activity against Mycobacterium. tuberculosis (strain type-ATCC 35828)at pH 5.8
In vitro activity against Mycobacterium. tuberculosis (strain type-H37Rv) at pH 6.6
In vitro activity against Mycobacterium. tuberculosis (strain type-H37Rv) at pH 5.8
In vitro activity against Mycobacterium. tuberculosis (strain type-BUR)at pH 6.6
In vitro activity against Mycobacterium. tuberculosis (strain type-ATCC 35828)at pH 6.6
In vitro activity against Mycobacterium strain BUR (Mycobacterium tuberculosis)
In vitro activity against Mycobacterium strain CES (Mycobacterium tuberculosis)
In vitro activity against Mycobacterium strain DOL (Mycobacterium tuberculosis)
In vitro activity against Mycobacterium strain SMA (Mycobacterium tuberculosis)
In vitro activity against Mycobacterium strain DUB (Mycobacterium tuberculosis)
In vitro activity against Mycobacterium strain GLA (Mycobacterium tuberculosis)
In vitro activity against Mycobacterium strain ING (Mycobacterium tuberculosis)
In vitro activity against Mycobacterium strain LEL (Mycobacterium tuberculosis)
In vitro activity against Mycobacterium strain MCQ (Mycobacterium tuberculosis)
In vitro activity against Mycobacterium strain WOO (Mycobacterium tuberculosis)
In vitro activity against Mycobacterium strain BAK (Mycobacterium tuberculosis)
In vitro activity against Mycobacterium strain DOU (Mycobacterium tuberculosis)
In vitro activity against Mycobacterium strain ATCC 35828 (Mycobacterium tuberculosis)
In vitro inhibitory activity against Mycobacterium tuberculosis (strain type-H37Rv) at pH 5.8
In vitro inhibitory activity against Mycobacterium tuberculosis (strain type-BUR) at pH 6.6
In vitro inhibitory activity against Mycobacterium tuberculosis (strain type-BUR) at pH 5.8
In vitro inhibitory activity against Mycobacterium strain BUR (Mycobacterium tuberculosis)
In vitro activity against Mycobacterium strains on DOL (Mycobacterium tuberculosis)
In vitro activity against Mycobacterium strains on SMA (Mycobacterium tuberculosis)
In vitro inhibitory activity against Mycobacterium strain DUB (Mycobacterium tuberculosis)
In vitro inhibitory activity against Mycobacterium strain GLA (Mycobacterium tuberculosis)
In vitro inhibitory activity against Mycobacterium strain ING (Mycobacterium tuberculosis)
In vitro inhibitory activity against Mycobacterium strain MCQ (Mycobacterium tuberculosis)
In vitro inhibitory activity against Mycobacterium strain WOO (Mycobacterium tuberculosis)
In vitro inhibitory activity against Mycobacterium strains on BAK (Mycobacterium tuberculosis)
In vitro inhibitory activity against Mycobacterium tuberculosis (strain type-H37Rv) at pH 6.6
In vitro inhibitory activity against Mycobacterium tuberculosis (strain type-ATCC 35828) at pH 5.8
In vitro activity against Mycobacterium tuberculosis (strain type-BUR) at pH 5.8
In vitro inhibitory activity against Mycobacterium tuberculosis (strain type-ATCC 35828)at pH 5.8
In vitro anti-mycobacterial activity against Mycobacterium tuberculosis H37Rv
In vitro inhibition of Mycobacterium Tuberculosis (My 331/88) growth after 14 days culture.
In vitro inhibition of Mycobacterium Tuberculosis (My 331/88) growth after 21 days culture.
In vitro minimum inhibitory concentration the compound for anti-mycobacterial activity was determined against Mycobacterium tuberculosis (My 331/88) by micromethod after 21 days of incubation
In vitro actual minimum inhibitory concentration value of the compound was determined against Mycobacterium tuberculosis
In vitro actual minimum inhibitory concentration value against Mycobacterium tuberculosis
In vitro minimum inhibitory concentration value against ethionamide resistant Mycobacterium tuberculosis in alamar assay
In vitro minimum inhibitory concentration value against ciprofloxacin resistant Mycobacterium tuberculosis in alamar assay
In vitro minimum inhibitory concentration value against Mycobacterium tuberculosis H37Rv strain in bactec assay
In vitro minimum inhibitory concentration value against isoniazid resistant Mycobacterium tuberculosis in alamar assay
In vitro minimum inhibitory concentration value against thiacetazone resistant Mycobacterium tuberculosis in alamar assay
In vitro minimum inhibitory concentration value against kanamycin resistant Mycobacterium tuberculosis in alamar assay
In vitro minimum inhibitory concentration value against Mycobacterium tuberculosis H37Rv strain in alamar assay
In vitro minimum inhibitory concentration value against Mycobacterium tuberculosis erdman strain in alamar assay
In vitro minimum inhibitory concentration value against ethambutol resistant Mycobacterium tuberculosis in alamar assay
In vitro minimum inhibitory concentration value against rifampin resistant Mycobacterium tuberculosis in alamar assay
In vitro actual minimum inhibitory concentration value of the compound was determined against Mycobacterium tuberculosis H37Rv strain; Range is 0.015-0.125
Minimum inhibitory concentration against sensitive Mycobacterium tuberculosis clinical isolates; N=9; range=8-16
Minimum inhibitory concentration against Mycobacterium tuberculosis H37Rv ATCC 27294
Minimum inhibitory concentration against sensitive Mycobacterium tuberculosis clinical isolates; N=9; range=4-8
Minimum inhibitory concentration against resistant Mycobacterium tuberculosis clinical isolates; N=9; range=8-16
Minimum inhibitory concentration against Mycobacterium tuberculosis sensitive clinical isolates; Range: 1-4 ug/ml
Minimum inhibitory concentration against sensitive Mycobacterium tuberculosis clinical isolates; N=9; range=2-4
Minimum inhibitory concentration against resistant Mycobacterium tuberculosis clinical isolates; N=9; range=4-8
Minimum inhibitory concentration against Mycobacterium tuberculosis resistant clinical isolates; Range: 1-4 ug/ml
Minimum inhibitory concentration against Mycobacterium tuberculosis sensitive clinical isolates; Range: 0.125-0.25 ug/ml
Minimum inhibitory concentration tested against Mycobacterium tuberculosis H37Rv ATCC 27294
Minimum inhibitory concentration tested against Mycobacterium tuberculosis sensitive clinical isolates; Range 8-16 ug/mL
Minimum inhibitory concentration tested against Mycobacterium tuberculosis resistant clinical isolates; Range 8-16 ug/mL
Minimum inhibitory concentration tested against Mycobacterium tuberculosis sensitive clinical isolates; Range 0.125-0.25 ug/ml
Minimum inhibitory concentration against sensitive Mycobacterium tuberculosis clinical isolates; N=9; range=1-4
Minimum inhibitory concentration against Mycobacterium tuberculosis sensitive clinical isolates; Range:4-16 ug/ml
Minimum inhibitory concentration against Mycobacterium tuberculosis resistant clinical isolates; Range:4-16 ug/ml
Minimum inhibitory concentration against sensitive Mycobacterium tuberculosis clinical isolates; N=9
Minimum inhibitory concentration against resistant Mycobacterium tuberculosis clinical isolates; N=9
Minimum inhibitory concentration against resistant Mycobacterium tuberculosis clinical isolates; N=9; Range 2-4
Minimum inhibitory concentration against sensitive Mycobacterium tuberculosis clinical isolates; N=9; Range = 0.12-0.25
Minimum inhibitory concentration against resistant Mycobacterium tuberculosis clinical isolates; N=9; Range=8-16
Minimum inhibitory concentration against sensitive Mycobacterium tuberculosis clinical isolates; N=9; Range=0.03-0.5
Minimum inhibitory concentration against resistant Mycobacterium tuberculosis clinical isolates; N=9; Range=2-16
Minimum inhibitory concentration tested against Mycobacterium tuberculosis sensitive clinical isolates; Range:1-4 ug/ml
Minimum inhibitory concentration tested against Mycobacterium tuberculosis resistant clinical isolates; Range:1-4 ug/ml
Minimum inhibitory concentration tested against Mycobacterium tuberculosis sensitive clinical isolates; Range:1-2 ug/ml
Minimum inhibitory concentration against Mycobacterium tuberculosis H37Rv; Range 0.125-0.25 ug/mL
Minimum inhibitory concentration against Mycobacterium tuberculosis H37Rv pFPCA1 in green fluorescent protein microplate assay
In vitro antimycobacterial activity against Mycobacterium tuberculosis H37Rv in broth cluture infected with macrophages
In vitro antimycobacterial activity against rifampin-resistant Mycobacterium tuberculosis strain 
In vitro antimycobacterial activity against ethionamide-resistant Mycobacterium tuberculosis strain 
In vitro antimycobacterial activity against Mycobacterium tuberculosis Erdman in broth cluture infected with macrophages
In vitro antimycobacterial activity against ethambutol-resistant Mycobacterium tuberculosis strain 
In vitro antimycobacterial activity against Mycobacterium tuberculosis H37Rv in broth cluture infected with macrophages; Range 0.025-0.05
Minimum inhibitory concentration against Mycobacterium tuberculosis H37Rv
In vitro minimal inhibitory concentration against Mycobacterium tuberculosis [H37Rv stain]
Minimum inhibitory concentration against H37Ra stain of Mycobacterium tuberculosis using MABA method
Minimum inhibitory concentration against H37Rv stain of Mycobacterium tuberculosis using Agar Microdilution
Antitubercular activity against Mycobacterium tuberculosis H37Ra
Antitubercular activity against Mycobacterium tuberculosis H37Rv by agar microdilution technique
Antitubercular activity against Mycobacterium tuberculosis H37Rv by standard BACTEC radiometric growth assay
Inhibitory activity against Mycobacterium tuberculosis H37Rv
Antibacterial activity against INH-resistant Mycobacterium tuberculosis
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis by broth microdilution assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv
Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis
Antibacterial activity against multi drug resistant Mycobacterium tuberculosis 275/05 isolate
Antibacterial activity against multi drug resistant Mycobacterium tuberculosis 482/98 isolate
Antibacterial activity against multi drug resistant Mycobacterium tuberculosis 296/04 isolate
Antibacterial activity against multi drug resistant Mycobacterium tuberculosis 520/98 isolate
Antibacterial activity against multi drug resistant Mycobacterium tuberculosis 134/02 isolate
Antibacterial activity against multi drug resistant Mycobacterium tuberculosis 158/97 isolate
Antibacterial activity against multi drug resistant Mycobacterium tuberculosis 43/05 isolate
Antibacterial activity against multi drug resistant Mycobacterium tuberculosis 586/98 isolate
Antibacterial activity against multi drug resistant Mycobacterium tuberculosis 421/96 isolate
Antibacterial activity against multi drug resistant Mycobacterium tuberculosis 149/03 isolate
Antibacterial activity against multi drug resistant Mycobacterium tuberculosis 326/04 isolate
Antibacterial activity against Mycobacterium tuberculosis 103471
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by BACTEC-460 radiometric assay
Antimycobacterial activity against INH-resistant Mycobacterium tuberculosis by agar dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv
Antibacterial activity against Mycobacterium tuberculosis H37Rv by alamar blue assay
Antituberculosis activity against Mycobacterium tuberculosis H37Rv
Antituberculosis activity against INH resistant Mycobacterium tuberculosis H37Rv
Antituberculosis activity against rifampicin resistant Mycobacterium tuberculosis H37Rv
Antibacterial activity against Mycobacterium tuberculosis H37Rv by microplate alamar blue assay
Antimycobacterial activity against rifampicin and rifabutin resistant Mycobacterium tuberculosis ATCC 35838
Antimycobacterial activity against streptomycin resistant Mycobacterium tuberculosis ATCC 35820
Antimycobacterial activity against ethambutol resistant Mycobacterium tuberculosis ATCC 35837
Antimycobacterial activity against isoniazid resistant Mycobacterium tuberculosis ATCC 35822
Antimycobacterial activity against Mycobacterium tuberculosis H37 Rv ATCC 27294
Antimycobacterial activity against rifampicin and rifabutin resistant Mycobacterium tuberculosis
Antimycobacterial activity against rifampicin and rifabutin sensitive Mycobacterium tuberculosis
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294
Antitubercular activity against Mycobacterium tuberculosis 90-221387
Antimicrobial activity against Mycobacterium tuberculosis at pH 6.8 by broth microdilution test
Antimicrobial activity against Mycobacterium tuberculosis at pH 6 by broth microdilution test
Antimicrobial activity against Mycobacterium tuberculosis H37Rv in 7H9 broth
Antimicrobial activity against Mycobacterium tuberculosis H37Rv infected in mouse J774A.1 macrophages
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 by microplate alamar blue assay
Antimycobacterial activity against para-aminosalicylic acid-resistant Mycobacterium tuberculosis H37Rv ATCC 35821 by microplate alamar blue assay
Antimycobacterial activity against cycloserine-resistant Mycobacterium tuberculosis H37Rv ATCC 35826 by microplate alamar blue assay
Antimycobacterial activity against kanamycin-resistant Mycobacterium tuberculosis H37Rv ATCC 35827 by microplate alamar blue assay
Antimycobacterial activity against pyrazinamide-resistant Mycobacterium tuberculosis H37Rv ATCC 35828 by microplate alamar blue assay
Antimycobacterial activity against thiacetazone-resistant Mycobacterium tuberculosis H37Rv ATCC 35829 by microplate alamar blue assay
Antimycobacterial activity against ethionamide-resistant Mycobacterium tuberculosis H37Rv ATCC 35830 by microplate alamar blue assay
Antimycobacterial activity against ethambutol-resistant Mycobacterium tuberculosis H37Rv ATCC 35837 by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium bovis BCG NCTC 5692
Antimycobacterial activity against Mycobacterium bovis BCG NCTC 5692 with ethR-knockout mutant
Antimicrobial activity against Mycobacterium tuberculosis H190
Antimicrobial activity against Mycobacterium tuberculosis H160
Antimicrobial activity against Mycobacterium tuberculosis H37Rv
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra by microplate Alamar Blue assay
Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in aerobic condition assessed as bacterial density after 7 days
Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in anaerobic condition assessed as bacterial density after 10 days
Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in aerobic condition assessed by relative light units after 7 days
Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in anaerobic condition assessed as relative light unit after 11 days by LORA assay
Antimycobacterial activity against Mycobacterium tuberculosis 331/88 after 14 days
Antimycobacterial activity against Mycobacterium tuberculosis 331/88 after 21 days
Antimicrobial activity against Mycobacterium tuberculosis My 331/88 after 14 days
Antimicrobial activity against Mycobacterium tuberculosis My 331/88 after 21 days
Antituberculosis activity against Mycobacterium tuberculosis H37Rv by microplate alamar blue assay
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis CIBIN 687 isolates
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis CIBIN 650 isolates
Antimycobacterial activity against streptomycin and isoniazid-resistant Mycobacterium tuberculosis CIBIN 675 isolates
"Antimycobacterial activity against streptomycin, isoniazid, rifampicin, pyrazinamide-resistant Mycobacterium tuberculosis CIBIN 234 isolates"
"Antimycobacterial activity against streptomycin, isoniazid, ethambutol-resistant Mycobacterium tuberculosis CIBIN 112 isolates"
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 6 days by colorimetric microassay
Antitubercular activity against Mycobacterium tuberculosis H37Rv by MABA assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv by microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv by BACTEC method
Antitubercular activity against Mycobacterium tuberculosis H37Rv by agar dilution assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv after 18 hrs by agar plate dilution method
Antibacterial activity against isoniazid-resistant Mycobacterium tuberculosis H37Rv after 18 hrs by agar plate dilution method
Antibacterial activity against rifampicin-resistant Mycobacterium tuberculosis H37Rv after 18 hrs by agar plate dilution method
Antibacterial activity against Mycobacterium tuberculosis H37Rv by micro plate alamar blue assay
Antituberculosis activity against Mycobacterium tuberculosis H37Rv by Microplate Alamar Blue Assay
Tuberculostatic activity against Mycobacterium tuberculosis H37Rv
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by broth micro dilution assay
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis by broth dilution assay
Antimicrobial activity against Mycobacterium tuberculosis after 20 hrs by broth microdilution method
Antibacterial activity against Mycobacterium tuberculosis H37Rv after 2 weeks by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis A-1-1 after 2 weeks by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis A-1-2 after 2 weeks by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis A-1-3 after 2 weeks by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis A-2-5 after 2 weeks by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis A-3-1 after 2 weeks by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis A-3-2 after 2 weeks by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis A-3-5 after 2 weeks by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis A-3-6 after 2 weeks by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis A-3-9 after 2 weeks by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis A-3-11 after 2 weeks by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis A-3-12 after 2 weeks by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis A-3-15 after 2 weeks by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis A-3-16 after 2 weeks by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis A-3-17 after 2 weeks by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis A-3-19 after 2 weeks by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis A-3-20 after 2 weeks by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis A-3-21 after 2 weeks by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis A-3-22 after 2 weeks by broth dilution method
Antimycobacterial activity against isoniazide resistant Mycobacterium tuberculosis A-2-1 after 2 weeks by broth dilution method
Antimycobacterial activity against isoniazide-rifampicin resistant Mycobacterium tuberculosis A-2-3 after 2 weeks by broth dilution method
Antimycobacterial activity against rifampicin resistant Mycobacterium tuberculosis A-2-4 after 2 weeks by broth dilution method
Antimycobacterial activity against isoniazide-rifampicin-streptomycin-ethambutol-resistant Mycobacterium tuberculosis A-2-6 after 2 weeks by broth dilution method
Antimycobacterial activity against streptomycin resistant Mycobacterium tuberculosis A-3-47 after 2 weeks by broth dilution method
Antimycobacterial activity against streptomycin resistant Mycobacterium tuberculosis A-4-8 after 2 weeks by broth dilution method
Antimycobacterial activity against isoniazide-streptomycin resistant Mycobacterium tuberculosis A-4-25 after 2 weeks by broth dilution method
Antimycobacterial activity against isoniazide-rifampicin-ethambutol-resistant Mycobacterium tuberculosis A-4-30 after 2 weeks by broth dilution method
Antimycobacterial activity against isoniazide-rifampicin-streptomycin-ethambutol-resistant Mycobacterium tuberculosis C-1-29 after 2 weeks by broth dilution method
Antimycobacterial activity against isoniazide-rifampicin-streptomycin-ethambutol-resistant Mycobacterium tuberculosis E-1-40 after 2 weeks by broth dilution method
Antimycobacterial activity against isoniazide-rifampicin-ethambutol-resistant Mycobacterium tuberculosis J-1-19 after 2 weeks by broth dilution method
Antimycobacterial activity against isoniazide resistant Mycobacterium tuberculosis K-3-6 after 2 weeks by broth dilution method
Antimycobacterial activity against isoniazide-rifampicin-streptomycin-ethambutol-resistant Mycobacterium tuberculosis M-1-32 after 2 weeks by broth dilution method
Antimycobacterial activity against isoniazide-rifampicin-ethambutol-resistant Mycobacterium tuberculosis N-4-11 after 2 weeks by broth dilution method
Antimycobacterial activity against isoniazide-rifampicin-streptomycin-ethambutol-resistant Mycobacterium tuberculosis N-5-2 after 2 weeks by broth dilution method
Antimycobacterial activity against isoniazide-rifampicin-streptomycin-ethambutol-resistant Mycobacterium tuberculosis P-1-50 after 2 weeks by broth dilution method
Antimycobacterial activity against isoniazide-rifampicin-streptomycin-ethambutol-resistant Mycobacterium tuberculosis P-4-11after 2 weeks by broth dilution method
Antimycobacterial activity against isoniazide-rifampicin-streptomycin-ethambutol-resistant Mycobacterium tuberculosis Q-4-1 after 2 weeks by broth dilution method
Antimycobacterial activity against isoniazide-rifampicin-streptomycin-ethambutol-resistant Mycobacterium tuberculosis R-1-38 after 2 weeks by broth dilution method
Antimycobacterial activity against isoniazide-rifampicin-streptomycin-ethambutol-resistant Mycobacterium tuberculosis S-1-14 after 2 weeks by broth dilution method
Antimycobacterial activity against isoniazide-rifampicin-streptomycin-ethambutol-resistant Mycobacterium tuberculosis U-2-15 after 2 weeks by broth dilution method
Antimycobacterial activity against isoniazide-rifampicin-streptomycin-ethambutol-resistant Mycobacterium tuberculosis U-4-6 after 2 weeks by broth dilution method
Antimycobacterial activity against isoniazide-rifampicin-streptomycin-ethambutol-resistant Mycobacterium tuberculosis V-1-16 after 2 weeks by broth dilution method
Antimycobacterial activity against isoniazide-rifampicin-streptomycin-ethambutol-resistant Mycobacterium tuberculosis Z-1-2 after 2 weeks by broth dilution method
Antimycobacterial activity against isoniazide-rifampicin-streptomycin-ethambutol-resistant Mycobacterium tuberculosis Z-1-4 after 2 weeks by broth dilution method
Antibacterial activity against Mycobacterium tuberculosis
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by agar dilution method using double dilution technique
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis by agar dilution method using double dilution technique
Antibacterial activity against Mycobacterium tuberculosis H37Rv by dilution method
Antibacterial activity against Mycobacterium tuberculosis H160 by dilution method
Antibacterial activity against Mycobacterium tuberculosis H190 by dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra
Antibacterial activity against Mycobacterium tuberculosis H37Rv by Alamar blue assay
Antimycobacterial activity against multi-drug-resistant Mycobacterium tuberculosis by agar dilution method
Antibacterial activity against Mycobacterium tuberculosis ATTC 27294 after 5 days by MABA assay
Antitubercular activity against actively growing Mycobacterium tuberculosis H37Rv by microplate alamar blue assay
Antitubercular activity against non-replicating Mycobacterium tuberculosis H37Rv by LORA
Antimycobacterial activity against Mycobacterium tuberculosis by agar dilution method
Antibacterial activity against Mycobacterium tuberculosis H37Rv by nitrate reductase assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by broth microdilution alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv by Agar dilution method
Antimicrobial activity against Mycobacterial tuberculosis H37Rv
Antibacterial activity against Mycobacterium tuberculosis H37Rv by microdilution resazurin assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv after 24 hrs
Antimicrobial activity against Mycobacterium tuberculosis H37Rv assessed per disk after 24 hrs
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis by agar dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Ra by alamar blue microplate assay
Antituberculosis activity against Mycobacterium tuberculosis H37Ra by microplate alamar blue assay
Antimicrobial activity against Mycobacterium tuberculosis
Antitubercular activity against Mycobacterium tuberculosis H37Rv under aerobic conditions
Antitubercular activity against Mycobacterium tuberculosis H37Rv by agar dilution method
Antimicrobial activity against Mycobacterium tuberculosis ATCC 2729411 by Almar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by micro-broth dilution method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv subculture 5 with wild type katG mutation in absence of catalase activity
Antimicrobial activity against Mycobacterium tuberculosis H37Rv subculture 1 with wild type katG mutation
Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis by agar dilution method
Antimicrobial activity against multidrug resistant Mycobacterium tuberculosis
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra by Alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by BACTEC 460 radiorespirometric assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by radiometric BACTEC 460 system
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by BACTEC 460 radiometric assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by broth microdilution assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv by alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Ra by microplate Alamar blue assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv by alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv micro-dilution Resazurin assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv by agar dilution method
Antimicrobial activity against Mycobacterium tuberculosis H160 by agar dilution method
Antimicrobial activity against Mycobacterium tuberculosis H190 by agar dilution method
Antitubercular activity against Mycobacterium bovis BCG
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra after 4 days by MTT assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by MTT assay after 4 days by MTT assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by microplate alamar blue assay
Antimicrobial activity against Mycobacterium bovis BCG by NCCLS M7-A6 method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by microplate alamar blue assay
Antimycobacterial activity against rifampin and isoniazid-susceptible Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 days by Alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 4 days by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv by low oxygen recovery assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv by microplate alamar blue assay
Antitubercular activity against replicating form of Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by microplate alamar blue assay
Antitubercular activity against non replicating persistent form of Mycobacterium tuberculosis H37Rv ATCC 27294 after 10 days by LORA
Antitubercular activity against rifampin-resistant Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by microplate alamar blue assay
Antitubercular activity against isoniazid-resistant Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by microplate alamar blue assay
Antitubercular activity against streptomycin-resistant Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by microplate alamar blue assay
Antitubercular activity against replicating form of Mycobacterium tuberculosis
Antitubercular activity against non replicating persistent form of Mycobacterium tuberculosis
Antibacterial activity against Mycobacterium tuberculosis H37Rv by agar dilution method
Antibacterial activity against multidrug-resistant Mycobacterium tuberculosis by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis CNCTC My 331/88 after 21 days by micromethod
Antimycobacterial activity against Mycobacterium tuberculosis CNCTC My 331/88 after 14 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 7357/98 after 14 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 7357/98 after 21 days by micromethod
Antimycobacterial activity against isoniazid and streptomycin-resistant Mycobacterium tuberculosis 4166/04 after 14 days by micromethod
Antimycobacterial activity against isoniazid and streptomycin-resistant Mycobacterium tuberculosis 4166/04 after 21 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 4977/03 after 14 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 4977/03 after 21 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 550/04 after 14 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 550/04 after 21 days by micromethod
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 4 weeks by serial twofold dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by Microplate Alamar blue assay
Antimicrobial activity against Mycobacterium tuberculosis infected in human monocytes
Antitubercular activity against Mycobacterium tuberculosis H37Ra after 5 days by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 24 hrs by agar microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis by middle-brook 7H10 agar proportion method
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra by alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by radiorespirometric bioassay
Antimicrobial activity against recombinant Mycobacterium bovis BCG expressing pMV361 lux after 5 days by luciferase assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 3 days by radiorespirometric assay
Antimycobacterial activity against Mycobacterium tuberculosis ATCC 27294 in radiometric culture by NCCLS method
Antitubercular activity against Mycobacterium tuberculosis H37Ra after 4 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra after 4 days by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv by microplate alamar blue assay
Antimicrobial activity against Mycobacterium tuberculosis H37Ra
Antimycobacterial activity against Mycobacterium tuberculosis 103471
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis
Antimycobacterial activity against Mycobacterium tuberculosis clinical isolates by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by microplate Alamar blue assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATTC 27294 by alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as drug level causing 90% growth inhibition after 7 days by microbroth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by resazurin method
"Antimycobacterial activity against isoniazid, rifampicin and streptomycin-resistant Mycobacterium tuberculosis after 7 days by resazurin method"
"Antimycobacterial activity against isoniazid, rifampicin and ethambutol-resistant Mycobacterium tuberculosis after 7 days by resazurin method"
Antimycobacterial activity against non-replicating Mycobacterium tuberculosis assessed as luciferase activity incubated for 8 days measured after 24 hrs of incubation by low oxygen recover assay
Antimycobacterial activity against wild type Mycobacterium tuberculosis H37Rv ATCC 27294 after 2 weeks
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 4 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium bovis BCG by alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by radiometric method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 21 to 28 days by two fold agar dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by microplate Alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Ra ATCC 25177 after 4 days by microtiter plate alamar blue technique
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 21 days by broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra by Microplate Alamar Blue Assay
Antitubercular activity against Mycobacterium bovis BCG under aerobic condition after 7 days by MTT method
Antitubercular activity against Mycobacterium bovis BCG under hypoxic condition after 14 days by MTT method
Antitubercular activity against Mycobacterium tuberculosis H37Ra under aerobic condition after 7 days by MTT method
Antitubercular activity against Mycobacterium tuberculosis H37Ra under hypoxic condition after 14 days by MTT method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 25618 after 14 days
Antitubercular activity against ethambutol-resistant Mycobacterium tuberculosis H37Rv ATCC 35837 after 14 days
Antitubercular activity against isoniazid-resistant Mycobacterium tuberculosis H37Rv ATCC 35822 after 14 days
Antitubercular activity against rifampicin-resistant Mycobacterium tuberculosis H37Rv ATCC 35838 after 14 days
Antitubercular activity against streptomycin-resistant Mycobacterium tuberculosis H37Rv ATCC 35820 after 14 days
Antitubercular activity against Mycobacterium tuberculosis Kurono ATCC 35812 after 14 days
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 4 weeks by agar dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 2 weeks
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 2 weeks by agar dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 2 days by mycobacteria growth indicator tube system
Antituberculosis activity against Mycobacterium tuberculosis
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 21 days by broth dilution assay
Antimicrobial activity against Mycobacterium tuberculosis after 8 days in aerobic condition by alamar blue assay
Antimicrobial activity against Mycobacterium tuberculosis after 11 days under anaerobic condition by luminescence-based low oxygen recovery assay
Antimycobacterial activity against pan-susceptible Mycobacterium tuberculosis H37Rv
Antimycobacterial activity against mono-rifampin-resistant Mycobacterium tuberculosis TN675
Antimycobacterial activity against pan-susceptible Mycobacterium tuberculosis TN913
Antimycobacterial activity against mono-rifampin-resistant Mycobacterium tuberculosis TN994
Antimycobacterial activity against pan-susceptible Mycobacterium tuberculosis TN1008
Antimycobacterial activity against pan-susceptible Mycobacterium tuberculosis TN1037
Antimycobacterial activity against pan-susceptible Mycobacterium tuberculosis TN1040
Antimycobacterial activity against pan-susceptible Mycobacterium tuberculosis TN1051
Antimycobacterial activity against pan-susceptible Mycobacterium tuberculosis TN1082
Antimycobacterial activity against pan-susceptible Mycobacterium tuberculosis TN2351
Antimycobacterial activity against pan-susceptible Mycobacterium tuberculosis TN2524
Antimycobacterial activity against pan-susceptible Mycobacterium tuberculosis TN3183
Antimycobacterial activity against pan-susceptible Mycobacterium tuberculosis TN3979
Antimycobacterial activity against pan-susceptible Mycobacterium tuberculosis TN4259
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis TN565
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis TN576
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis TN702
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis TN715
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis TN768
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis TN772
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis TN1195
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis TN1314
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis TN1618
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis TN1811
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis TN2557
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 3 to 42 days
Antimycobacterial activity against rifampin-resistant Mycobacterium tuberculosis after 3 to 42 days
Antimycobacterial activity against isoniazid and streptomycin-resistant Mycobacterium tuberculosis after 3 to 42 days
Antimycobacterial activity against ethambutol-resistant Mycobacterium tuberculosis after 3 to 42 days
Antimycobacterial activity against pyrazinamide-resistant Mycobacterium tuberculosis after 3 to 42 days
Antimycobacterial activity against Mycobacterium tuberculosis
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 14 days
Antimycobacterial activity against Mycobacterium tuberculosis ATCC 35838 after 14 days
Antimycobacterial activity against Mycobacterium tuberculosis ATCC 35822 after 14 days
Antimycobacterial activity against Mycobacterium tuberculosis ATCC 35837 after 14 days
Antimycobacterial activity against Mycobacterium tuberculosis ATCC 35820 after 14 days
Antimycobacterial activity against Mycobacterium tuberculosis ATCC 35812 after 14 days
Antimicrobial activity against drug-susceptible Mycobacterium tuberculosis isolate by alamar blue assay
Antimicrobial activity against isoniazid-resistant Mycobacterium tuberculosis isolate by alamar blue assay
Antimicrobial activity against multidrug-resistant Mycobacterium tuberculosis isolate by alamar blue assay
Antimicrobial activity against Mycobacterium tuberculosis H37Ra by Microplate Alamar blue assay
Antimicrobial activity against Mycobacterium tuberculosis H37Ra by microplate alamar blue assay
Antituberculosis activity against Mycobacterium tuberculosis H37Rv after 24 hrs by alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by radiorespirometric bioassay
Antibacterial activity against Mycobacterium tuberculosis by standard broth microdilution technique
Antimicrobial activity against Mycobacterium tuberculosis H37Rv by Alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 21 to 28 days by twofold agar dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by radiometric respiratory technique
Antimicrobial activity against Mycobacterium bovis BCG after 4 days by alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 14 days by turbidimetric assay
Antitubercular activity against isoniazid-resistant Mycobacterium tuberculosis after 14 days by turbidimetric assay
Antitubercular activity against streptomycin-resistant Mycobacterium tuberculosis after 14 days by turbidimetric assay
Antitubercular activity against rifampicin-resistant Mycobacterium tuberculosis after 14 days by turbidimetric assay
Antitubercular activity against pyrazinamide-resistant Mycobacterium tuberculosis after 14 days by turbidimetric assay
Antitubercular activity against Beijing W multidrug resistant Mycobacterium tuberculosis after 14 days by turbidimetric assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 5 to 8 days
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 6 days by MTT reduction assay
Antimycobacterial activity against log-phase culture of Mycobacterium tuberculosis H37Rv by agar dilution method
Antimycobacterial activity against 6-week-starved culture of Mycobacterium tuberculosis H37Rv by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 21 days by agar proportion method
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 5 days by microplate alamar blue assay
Antimycobacterial activity against log phase culture of Mycobacterium tuberculosis H37Rv by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 2517-infected hollow fiber system based in vitro pharmacokinetic-pharmacodynamic tuberculosis model
Antimycobacterial activity against wild-type Mycobacterium tuberculosis H37Rv ATCC 25618 expressing VV16 plasmid by colorimetric resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 25618 overexpressing ethA gene by colorimetric resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis isolate Mt103 expressing VV16 plasmid by colorimetric resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis MT1K ISO-R22 mutant overexpressing ethA gene by colorimetric resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis MT1K ISO-R33 mutant overexpressing ethA gene by colorimetric resazurin microtiter assay
Antimycobacterial activity against wild-type Mycobacterium tuberculosis H37Rv expressing VV16 plasmid by agar dilution method
Antimycobacterial activity against wild-type Mycobacterium tuberculosis Mt103 expressing VV16 plasmid by agar dilution method
Antimicrobial activity against drug-susceptible Mycobacterium tuberculosis isolate after 2 to 4 weeks by two fold dilution method
Antimicrobial activity against multidrug-resistant Mycobacterium tuberculosis isolate after 2 to 4 weeks by two fold dilution method
Antimycobacterial activity against Mycobacterium tuberculosis CNCTC My 331/88 after 14 days
Antimycobacterial activity against Mycobacterium tuberculosis CNCTC My 331/88 after 21 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 6 weeks
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 24 hrs by microplate alamar blue assay
Antibacterial activity against Mycobacterium bovis BCG after 14 days by spot-culture growth inhibition assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv by microplate Alamar blue assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv after 9 to 12 days by CLSI microbroth dilution technique
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 2 weeks by proportion method
Antimycobacterial activity against multi drug-resistant Mycobacterium tuberculosis
Antimicrobial activity against avirulent Mycobacterium tuberculosis H37Ra
Antituberculosis activity against Mycobacterium tuberculosis by bactec 460 TB method
Antituberculosis activity against Mycobacterium tuberculosis by bactec MGIT 960 method
Antituberculosis activity against linezolid-resistant Mycobacterium tuberculosis having mutation in 23S rRNA with identical G to T base pair exchange at position 2061
Antituberculosis activity against linezolid-resistant Mycobacterium tuberculosis having mutation in 23S rRNA with G to T base pair exchange at position 2576
Antituberculosis activity against linezolid-resistant Mycobacterium tuberculosis without mutation in 23S rRNA
Antitubercular activity against Mycobacterium tuberculosis H37Ra by green fluorescent protein microplate assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra after 24 hrs by microplate alamar Blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv by microdilution resazurin assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv in 7H9 liquid medium after 7 days
Antimycobacterial activity against Mycobacterium bovis var. bovis BCG in 7H9 liquid medium after 7 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv in 7H11 solid medium after 7 days
Antimycobacterial activity against Mycobacterium bovis var. bovis BCG in 7H11 solid medium after 7 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 8 days in absence of BSA
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 8 days in presence of 0.04 to 5 mg/mL of BSA
Antitubercular activity against Mycobacterium tuberculosis isolate UC0801 by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis isolate UC0802 by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis isolate UC0803 by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis isolate UC0804 by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 21 days by agar proportion method
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra after 5 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by agar microdilution assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 5 to 8 days by BACTEC radiometric assay
Antimycobacterial against Mycobacterium tuberculosis H37Rv by agar dilution method
Antimycobacterial against multidrug resistant Mycobacterium tuberculosis by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis by microplate blue alamar assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 14 days by serial dilution technique
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 21 days by serial dilution technique
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 30 days by serial dilution technique
Antitubercular activity against Mycobacterium tuberculosis H37Rv by broth dilution method
Antitubercular activity against Mycobacterium tuberculosis Erdman by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by BACTEC radiometric respiratory technique
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 days by microplate Alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 to 7 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis CIB99 after 5 to 7 days by microplate alamar blue assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 528 after 5 to 7 days by microplate alamar blue assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 160 after 5 to 7 days by microplate alamar blue assay
"Antimycobacterial activity against multidrug-resistant, ethambutol-sensitive Mycobacterium tuberculosis 401 after 5 to 7 days by microplate alamar blue assay"
"Antimycobacterial activity against multidrug-resistant, ethambutol-sensitive Mycobacterium tuberculosis 494 after 5 to 7 days by microplate alamar blue assay"
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 411 after 5 to 7 days by microplate alamar blue assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 331 after 5 to 7 days by microplate alamar blue assay
"Antimycobacterial activity against multidrug-resistant, streptomycin-sensitive Mycobacterium tuberculosis 429 after 5 to 7 days by microplate alamar blue assay"
"Antimycobacterial activity against multidrug-resistant, pyrazinamide-sensitive Mycobacterium tuberculosis 366 after 5 to 7 days by microplate alamar blue assay"
"Antimycobacterial activity against streptomycin, rifampicin, pyrazinamide-sensitive isoniazid, ethambutol-resistant Mycobacterium tuberculosis 363 after 5 to 7 days by microplate alamar blue assay"
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 332 after 5 to 7 days by microplate alamar blue assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 535 after 5 to 7 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv at pH 6.8 by Alamar blue susceptibility assay
Antitubercular activity against replicating Mycobacterium tuberculosis
Antitubercular activity against non replicating Mycobacterium tuberculosis
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 30 days by agar microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 25618 after 7 days
Antitubercular activity against drug-sensitive Mycobacterium tuberculosis by radiometric BACTEC460 method
"Antitubercular activity against isoniazid, rifampin, ethambutol, streptomycin-resistant Mycobacterium tuberculosis by radiometric BACTEC460 method"
"Antitubercular activity against isoniazid, rifampin-resistant Mycobacterium tuberculosis by radiometric BACTEC460 method"
Antitubercular activity against Mycobacterium tuberculosis H37Ra after 7 days
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 28 days by agar dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv in aerobic condition after 7 days by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv in anaerobic condition after 7 days by low oxygen recovery assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 16 to 24 hrs by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv expressing pFCA-luxAB after 10 days by luminescence-based low-oxygen recovery assay
Antituberculosis activity against Mycobacterium tuberculosis H37Rv by broth dilution method
Antimycobacterial activity against drug-susceptive Mycobacterium tuberculosis isolate A-1-1 by agar proportion method
Antimycobacterial activity against drug-susceptive Mycobacterium tuberculosis isolate A-1-2 by agar proportion method
Antimycobacterial activity against drug-susceptive Mycobacterium tuberculosis isolate A-3-5 by agar proportion method
Antimycobacterial activity against drug-susceptive Mycobacterium tuberculosis isolate A-3-11 by agar proportion method
Antimycobacterial activity against drug-susceptive Mycobacterium tuberculosis isolate A-3-12 by agar proportion method
Antimycobacterial activity against drug-susceptive Mycobacterium tuberculosis isolate A-3-13 by agar proportion method
Antimycobacterial activity against drug-susceptive Mycobacterium tuberculosis isolate A-3-15 by agar proportion method
Antimycobacterial activity against drug-susceptive Mycobacterium tuberculosis isolate A-3-16 by agar proportion method
Antimycobacterial activity against drug-susceptive Mycobacterium tuberculosis isolate A-3-20 by agar proportion method
Antimycobacterial activity against drug-susceptive Mycobacterium tuberculosis isolate A-3-21 by agar proportion method
Antimycobacterial activity against drug-susceptive Mycobacterium tuberculosis isolate A-3-22 by agar proportion method
Antimycobacterial activity against drug-susceptive Mycobacterium tuberculosis isolate A-3-9 by agar proportion method
Antimycobacterial activity against drug-susceptive Mycobacterium tuberculosis isolate A-1-3 by agar proportion method
Antimycobacterial activity against drug-susceptive Mycobacterium tuberculosis isolate A-2-5 by agar proportion method
Antimycobacterial activity against drug-susceptive Mycobacterium tuberculosis isolate A-3-1 by agar proportion method
Antimycobacterial activity against drug-susceptive Mycobacterium tuberculosis isolate A-3-2 by agar proportion method
Antimycobacterial activity against drug-susceptive Mycobacterium tuberculosis isolate A-3-6 by agar proportion method
Antimycobacterial activity against drug-susceptive Mycobacterium tuberculosis isolate A-3-17 by agar proportion method
Antimycobacterial activity against drug-susceptive Mycobacterium tuberculosis isolate A-3-19 by agar proportion method
Antimycobacterial activity against streptomycin-resistant Mycobacterium tuberculosis isolate A-3-47 by agar proportion method
Antimycobacterial activity against streptomycin-resistant Mycobacterium tuberculosis isolate A-4-8 by agar proportion method
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis isolate A-2-1 by agar proportion method
"Antimycobacterial activity against isoniazid, rifampicin-resistant Mycobacterium tuberculosis isolate A-2-3 by agar proportion method"
"Antimycobacterial activity against isoniazid, rifampicin-resistant Mycobacterium tuberculosis isolate J-1-19 by agar proportion method"
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate K-3-6 by agar proportion method
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate M-1-32 by agar proportion method
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate N-4-11 by agar proportion method
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate N-5-2 by agar proportion method
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate P-1-50 by agar proportion method
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate P-4-11 by agar proportion method
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate Q-4-1 by agar proportion method
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate R-1-38 by agar proportion method
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate U-2-15 by agar proportion method
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate U-4-6 by agar proportion method
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate Z-1-4 by agar proportion method
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate A-2-6 by agar proportion method
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis isolate A-2-4 by agar proportion method
"Antimycobacterial activity against isoniazid, streptomycin-resistant Mycobacterium tuberculosis isolate A-4-25 by agar proportion method"
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 16 to 24 hrs by microplate alamar
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv expressing pFCA-luxAB after 10 days by low-oxygen recovery assay
Antimycobacterial activity against rifampin-resistant Mycobacterium tuberculosis H37Rv after 16 to 24 hrs by microplate alamar
Antimycobacterial activity against streptomycin-resistant Mycobacterium tuberculosis H37Rv after 16 to 24 hrs by microplate alamar
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis H37Rv after 16 to 24 hrs by microplate alamar
Antimycobacterial activity against Mycobacterium tuberculosis XDR infected in MDBK by BACTEC analysis
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv infected in MDBK by BACTEC analysis
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 21 days by broth macrodilution method
Antituberculosis activity against Mycobacterium tuberculosis H37Rv by microbroth dilution assay
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis ATCC 35838 by twofold agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by twofold agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis CIP 103471 by twofold agar dilution method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as minimum inhibitory concentration after 24 hrs by micro plate Alamar blue assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv in african green monkey Vero cells by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 16 to 24 hrs by microplate alamar blue assay
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 10 to 14 days by broth microdilution assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 10 to 14 days by BACTEC assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv by BACTEC460 radiometric susceptibility assay
Antimicrobial activity against Mycobacterium tuberculosis Erdman
Antitubercular activity against Mycobacterium tuberculosis H37Rv at pH 6.8 by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv at pH 6 by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 72 hrs by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 28 hrs by low oxygen recovery assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv by microplate Alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv by low-oxygen-recovery assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by resazurin assay
Antimycobacterial activity against Mycobacterium tuberculosis 331/88 after 14 days by micromethod
Antimycobacterial activity against Mycobacterium tuberculosis 331/88 after 21 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate 7357/98 after 14 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate 7357/98 after 21 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate 9449/06 after 14 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate 9449/06 after 21 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate 2092/05 after 14 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate 2092/05 after 21 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate Praha 1 after 14 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate Praha 1 after 21 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate Praha 128 after 14 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate Praha 128 after 21 days by micromethod
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by microbroth dilution method
Antituberculosis activity against Mycobacterium tuberculosis H37Rv after 4 days by alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv by radiometric method
Antitubercular activity against Mycobacterium tuberculosis H37Rv infected in human U937 cells by radiometric method
Antituberculosis activity against Mycobacterium tuberculosis H37Ra after 4 days by Alamar blue assay
Antituberculosis activity against Mycobacterium tuberculosis H37Rv after 7 days by resazurin microtiter assay
Antitubercular activity against Mycobacterium tuberculosis H37Ra ATCC 27294 after 4 days by microplate alamar blue assay
Antibacterial activity against Mycobacterium tuberculosis H37Ra by Green fluorescent protein microplate assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 24 hrs by broth microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra by microplate Alamar blue assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by microplate Almar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra after 4 days by almar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by low oxygen recovery assay
Antituberculosis activity against Mycobacterium tuberculosis H37Rv after 4 weeks by agar slant proportion method
Antituberculosis activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 4 days by microplate alamar blue assay
Antituberculosis activity against Mycobacterium tuberculosis H37Ra by green fluorescent protein microplate assay
Antituberculosis activity against Mycobacterium tuberculosis Erdman by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 in GAS medium after 1 week by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 in GAST medium after 1 week by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated 10 days under anaerobic condition measured after 24 hrs recovery in air by luciferase based low oxygen recovery assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by BACTEC 460
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 21 days by broth dilution assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 25618 by BACTEC 460 radiometric method
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis XDR 173 by BACTEC 460 radiometric method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by resazurine microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 2 weeks
Antitubercular activity against Mycobacterium bovis BCG after 7 days by alamar blue assay
Antimycobacterial activity against Mycobacterium bovis BCG under aerobic condition
Antimycobacterial activity against Mycobacterium bovis BCG under dormancy-inducing hypoxic condition
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv under aerobic condition
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv under dormancy-inducing hypoxic condition
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 48 hrs by green fluorescent protein-based assay
Antituberculosis activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 2 weeks by microbroth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis CNCTC My 331/88 after 14 days by microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis CNCTC My 331/88 after 21 days by microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis 09710 after 72 hrs by serial double dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 72 hrs by serial double dilution method
Antituberculosis activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days using resazurin dye by broth microdilution assay
Antituberculosis activity against multi drug-resistant Mycobacterium tuberculosis after 7 days using resazurin dye by broth microdilution assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 24 hrs after 4 weeks
Antimicrobial activity aagainst Mycobacterium tuberculosis ATCC 14468 in log phase by agar dilution method
Antimicrobial activity aagainst Mycobacterium tuberculosis ATCC 14468 in starved phase by agar dilution method
Antimicrobial activity against wild type Mycobacterium tuberculosis 210 after 4 weeks by 7H agar proportion method
Antimicrobial activity against wild type Mycobacterium tuberculosis 210 after 4 weeks by Bactec 460TB method
Antimicrobial activity against wild type Mycobacterium tuberculosis 8C1 after 4 weeks by 7H agar proportion method
Antimicrobial activity against wild type Mycobacterium tuberculosis 8C1 after 4 weeks by Bactec 460TB method
Antimicrobial activity against wild type Mycobacterium tuberculosis 8C2 after 4 weeks by 7H agar proportion method
Antimicrobial activity against wild type Mycobacterium tuberculosis 8C2 after 4 weeks by Bactec 460TB method
Antimicrobial activity against wild type Mycobacterium tuberculosis 8C3 after 4 weeks by Bactec 460TB method
Antimicrobial activity against Mycobacterium tuberculosis 8C5 harboring embC13 CGG-CTG(Arg-Leu) mutation in embCAB gene after 4 weeks by 7H agar proportion method
Antimicrobial activity against Mycobacterium tuberculosis 8C5 harboring embC13 CGG-CTG(Arg-Leu) mutation in embCAB gene after 4 weeks by Bactec 460TB method
Antimicrobial activity against wild type Mycobacterium tuberculosis 8C6 after 4 weeks by 7H agar proportion method
Antimicrobial activity against wild type Mycobacterium tuberculosis 8C6 after 4 weeks by Bactec 460TB method
Antimicrobial activity against Mycobacterium tuberculosis 8C7 harboring embB445 CAG-CGG(Gln-Arg) mutation in embCAB gene after 4 weeks by 7H agar proportion method
Antimicrobial activity against Mycobacterium tuberculosis 8C7 harboring embB445 CAG-CGG(Gln-Arg) mutation in embCAB gene after 4 weeks by Bactec 460TB method
Antimicrobial activity against Mycobacterium tuberculosis 16C6 harboring embB320 TTC-TTG(phe-Leu) mutation in embCAB gene after 4 weeks by 7H agar proportion method
Antimicrobial activity against Mycobacterium tuberculosis 16C6 harboring embB320 TTC-TTG(phe-Leu) mutation in embCAB gene after 4 weeks by Bactec 460TB method
Antimicrobial activity against Mycobacterium tuberculosis 16C7 harboring embB445 CAG-CGG(Gln-Arg) mutation in embCAB gene after 4 weeks by Bactec 460TB method
Antimicrobial activity against Mycobacterium tuberculosis 16C9 harboring embB497 CAG-CGG(Gln-Arg) mutation in embCAB gene after 4 weeks by Bactec 460TB method
Antimicrobial activity against wild type Mycobacterium tuberculosis 16C10 after 4 weeks by 7H agar proportion method
Antimicrobial activity against wild type Mycobacterium tuberculosis 16C10 after 4 weeks by Bactec 460TB method
Antimicrobial activity against Mycobacterium tuberculosis 16C11 harboring embB397 CCG-TCG(Pro-Ser) mutation in embCAB gene after 4 weeks by 7H agar proportion method
Antimicrobial activity against Mycobacterium tuberculosis 16C11 harboring embB397 CCG-TCG(Pro-Ser) mutation in embCAB gene after 4 weeks by Bactec 460TB method
Antimicrobial activity against wild type Mycobacterium tuberculosis 16C12 after 4 weeks by 7H agar proportion method
Antimicrobial activity against wild type Mycobacterium tuberculosis 16C12 assessed as inhibition of growth after 4 weeks by Bactec 460TB method
Antimicrobial activity against Mycobacterium tuberculosis 16C14 harboring embB445 CAG-CGG(Gln-Arg) mutation in embCAB gene after 4 weeks by 7H agar proportion method
Antimicrobial activity against Mycobacterium tuberculosis 16C14 harboring embB445 CAG-CGG(Gln-Arg) mutation in embCAB gene after 4 weeks by Bactec 460TB method
Antimicrobial activity against Mycobacterium tuberculosis 16C15 harboring embB497 CAG-CGG(Gln-Arg) mutation in embCAB gene after 4 weeks by Bactec 460TB method
Antimicrobial activity against Mycobacterium tuberculosis 16C16 harboring embB1024 GAC-AAC(Asp-Asn) mutation in embCAB gene after 4 weeks by 7H agar proportion method
Antimicrobial activity against Mycobacterium tuberculosis 16C16 harboring embB1024 GAC-AAC(Asp-Asn) mutation in embCAB gene after 4 weeks by Bactec 460TB method
Antimicrobial activity against Mycobacterium tuberculosis 32C1 harboring embB445 CAG-CGG(Gln-Arg) mutation in embCAB gene after 4 weeks by 7H agar proportion method
Antimicrobial activity against Mycobacterium tuberculosis 32C1 harboring embB445 CAG-CGG(Gln-Arg) mutation in embCAB gene after 4 weeks by Bactec 460TB method
Antimicrobial activity against Mycobacterium tuberculosis 32C2 harboring embB497 CAG-CGG(Gln-Arg) mutation in embCAB gene after 4 weeks by Bactec 460TB method
Antimicrobial activity against Mycobacterium tuberculosis 32C3 harboring embB497 CAG-CGG(Gln-Arg) mutation in embCAB gene after 4 weeks by Bactec 460TB method
Antimicrobial activity against Mycobacterium tuberculosis 32C4 harboring embB497 CAG-CGG(Gln-Arg) mutation in embCAB gene after 4 weeks by Bactec 460TB method
Antimicrobial activity against Mycobacterium tuberculosis 32C5 harboring embB324 GGC-CGC(Gly-Arg) mutation in embCAB gene after 4 weeks by 7H agar proportion method
Antimicrobial activity against Mycobacterium tuberculosis 32C5 harboring embB324 GGC-CGC(Gly-Arg) mutation in embCAB gene after 4 weeks by Bactec 460TB method
Antimicrobial activity against wild type Mycobacterium tuberculosis 210 after 4 weeks
Antimicrobial activity against Mycobacterium tuberculosis NJT210CGG harboring embB497 CAG-CGG(Gln-Arg) mutation in embB gene after 4 weeks
Antimicrobial activity against wild type Mycobacterium tuberculosis NJT210CGG-CAG after 4 weeks
Antimicrobial activity against Mycobacterium tuberculosis NJT210GCC harboring embB406 GGC-GCC(Gly-Ala) mutation in embB gene after 4 weeks
Antimicrobial activity against Mycobacterium tuberculosis NJT210GAC harboring embB406 GGC-GAC(Gly-Asp) mutation in embB gene after 4 weeks
Antimicrobial activity against Mycobacterium tuberculosis NJT210TGC harboring embB406 GGC-TGC(Gly-Cys) mutation in embB gene after 4 weeks
Antimicrobial activity against Mycobacterium tuberculosis NJT210TCC harboring embB406 GGC-TCC(Gly-Ser) mutation in embB gene after 4 weeks
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by low oxygen recovery assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra by green fluorescent protein-based fluorescent assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv by 7H9 broth dilution method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv by 7H10 broth dilution method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv isolate LV13 expressing ATP synthase atpE I66M mutant protein by 7H9 broth dilution method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv isolate LV13 expressing ATP synthase atpE I66M mutant protein by 7H10 broth dilution method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv isolate BK12 expressing ATP synthase atpE A63P mutant protein by 7H9 broth dilution method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv isolate BK12 expressing ATP synthase atpE A63P mutant protein by 7H10 broth dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 days by resazurin microtiter assay
Antitubercular activity against rifampicin-resistant Mycobacterium tuberculosis H37Rv ATCC 35338 after 7 days by resazurin microtiter assay
Antitubercular activity against isoniazid-resistant Mycobacterium tuberculosis H37Rv ATCC 35822 after 7 days by resazurin microtiter assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 24 hrs by BACTEC radiometric susceptibility assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after up to 28 days
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 6 weeks
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis H37Rv after 6 weeks
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 3 to 4 weeks by broth microdilution assay
Antibacterial activity against rifampicin-resistant Mycobacterium tuberculosis after 7 days by microplate alamar blue assay
Antibacterial activity against isoniazid-resistant Mycobacterium tuberculosis after 7 days by microplate alamar blue assay
Antibacterial activity against streptomycin-resistant Mycobacterium tuberculosis after 7 days by microplate alamar blue assay
Antibacterial activity against kanamycin-resistant Mycobacterium tuberculosis after 7 days by microplate alamar blue assay
Antibacterial activity against clofazimine-resistant Mycobacterium tuberculosis after 7 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra after 24 hrs by microtiter alamar blue assay
"Antimycobacterial activity against isoniazid, rifampin and streptomycin-resistant Mycobacterium tuberculosis M3 after 24 hrs by microtiter alamar blue assay"
"Antimycobacterial activity against isoniazid, rifampin, ethambutol and streptomycin-resistant Mycobacterium tuberculosis M4 after 24 hrs by microtiter alamar blue assay"
"Antimycobacterial activity against isoniazid, rifampin and streptomycin-resistant Mycobacterium tuberculosis M5 after 24 hrs by microtiter alamar blue assay"
Antimycobacterial activity against isoniazid and rifampin-resistant Mycobacterium tuberculosis M6 after 24 hrs by microtiter alamar blue assay
"Antimycobacterial activity against isoniazid, rifampin, ethambutol and streptomycin-resistant Mycobacterium tuberculosis M8 after 24 hrs by microtiter alamar blue assay"
Antimycobacterial activity against isoniazid and rifampin-resistant Mycobacterium tuberculosis M11 after 24 hrs by microtiter alamar blue assay
"Antimycobacterial activity against isoniazid, rifampin and ethambutol-resistant Mycobacterium tuberculosis M16 after 24 hrs by microtiter alamar blue assay"
"Antimycobacterial activity against isoniazid, rifampin, ethambutol and streptomycin-resistant Mycobacterium tuberculosis M21 after 24 hrs by microtiter alamar blue assay"
Antimycobacterial activity against isoniazid and rifampin -resistant Mycobacterium tuberculosis M22 after 24 hrs by microtiter alamar blue assay
Antimycobacterial activity against isoniazid and rifampin -resistant Mycobacterium tuberculosis M27 after 24 hrs by microtiter alamar blue assay
"Antimycobacterial activity against isoniazid, rifampin, ethambutol, streptomycin, ofloxacin and ciprofloxacin-resistant Mycobacterium tuberculosis M46 after 24 hrs by microtiter alamar blue assay"
"Antimycobacterial activity against isoniazid, rifampin, ethambutol, streptomycin, ofloxacin and ciprofloxacin-resistant Mycobacterium tuberculosis M48 after 24 hrs by microtiter alamar blue assay"
"Antimycobacterial activity against isoniazid, rifampin, ethambutol, streptomycin, ofloxacin and ciprofloxacin-resistant Mycobacterium tuberculosis M53 after 24 hrs by microtiter alamar blue assay"
Antimycobacterial activity against Pan-sensitive Mycobacterium tuberculosis H37Ra after 24 hrs by microtiter alamar blue assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by microplate alamar blue assay
Antibacterial activity against multidrug-resistant Mycobacterium tuberculosis H37Rv carrying luxAB incubated for 10 days under low oxygen followed by 28 hrs normoxic recovery by low-oxygen-recovery assay
Antimicrobial activity against multidrug-resistant Mycobacterium tuberculosis H37Rv
Antimicrobial activity against drug-susceptible Mycobacterium tuberculosis H37Rv
Antimicrobial activity against multidrug-resistant Mycobacterium tuberculosis isolate 1 expressing atpE Glu61Asp mutant selected after 10 times MIC drug exposure
Antimicrobial activity against multidrug-resistant Mycobacterium tuberculosis isolate 1 expressing wild type atpE selected after 10 times MIC drug exposure
Antimicrobial activity against multidrug-resistant Mycobacterium tuberculosis isolate 1 expressing atpE Glu63Asp mutant selected after 30 times MIC drug exposure
Antimicrobial activity against multidrug-resistant Mycobacterium tuberculosis isolate 2 expressing atpE Ala28Val mutant selected after 10 times MIC drug exposure
Antimicrobial activity against multidrug-resistant Mycobacterium tuberculosis isolate 2 expressing atpE Glu61Asp mutant selected after 10 times MIC drug exposure
Antimicrobial activity against multidrug-resistant Mycobacterium tuberculosis isolate 2 expressing wild type atpE selected after 10 times MIC drug exposure
Antimicrobial activity against multidrug-resistant Mycobacterium tuberculosis isolate 3 expressing wild type atpE selected after 10 times MIC drug exposure
Antimicrobial activity against multidrug-resistant Mycobacterium tuberculosis isolate 3 expressing wild type atpE and F0 operon selected after 10 times MIC drug exposure
Antimicrobial activity against multidrug-resistant Mycobacterium tuberculosis isolate 3 expressing wild type atpE and ATP synthase selected after 10 times MIC drug exposure
Antimicrobial activity against multidrug-resistant Mycobacterium tuberculosis isolate 3 expressing wild type atpE selected after 30 times MIC drug exposure
Antimicrobial activity against multidrug-resistant Mycobacterium tuberculosis isolate 3 expressing wild type atpE and F0 operon selected after 30 times MIC drug exposure
Antimicrobial activity against multidrug-resistant Mycobacterium tuberculosis isolate 5 expressing wild type atpE selected after 10 times MIC drug exposure
Antimicrobial activity against multidrug-resistant Mycobacterium tuberculosis isolate 5 expressing wild type atpE Ala63Pro mutant selected after 10 times MIC drug exposure
Antimicrobial activity against multidrug-resistant Mycobacterium tuberculosis isolate 5 expressing wild type atpE Ile66Met mutant selected after 30 times MIC drug exposure
Antimicrobial activity against multidrug-resistant Mycobacterium tuberculosis isolate 5 expressing wild type atpE and F0 operon selected after 10 times MIC drug exposure
Antimicrobial activity against drug-susceptible Mycobacterium tuberculosis isolate 4 expressing wild type atpE Asp28Pro mutant selected after 10 times MIC drug exposure
Antimicrobial activity against drug-susceptible Mycobacterium tuberculosis isolate 4 expressing wild type atpE Glu61Asp mutant selected after 10 times MIC drug exposure
Antimicrobial activity against drug-susceptible Mycobacterium tuberculosis isolate 4 expressing wild type atpE selected after 10 times MIC drug exposure
Antimicrobial activity against drug-susceptible Mycobacterium tuberculosis isolate 4 expressing wild type atpE and F0 operon selected after 10 times MIC drug exposure
Antimicrobial activity against drug-susceptible Mycobacterium tuberculosis isolate 4 expressing wild type atpE Glu61Asp mutant selected after 30 times MIC drug exposure
Antimicrobial activity against drug-susceptible Mycobacterium tuberculosis isolate 6 expressing wild type atpE selected after 10 times MIC drug exposure
Antimicrobial activity against drug-susceptible Mycobacterium tuberculosis isolate 6 expressing wild type atpE Glu61Asp mutant selected after 30 times MIC drug exposure
Antimicrobial activity against drug-susceptible Mycobacterium tuberculosis isolate 6 expressing wild type atpE Ala63Pro mutant selected after 30 times MIC drug exposure
Antimicrobial activity against drug-susceptible Mycobacterium tuberculosis isolate 6 expressing wild type atpE selected after 30 times MIC drug exposure
Antimicrobial activity against drug-susceptible Mycobacterium tuberculosis H37Rv expressing wild type atpE selected after 10 times MIC drug exposure
Antimicrobial activity against drug-susceptible Mycobacterium tuberculosis Mycobacterium tuberculosis H37Rv expressing wild type atpE and F0 operon selected after 10 times MIC drug exposure
Antimicrobial activity against drug-susceptible Mycobacterium tuberculosis H37Rv expressing wild type atpE Ala63Pro mutant selected after 30 times MIC drug exposure
Antimicrobial activity against drug-susceptible Mycobacterium tuberculosis H37Rv expressing wild type atpE selected after 30 times MIC drug exposure
Antimicrobial activity against Mycobacterium tuberculosis H37Rv by macrodilution method
Antimicrobial activity against vancomycin-resistant Mycobacterium tuberculosis
Antitubercular activity against Mycobacterium tuberculosis H37Rv by twofold dilution method
Antimycobacterial activity against drug-susceptible Mycobacterium tuberculosis after 21 days by agar dilution method
Antimycobacterial activity against quinolone-resistant multidrug-resistant Mycobacterium tuberculosis after 21 days by agar dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv by resazurin microtiter assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv after 5 to 7 days by alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by agar microdilution method
Antimicrobial activity against Mycobacterium tuberculosis ATCC 35802
Antimicrobial activity against pansusceptible Mycobacterium tuberculosis isolate 1
Antimicrobial activity against pansusceptible Mycobacterium tuberculosis isolate 2
Antimicrobial activity against pansusceptible Mycobacterium tuberculosis isolate 3
Antimicrobial activity against pansusceptible Mycobacterium tuberculosis isolate 4
Antimicrobial activity against pansusceptible Mycobacterium tuberculosis isolate 5
Antimicrobial activity against pansusceptible Mycobacterium tuberculosis isolate 6
Antimicrobial activity against pansusceptible Mycobacterium tuberculosis isolate 7
Antimicrobial activity against streptomycin-resistant Mycobacterium tuberculosis isolate 8
Antimicrobial activity against multidrug-resistant Mycobacterium tuberculosis isolate 9
Antimicrobial activity against quinolone-resistant Mycobacterium tuberculosis isolate 10
Antimicrobial activity against quinolone-resistant Mycobacterium tuberculosis isolate 11
Antimicrobial activity against quinolone-resistant Mycobacterium tuberculosis isolate 12
Antimicrobial activity against Mycobacterium tuberculosis isolate 13 isolated from Beijing
Antimicrobial activity against pansusceptible Mycobacterium tuberculosis isolate 14
Antimicrobial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 16
Antimicrobial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 17
Antimicrobial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 18
Antimicrobial activity against multidrug-resistant Mycobacterium tuberculosis isolate 19
Antimicrobial activity against multidrug drug-resistant Mycobacterium tuberculosis isolate 20
Antimicrobial activity against isoniazid-resistant Mycobacterium tuberculosis isolate 15
Antimycobacterial activity against Mycobacterium tuberculosis CIP 103471 after 3 to 28 days by twofold dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 3 to 28 days by twofold dilution method
Antimycobacterial activity against rifampin-resistant Mycobacterium tuberculosis after 3 to 28 days by twofold dilution method
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis after 3 to 28 days by twofold dilution method
Antimicrobial activity against wild-type Mycobacterium bovis BCG by microplate Alamar blue assay
"Antimicrobial activity against Mycobacterium tuberculosis infected in patient at 1000 mg/day, po administered for 7 days by HPLC"
"Antimicrobial activity against Mycobacterium tuberculosis infected in patient at 400 mg/day, po administered for 7 days by HPLC"
Antimicrobial activity against drug-sensitive Mycobacterium tuberculosis
Antimicrobial activity against drug-resistant Mycobacterium tuberculosis
Antimycobacterial activity against Mycobacterium tuberculosis isolate 210 at 37 degC after 10 to 11 days by radiometric Bactec 460TB method
Antimycobacterial activity against Mycobacterium tuberculosis isolate NJT210 expressing embB codon 306 ATA mutant at 37 degC after 10 to 11 days by radiometric Bactec 460TB method
Antimycobacterial activity against Mycobacterium tuberculosis isolate NJT210 expressing embB codon 306 ATC mutant at 37 degC after 10 to 11 days by radiometric Bactec 460TB method
Antimycobacterial activity against Mycobacterium tuberculosis isolate NJT210 expressing embB codon 306 CTG mutant at 37 degC after 10 to 11 days by radiometric Bactec 460TB method
Antimycobacterial activity against Mycobacterium tuberculosis isolate NJT210 expressing embB codon 306 GTG mutant at 37 degC after 10 to 11 days by radiometric Bactec 460TB method
Antimycobacterial activity against Mycobacterium tuberculosis isolate NJT210 expressing embB codon 306 ATC-ATG mutant at 37 degC after 10 to 11 days by radiometric Bactec 460TB method
Antimycobacterial activity against Mycobacterium tuberculosis isolate NJT210 expressing embB codon 306 CTG-ATG mutant at 37 degC after 10 to 11 days by radiometric Bactec 460TB method
"Antimycobacterial activity against isoniazid, rifampin, ethambutol resistant Mycobacterium tuberculosis isolate 5310 at 37 degC after 3 to 4 weeks by radiometric Bactec 460TB method"
"Antimycobacterial activity against isoniazid, rifampin, ethambutol resistant Mycobacterium tuberculosis isolate NJT5310 expressing embB codon 306 ATG mutant at 37 degC after 3 to 4 weeks by radiometric Bactec 460TB method"
"Antimycobacterial activity against isoniazid, rifampin, ethambutol resistant Mycobacterium tuberculosis isolate NJT5310 expressing embB codon 306 ATG-ATA mutant at 37 degC after 3 to 4 weeks by radiometric Bactec 460TB method"
"Antimycobacterial activity against isoniazid, rifampin, ethambutol resistant Mycobacterium tuberculosis isolate NJT5310 expressing embB codon 306 ATG-ATC mutant at 37 degC after 3 to 4 weeks by radiometric Bactec 460TB method"
"Antimycobacterial activity against isoniazid, rifampin, ethambutol resistant Mycobacterium tuberculosis isolate NJT5310 expressing embB codon 306 ATG-CTG mutant at 37 degC after 3 to 4 weeks by radiometric Bactec 460TB method"
"Antimycobacterial activity against isoniazid, rifampin, ethambutol resistant Mycobacterium tuberculosis isolate NJT5310 expressing embB codon 306 ATG-GTG mutant at 37 degC after 3 to 4 weeks by radiometric Bactec 460TB method"
"Antimycobacterial activity against rifampin, ethambutol resistant Mycobacterium tuberculosis isolate 30167 at 37 degC after 3 to 4 weeks by radiometric Bactec 460TB method"
"Antimycobacterial activity against rifampin, ethambutol resistant Mycobacterium tuberculosis isolate NJT30167 expressing embB codon 306 ATG mutant at 37 degC after 3 to 4 weeks by radiometric Bactec 460TB method"
"Antimycobacterial activity against rifampin, ethambutol resistant Mycobacterium tuberculosis isolate 5041 at 37 degC after 3 to 4 weeks by radiometric Bactec 460TB method"
"Antimycobacterial activity against rifampin, ethambutol resistant Mycobacterium tuberculosis isolate A2558 at 37 degC after 3 to 4 weeks by radiometric Bactec 460TB method"
Antimycobacterial activity against ethambutol resistant Mycobacterium tuberculosis isolate NJT210EMB-R-C1 assessed as bacterial colony formation at 37 degC after 10 to 11 days by radiometric Bactec 460TB method
Antimycobacterial activity against ethambutol resistant Mycobacterium tuberculosis isolate NJT210EMB-R-C2 assessed as bacterial colony formation at 37 degC after 10 to 11 days by radiometric Bactec 460TB method
Antimycobacterial activity against ethambutol resistant Mycobacterium tuberculosis isolate NJT210EMB-R-C3 assessed as bacterial colony formation at 37 degC after 10 to 11 days by radiometric Bactec 460TB method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv after 30 days by agar microdilution method
Antibacterial activity against Mycobacterium tuberculosis H37Rv by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis Beijing by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis B74 harboring embB GAC-GGC (D300G) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis Rv7 harboring embB ATG-GTG (M306V) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis Rv18 harboring embB ATG-GTG (M306V) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis B55 harboring embB ATG-GTG (M306V) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis B59 harboring embB ATG-GTG (M306V) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis Rv8 harboring embB ATG-GTG (M306V) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis Rv17 harboring embB ATG-GTG (M306V) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis Rv23 harboring embB ATG-GTG (M306V) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis B52 harboring embB ATG-GTG (M306V) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis B56 harboring embB ATG-GTG (M306V) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis B64 harboring embB ATG-GTG (M306V) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis Rv44 harboring embB ATG-ATA (M306I) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis B54 harboring embB ATG-ATA (M306I) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis B85 harboring embB ATG-ATA (M306I) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis B95 harboring embB ATG-ATA (M306I) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis B84 harboring embB ATG-ATC (M306I) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis B97 harboring embB ATG-ATC (M306I) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis B70 harboring embB ATG-ATC (M306I) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis Rv11 harboring embB ATG-CTG (M306L) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis B51 harboring embB ATG-ACG (M306T) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis B68 harboring embB TTC-TTA (F320L) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis Rv10 harboring embB TTC-CTC (F320L) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis B71 harboring embB TTC-CTC (F320L) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis B99 harboring embB CGC-CAC (R321H) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis Rv39 harboring embB GGC-CGC (G324R) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis B79 harboring embB GGC-CGC (G324R) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis Rv21 harboring embB GAT-TAT (D328Y) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis Rv31 harboring embB GAT-TAT (D328Y) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis B53 harboring embB GAT-TAT (D328Y) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis B96 harboring embB GAT-TAT (D328Y) mutation in embB by modified conventional agar proportion method
Antibacterial activity against Mycobacterium tuberculosis B92 harboring embB GAC-GCC (D354A) mutation in embB by modified conventional agar proportion method
Antibacterial activity against HYG cassette-negative EMB-resistant Mycobacterium tuberculosis Rv8 harboring embB M306V mutant gene by modified conventional agar proportion method
Antibacterial activity against HYG cassette-positive Mycobacterium tuberculosis Rv8100 by modified conventional agar proportion method
Antibacterial activity against HYG cassette-positive Mycobacterium tuberculosis Rv8101 by modified conventional agar proportion method
Antibacterial activity against HYG cassette-positive Mycobacterium tuberculosis Rv8102 harboring embB M306V mutant gene by modified conventional agar proportion method
Antibacterial activity against HYG cassette-negative EMB-resistant Mycobacterium tuberculosis Rv44 harboring embB M306I mutant gene by modified conventional agar proportion method
Antibacterial activity against HYG cassette-positive Mycobacterium tuberculosis Rv4400 by modified conventional agar proportion method
Antibacterial activity against HYG cassette-positive Mycobacterium tuberculosis Rv4401 by modified conventional agar proportion method
Antibacterial activity against HYG cassette-positive Mycobacterium tuberculosis Rv4402 harboring embB M306I mutant gene by modified conventional agar proportion method
Antibacterial activity against HYG cassette-negative EMB-resistant Mycobacterium tuberculosis B52 harboring embB M306V mutant gene by modified conventional agar proportion method
Antibacterial activity against HYG cassette-positive Mycobacterium tuberculosis B5200 by modified conventional agar proportion method
Antibacterial activity against HYG cassette-positive Mycobacterium tuberculosis B5201 by modified conventional agar proportion method
Antibacterial activity against HYG cassette-positive Mycobacterium tuberculosis B5202 harboring embB M306V mutant gene by modified conventional agar proportion method
Antibacterial activity against HYG cassette-negative EMB-resistant Mycobacterium tuberculosis B54 harboring embB M306I mutant gene by modified conventional agar proportion method
Antibacterial activity against HYG cassette-positive Mycobacterium tuberculosis B5400 by modified conventional agar proportion method
Antibacterial activity against HYG cassette-positive Mycobacterium tuberculosis B5401 by modified conventional agar proportion method
Antibacterial activity against HYG cassette-positive Mycobacterium tuberculosis B5402 harboring embB M306I mutant gene by modified conventional agar proportion method
Antibacterial activity against HYG cassette-negative Mycobacterium tuberculosis H37Rv by modified conventional agar proportion method
Antibacterial activity against HYG cassette-positive Mycobacterium tuberculosis RvAS1 harboring embB M306V mutant gene by modified conventional agar proportion method
Antibacterial activity against HYG cassette-positive Mycobacterium tuberculosis RvAS2 harboring embB M306V mutant gene by modified conventional agar proportion method
Antibacterial activity against HYG cassette-positive Mycobacterium tuberculosis RvAS3 harboring embB M306I mutant gene by modified conventional agar proportion method
Antibacterial activity against HYG cassette-positive Mycobacterium tuberculosis RvAS4 harboring embB M306I mutant gene by modified conventional agar proportion method
Antibacterial activity against HYG cassette-positive Mycobacterium tuberculosis RvAS9 by modified conventional agar proportion method
Antibacterial activity against HYG cassette-negative Mycobacterium tuberculosis Beijing by modified conventional agar proportion method
Antibacterial activity against HYG cassette-positive Mycobacterium tuberculosis BAS5 harboring embB M306V mutant gene by modified conventional agar proportion method
Antibacterial activity against HYG cassette-positive Mycobacterium tuberculosis BAS6 harboring embB M306V mutant gene by modified conventional agar proportion method
Antibacterial activity against HYG cassette-positive Mycobacterium tuberculosis BAS7 harboring embB M306I mutant gene by modified conventional agar proportion method
Antibacterial activity against HYG cassette-positive Mycobacterium tuberculosis BAS8 harboring embB M306I mutant gene by modified conventional agar proportion method
Antibacterial activity against HYG cassette-positive Mycobacterium tuberculosis BAS10 by modified conventional agar proportion method
Growth inhibition of Mycobacterium tuberculosis H37 by radiometric BACTEC 460 assay
Growth inhibition of multidrug resistance Mycobacterium tuberculosis 2745/09
Antitubercular activity against Mycobacterium tuberculosis H37Rv by MABA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv by LORA method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv 331/88 after 14 days by micromethod
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv 331/88 after 21 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 357/2005 after 14 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 357/2005 after 21 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 53/2009 after 14 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 53/2009 after 21 days by micromethod
Antimycobacterial activity against extensively drug resistant Mycobacterium tuberculosis Praha 1 after 14 days by micromethod
Antimycobacterial activity against extensively drug resistant Mycobacterium tuberculosis Praha 1 after 21 days by micromethod
Antimycobacterial activity against extensively drug resistant Mycobacterium tuberculosis Praha 131 after 14 days by micromethod
Antimycobacterial activity against extensively drug resistant Mycobacterium tuberculosis Praha 131 after 21 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 362/1998 after 14 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 362/1998 after 21 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 9449/2007 after 14 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 9449/2007 after 21 days by micromethod
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis
Antitubercular activity against Mycobacterium tuberculosis by agar dilution method
Antitubercular activity against multi drug-resistant Mycobacterium tuberculosis clinical isolate after 30 days by agar microdilution method
Antitubercular activity against extensively drug-resistant Mycobacterium tuberculosis clinical isolate after 30 days by agar microdilution method
Antitubercular activity against RMF-resistant Mycobacterium tuberculosis clinical isolate1 after 30 days by agar microdilution method
Antitubercular activity against RMF-resistant Mycobacterium tuberculosis clinical isolate2 after 30 days by agar microdilution method
Antitubercular activity against Mycobacterium tuberculosis ATCC 27294 by Alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of colonies after 30 days by agar microdilution method
Antituberculosis activity against Mycobacterium tuberculosis H37Rv after 2 weeks
Antituberculosis activity against Mycobacterium tuberculosis H37Rv F420 mutant after 2 weeks
Antituberculosis activity against Mycobacterium tuberculosis H37Rv Ddn mutant after 2 weeks
Antimicrobial activity against Mycobacterium tuberculosis harboring 259A to P mutation in thymidylate synthase A by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra assessed as inhibition of bacterial growth in log phase by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra assessed as inhibition of bacterial growth in dormant phase
Antimycobacterial activity against Mycobacterium tuberculosis 00-0715 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 03-0738 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 02-2934 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-1647 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-0930 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0757 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0785 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0790 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0791 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0797 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 99-1914 harboring gyrA Asp94Gly mutant gene by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis 02-1975 harboring gyrA Asp94Gly mutant gene by resazurin microtiter assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-2614 harboring gyrA Asp94Gly mutant gene by resazurin microtiter assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-2230 harboring gyrA Asp94Gly mutant gene by resazurin microtiter assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0744 harboring gyrA Asp94Tyr mutant gene by resazurin microtiter assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0810 harboring gyrA Asp94Tyr mutant gene by resazurin microtiter assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0821 harboring gyrA Asp94Tyr mutant gene by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis 04-0649 harboring gyrA Asp94Asn mutant gene by resazurin microtiter assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 02-2399 harboring gyrA Asp94Tyr mutant gene by resazurin microtiter assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 02-0319 harboring gyrA Asp94Ala mutant gene by resazurin microtiter assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-0172 harboring gyrA Asp94Ala mutant gene by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis 08-0787 harboring gyrA Asp94His mutant gene and deletion of codons 678 and 679 in gyrB mutant gene by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis 08-0745 harboring gyrA Asp89Asn mutant gene by resazurin microtiter assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 02-1234 harboring gyrA Asn533Thr gyrB mutant gene by resazurin microtiter assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-2834 by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis 08-0769 harboring gyrA putative promoter mutant gene by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis 08-0771 harboring gyrA putative promoter mutant gene by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis 08-0782 by resazurin microtiter assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0794 harboring gyrA Thr80Ala mutant gene by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis 08-0773 harboring gyrA Pro8Ala mutant gene by resazurin microtiter assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0746 by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis 08-0762 by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis 08-0764 by resazurin microtiter assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0777 by resazurin microtiter assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0779 by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis 08-0789 by resazurin microtiter assay
Antibacterial activity against Mycobacterium tuberculosis H37Ra by by 7H11 agar plate method
Antibacterial activity against Mycobacterium tuberculosis H37Ra by by 7H10 agar plate method
Antibacterial activity against Mycobacterium tuberculosis H37Ra by by BACTEC MGIT 960 method
Antibacterial activity against ethambutol-resistant Mycobacterium tuberculosis H37Ra
Antibacterial activity against isoniazid-resistant Mycobacterium tuberculosis H37Ra
Antibacterial activity against rifampin-resistant Mycobacterium tuberculosis H37Ra
Antibacterial activity against pyrazinamide-resistant Mycobacterium tuberculosis H37Ra
Antibacterial activity against Mycobacterium tuberculosis H37Ra by by 7H9 broth dilution method
Antibacterial activity against Mycobacterium tuberculosis H37Ra by broth microdilution method
Antibacterial activity against Mycobacterium tuberculosis H37Ra by by BACTEC method
Antimicrobial activity against Mycobacterium tuberculosis in human adults with pulmonary tuberculosis at 600 mg administered daily for 7 days
Antimicrobial activity against Mycobacterium tuberculosis in human adults with pulmonary tuberculosis at 600 mg administered twice for 7 days
Antimicrobial activity against Mycobacterium bovis BCG by resazurine microtiter assay
Antimicrobial activity against Mycobacterium bovis BCG by twofold dilution method
Antimicrobial activity against Mycobacterium bovis BCG harboring pPAZ23 carrying p27-p55 operon by twofold dilution method
Antimicrobial activity against Mycobacterium bovis BCG by resazurine microtiter assay in presence of 1 mg/liter CCCP
Antimicrobial activity against Mycobacterium bovis BCG by resazurine microtiter assay in presence of 0.1 mg/liter valinomycin
Antimicrobial activity against Mycobacterium bovis BCG by resazurine microtiter assay in presence of 0.5 mg/liter reserpine
Antimicrobial activity against Mycobacterium bovis BCG harboring pPAZ23 carrying p27-p55 operon by resazurine microtiter assay
Antimicrobial activity against Mycobacterium tuberculosis expressing EmbC gene after 48 hrs
Antimicrobial activity against Mycobacterium tuberculosis expressing EmbC M300L mutant gene after 48 hrs
Antimicrobial activity against Mycobacterium tuberculosis expressing EmbC M300V mutant gene after 48 hrs
Antimicrobial activity against Mycobacterium tuberculosis expressing EmbC T270I mutant gene after 48 hrs
Antimicrobial activity against Mycobacterium tuberculosis expressing EmbC D249G mutant gene after 48 hrs
Antimicrobial activity against Mycobacterium tuberculosis embA gene after 48 hrs by agar proportion method
Antimicrobial activity against Mycobacterium tuberculosis embA V280M gene after 48 hrs by agar proportion method
Antimicrobial activity against Mycobacterium tuberculosis harboring Mycobacterium smegmatis embB gene after 48 hrs by agar proportion method
Antimicrobial activity against Mycobacterium tuberculosis harboring Mycobacterium smegmatis embB M292L mutant gene after 48 hrs by agar proportion method
Antimicrobial activity against Mycobacterium tuberculosis harboring Mycobacterium smegmatis embB M292I mutant gene after 48 hrs by agar proportion method
Antimicrobial activity against Mycobacterium tuberculosis harboring Mycobacterium smegmatis embB M292V mutant gene after 48 hrs by agar proportion method
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra by twofold agar dilution method
Antimycobacterial activity against Mycobacterium bovis BCG after 7 days by broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by serial double dilution technique
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 09710 after 7 days by serial double dilution technique
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis isolate 1
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis isolate 2
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis isolate 3
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis isolate 4
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis isolate 5
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis isolate 6
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis isolate 7
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis isolate 8
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis isolate 9
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis isolate 10
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis isolate 11
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis isolate 12
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis isolate 13
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis isolate 14
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis isolate 15
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis isolate 16
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis isolate 17
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis isolate 18
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis isolate 19
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis isolate 20
Antimycobacterial activity against Mycobacterium bovis BCG carrying pMV261
Antimycobacterial activity against Mycobacterium bovis BCG carrying pMV261::ethA
Antimycobacterial activity against Mycobacterium bovis BCG carrying pMV261::ethR
"Antimycobacterial activity against INH, RFP, EB, LVFX, SPFX, CPFX-resistant Mycobacterium tuberculosis isolate 1"
"Antimycobacterial activity against INH, RFP, EB, LVFX, SPFX, CPFX-resistant Mycobacterium tuberculosis isolate 2"
"Antimycobacterial activity against RFP, EB-resistant Mycobacterium tuberculosis isolate 3"
"Antimycobacterial activity against INH, RFP, EB, LVFX, CPFX-resistant Mycobacterium tuberculosis isolate 4"
"Antimycobacterial activity against INH, RFP, EB, KM, LVFX, SPFX, CPFX-resistant Mycobacterium tuberculosis isolate 5"
"Antimycobacterial activity against INH, RFP, SM, EB, KM, LVFX, SPFX, CPFX-resistant Mycobacterium tuberculosis isolate 6"
Antimycobacterial activity against RFP-resistant Mycobacterium tuberculosis isolate 7
Antimycobacterial activity against RFP-resistant Mycobacterium tuberculosis isolate 8
"Antimycobacterial activity against INH, RFP, KM, LVFX, SPFX, CPFX-resistant Mycobacterium tuberculosis isolate 9"
Antimycobacterial activity against RFP-resistant Mycobacterium tuberculosis isolate 10
"Antimycobacterial activity against INH, RFP, EB, KM, LVFX, SPFX, CPFX-resistant Mycobacterium tuberculosis isolate 11"
"Antimycobacterial activity against INH, RFP, EB-resistant Mycobacterium tuberculosis isolate 12"
"Antimycobacterial activity against INH, RFP, SM, EB-resistant Mycobacterium tuberculosis isolate 13"
"Antimycobacterial activity against INH, RFP, EB-resistant Mycobacterium tuberculosis isolate 14"
"Antimycobacterial activity against INH, RFP, EB, LVFX, SPFX, CPFX-resistant Mycobacterium tuberculosis isolate 15"
"Antimycobacterial activity against INH, RFP, SM, EB, KM, PAS, EVM, LVFX-resistant Mycobacterium tuberculosis isolate 16"
"Antimycobacterial activity against INH, RFP-resistant Mycobacterium tuberculosis isolate 17"
"Antimycobacterial activity against INH, RFP, SM, EB, PAS-resistant Mycobacterium tuberculosis isolate 18"
"Antimycobacterial activity against INH, RFP, SM, EB, PAS, LVFX-resistant Mycobacterium tuberculosis isolate 19"
"Antimycobacterial activity against INH, RFP, ETH-resistant Mycobacterium tuberculosis isolate 20"
Antibacterial activity against Mycobacterium tuberculosis by microplate Alamar Blue assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv by microplate Alamar Blue assay
Antibacterial activity against isoniazid-resistant Mycobacterium tuberculosis by microplate Alamar Blue assay
Antibacterial activity against rifampin-resistant Mycobacterium tuberculosis by microplate Alamar Blue assay
Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis H37Rv by CLSI method
"Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 2301 horboring rpoB S531L, katG R463L/E217G, gyrA D94N/S95T, rrs A1401G by CLSI method"
"Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 2474 horboring rpoB H526Y, katG D329A/R463L, gyrA D94G/S95T, rrs A1401G by CLSI method"
"Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 2911 horboring rpoB D516V, katG S315T/R463L, gyrA D94G/S95T/R128S/Y129C, rrs A1401G by CLSI method"
"Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 625 horboring rpoB S531L/G566R/I569L, katG S315T/R463L, gyrA A90V/S95T, rrs A1401G by CLSI method"
"Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 761 horboring rpoB S531L/Q510P, katG S315T/R463L, gyrA D94N/S95T, rrs G1484T by CLSI method"
Antibacterial activity against thiacetazone-resistant Mycobacterium tuberculosis by microplate Alamar Blue assay
Antibacterial activity against ethambutol-resistant Mycobacterium tuberculosis by microplate Alamar Blue assay
Antibacterial activity against ciprofloxacin-resistant Mycobacterium tuberculosis by microplate Alamar Blue assay
Antibacterial activity against kanamycin-resistant Mycobacterium tuberculosis by microplate Alamar Blue assay
Antibacterial activity against ethionamide-resistant Mycobacterium tuberculosis by microplate Alamar Blue assay
Antibacterial activity against p-aminosalicylic acid-resistant Mycobacterium tuberculosis by microplate Alamar Blue assay
Antibacterial activity against wild-type Mycobacterium bovis BCG by microplate Alamar Blue assay
Antibacterial activity against Mycobacterium bovis BCG harboring fgd gene by microplate Alamar Blue assay
Antibacterial activity against Mycobacterium bovis BCG harboring moaA gene by microplate Alamar Blue assay
Antibacterial activity against Mycobacterium bovis BCG harboring fbiC gene by microplate Alamar Blue assay
Antibacterial activity against Mycobacterium bovis BCG harboring moaD gene by microplate Alamar Blue assay
Antibacterial activity against Mycobacterium bovis BCG harboring pil8 gene by microplate Alamar Blue assay
Antimicrobial activity against Mycobacterium tuberculosis Erdman by microplate Alamar Blue assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv under aerobic conditions
Antibacterial activity against Mycobacterium tuberculosis H37Rv under anaerobic conditions by luciferase based low oxygen recovery assay
Antimicrobial activity against Mycobacterium tuberculosis LAM 7968/03 harboring thyA Thr202Ala single nucleotide polymorphism grown in Lowenstein-Jensen medium
Antimicrobial activity against Mycobacterium tuberculosis LAM 8885/05 harboring thyA Thr202Ala single nucleotide polymorphism grown in Lowenstein-Jensen medium
Antimicrobial activity against Mycobacterium tuberculosis Beijing 1934/03 harboring thyA Thr202Ala single nucleotide polymorphism grown in Lowenstein-Jensen medium
Antimicrobial activity against Mycobacterium tuberculosis Haarlem 9532/03 harboring thyA Thr202Ala single nucleotide polymorphism grown in Lowenstein-Jensen medium
Antimicrobial activity against Mycobacterium tuberculosis H37Rv 9679/00 harboring thyA Thr202Ala single nucleotide polymorphism grown in Lowenstein-Jensen medium
Antimicrobial activity against wild-type Mycobacterium tuberculosis H37Rv by MTT assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv by agar proportion method
Antibacterial activity against multidrug-resistant Mycobacterium tuberculosis harboring gyrA D94A mutation by agar proportion method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv CNCTC My 331/88 after 14 days by microdilution method
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis H37Rv after 7 days by alamar blue assay
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis H37Rv under anaerobic condition after 7 days by GFP reporter gene assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis clinical isolate after 5 days by tetrazolium microplate assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 5 days by tetrazolium microplate assay
Antimicrobial activity against Mycobacterium tuberculosis H37Ra after 11 days by broth microdilution method at pH 6.8
Antimicrobial activity against Mycobacterium tuberculosis H37Ra after 11 days by broth microdilution method at pH 6
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 24 hrs by alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as reduction in CFU count by agar proportion method
Antituberculosis activity against Mycobacterium tuberculosis H37Rv after 7 days by MTT assay
Antituberculosis activity against Mycobacterium tuberculosis MYC5165 harboring InhA mutant gene after 7 days by MTT assay
Antituberculosis activity against Mycobacterium tuberculosis 1400 harboring KatG mutant gene after 7 days by MTT assay
Antimicrobial activity against rifampicin-resistant Mycobacterium tuberculosis
Antimicrobial activity against rifampicin-sensitive Mycobacterium tuberculosis
Antimicrobial activity against multiple drug-resistant Mycobacterium tuberculosis
Antimicrobial activity against compound-susceptible Mycobacterium tuberculosis
Antimicrobial activity against compound-resistant Mycobacterium tuberculosis
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 3 to 4 weeks by microplate alamar blue assay
Antimycobacterial activity against fluoroquinolone-resistant Mycobacterium tuberculosis Beijing genotype isolates without carrying multiple mutation and harboring gyrA A90V mutant gene
Antimycobacterial activity against fluoroquinolone-resistant Mycobacterium tuberculosis Beijing genotype isolates without carrying multiple mutation and harboring gyrA D94A mutant gene
Antimycobacterial activity against fluoroquinolone-resistant Mycobacterium tuberculosis Beijing genotype isolates without carrying multiple mutation and harboring gyrA D94G mutant gene
Antimycobacterial activity against fluoroquinolone-resistant Mycobacterium tuberculosis Beijing genotype isolates without carrying multiple mutation and harboring gyrA D94N mutant gene
Antimycobacterial activity against fluoroquinolone-resistant Mycobacterium tuberculosis Beijing genotype isolates without carrying multiple mutation and harboring gyrA D94Y mutant gene
Antimycobacterial activity against fluoroquinolone-resistant Mycobacterium tuberculosis Beijing genotype isolates without carrying multiple mutation and harboring gyrB D540D mutant gene
Antimycobacterial activity against fluoroquinolone-resistant Mycobacterium tuberculosis Beijing genotype isolates without carrying mutation
Antimycobacterial activity against mixture of fluoroquinolone-resistant and sensitive Mycobacterium tuberculosis Beijing genotype isolates carrying heteropeaks upon sequencing at mutation site and harboring gyrA A90V mutant gene
Antimycobacterial activity against mixture of fluoroquinolone-resistant and sensitive Mycobacterium tuberculosis Beijing genotype isolates carrying heteropeaks upon sequencing at mutation site and harboring gyrA D94A mutant gene
Antimycobacterial activity against mixture of fluoroquinolone-resistant and sensitive Mycobacterium tuberculosis Beijing genotype isolates carrying heteropeaks upon sequencing at mutation site and harboring gyrA D94G mutant gene
Antimycobacterial activity against mixture of fluoroquinolone-resistant and sensitive Mycobacterium tuberculosis Beijing genotype isolates carrying heteropeaks upon sequencing at mutation site and harboring gyrA D94N mutant gene
Antimycobacterial activity against mixture of fluoroquinolone-resistant and sensitive Mycobacterium tuberculosis Beijing genotype isolates carrying heteropeaks upon sequencing at mutation site and harboring gyrA G88A mutant gene
Antimycobacterial activity against mixture of fluoroquinolone-resistant and sensitive Mycobacterium tuberculosis Beijing genotype isolates carrying heteropeaks upon sequencing at mutation site and harboring gyrB D500N mutant gene
Antimycobacterial activity against mixture of fluoroquinolone-resistant and sensitive Mycobacterium tuberculosis Beijing genotype isolates carrying heteropeaks upon sequencing at mutation site and harboring gyrB D540D mutant gene
Antimycobacterial activity against mixture of fluoroquinolone-resistant and sensitive Mycobacterium tuberculosis Beijing genotype isolates carrying heteropeaks upon sequencing
Antimycobacterial activity against mixture of fluoroquinolone-resistant and sensitive Mycobacterium tuberculosis Beijing genotype isolates carrying heteropeaks upon sequencing at mutation site and harboring gyrB A90V and D500A mutant genes
Antimycobacterial activity against mixture of fluoroquinolone-resistant and sensitive Mycobacterium tuberculosis Beijing genotype isolates carrying heteropeaks upon sequencing at mutation site and harboring gyrA A90V and D94A mutant genes
Antimycobacterial activity against mixture of fluoroquinolone-resistant and sensitive Mycobacterium tuberculosis Beijing genotype isolates carrying heteropeaks upon sequencing at mutation site and harboring gyrA A90V and D94G mutant genes
Antimycobacterial activity against mixture of fluoroquinolone-resistant and sensitive Mycobacterium tuberculosis Beijing genotype isolates carrying heteropeaks upon sequencing at mutation site and harboring gyrA D94G and D94A mutant genes
Antimicrobial activity against multidrug-resisntat Mycobacterium tuberculosis by agar dilution method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv after 48 hrs by resazurin microplate broth microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv by LORA assay
Antimycobacterial activity against multidrug-susceptible Mycobacterium tuberculosis H37Rv ATCC 27294 after 4 weeks
Antimicrobial activity against multidrug-resistant Mycobacterium tuberculosis C110/09 after 4 weeks
Antituberculosis activity against Mycobacterium tuberculosis H37Rv by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by resazurin method
Antitubercular activity against drug-sensitive Mycobacterium tuberculosis 2280 after 24 hrs by BACTEC radiometric susceptibility assay
Antitubercular activity against rifampin and isoniazid-resistant Mycobacterium tuberculosis TB-1678/05 after 24 hrs by BACTEC radiometric susceptibility assay
Antitubercular activity against rifampin and isoniazid-resistant Mycobacterium tuberculosis 2643 after 24 hrs by BACTEC radiometric susceptibility assay
Antitubercular activity against ethambutol-resistant Mycobacterium tuberculosis TB-2506/06 after 24 hrs by BACTEC radiometric susceptibility assay
Antitubercular activity against isoniazid-resistant Mycobacterium tuberculosis 433 after 24 hrs by BACTEC radiometric susceptibility assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 24 hrs by BACTEC radiometric susceptibility assay
Antimycobacterial activity against drug-resistant Mycobacterium tuberculosis clinical isolate
Antimycobacterial activity against rifampin and isoniazid-resistant Mycobacterium tuberculosis
Antitubercular activity against Mycobacterium tuberculosis H37Rv by Bactec 460 method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv after 28 days by agar dilution method
Antitubercular activity against replicating Mycobacterium tuberculosis H37Rv ATCC 27294 after 1 week by microplate alamar blue assay
Antitubercular activity against non-replicating Mycobacterium tuberculosis H37Rv ATCC 27294 incubated 10 days under anaerobic condition measured after 28 hrs of recovery in air by luciferase based low oxygen recovery assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis isolate 02TBDM039EP097 after 24 hrs by tetrazolium microplate assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 24 hrs by tetrazolium microplate assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv after 14 days by broth dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 2 weeks by agar plate assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 16 to 24 hrs by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 30 days by agar microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 4 days by MABA assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv transfected with pFPCA-luxAB grown under anaerobic condition for 10 days followed by 24 hrs incubation under aerobic condition by LORA assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 3 weeks by turbidity assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 days by MTT assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 4 days by MABA assay
Antituberculosis activity against Mycobacterium tuberculosis H37Rv after 24 hrs by Lowenstein-Jensen method
Antimycobacterial activity against active log phase Mycobacterium tuberculosis H37Rv by agar dilution method
Antimycobacterial activity against 6-weeks nutrient starved phase cultures of Mycobacterium tuberculosis H37Rv treated for 7 days measured after 4 weeks by agar dilution method
Antituberculosis activity against Mycobacterium tuberculosis H37Rv after 7 days by microbroth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis by whole-cell assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 4 weeks by agar proportion method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 25618 after 10 to 14 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 2 weeks by BACTEC 460 radiometric method
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis after 2 weeks by BACTEC 460 radiometric method
Antitubercular activity against drug sensitive Mycobacterium tuberculosis H37Rv ATCC 27294 by microplate Alamar blue assay
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis CIBIN/UMF15:99 isolate by microplate Alamar blue assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 days by Microplate Alamar blue assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv by Microplate Alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 9 days by resazurin reduction assay
Antitubercular activity against rifampicin-resistant Mycobacterium tuberculosis ATCC 35338 harboring His-526-Tri mutation in rpoB gene after 9 days by resazurin reduction assay
Antitubercular activity against isoniazid-resistant Mycobacterium tuberculosis ATCC 35822 harboring Ser-315-Tri mutation in katG gene after 9 days by resazurin reduction assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 28 days by agar dilution method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by resazurin assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by colony forming unit determination
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis A8 241 after 28 days by colony forming unit determination
Antimicrobial activity against replicating Mycobacterium tuberculosis
Antimicrobial activity against non-replicating Mycobacterium tuberculosis
Antimicrobial activity against Mycobacterium tuberculosis H37Rv after 4 weeks by agar dilution assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv after 11 days using [14]C labeled palmitic acid as substrate by radiometric Bactec 460TB method
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis H37Rv after 28 days by agar dilution method
Antituberculosis activity against 5 x 10'4 inoculum per tube Mycobacterium tuberculosis H37Rv after 24 hrs by Lowenstein-Jensen method
Antibacterial activity against Mycobacterium tuberculosis H37Rv after 18 to 24 hrs by CLSI M100-S17 method
Antituberculosis activity against Mycobacterium tuberculosis H37Rv under aerobic conditions by microplate alamar blue assay
Antituberculosis activity against Mycobacterium tuberculosis H37Rv under anaerobic conditions by fluorescence based low-oxygen-recovery assay
Antituberculosis activity against 10'7 cfu/mL Mycobacterium tuberculosis H37Rv after 28 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by twofold dilution method
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis by two fold serial dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv by two fold serial dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 24 hrs by microplate alamar blue assay
Antitubercular activity against rifampicin and isoniazid-resistant Mycobacterium tuberculosis isolate 2199 after 24 hrs by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 using compound level ranging from 1 to 100 ug/mL after 7 days by resazurin reduction test
"Antimycobacterial activity against isoniazid, rifampicin and ethambuto-resistant Mycobacterium tuberculosis using compound level ranging from 0.3125 to 5 ug/mL after 7 days by resazurin reduction test"
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 using compound level ranging from 0.3125 to 5 ug/mL after 7 days by resazurin reduction test
Antimycobacterial activity against Mycobacterium tuberculosis CNTC My 331/88 ATCC 27294 after 14 days
Antimycobacterial activity against Mycobacterium tuberculosis CNTC My 331/88 ATCC 27294 after 21 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by resazurin based microdilution assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by agar diffusion method
Antimycobacterial activity Mycobacterium tuberculosis H37Rv after 6 days by MTT colorimetric assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 6 days by MTT colorimetric microassay
Antimycobacterial activity against drug-resistant Mycobacterium tuberculosis
Antimycobacterial activity against drug-susceptible Mycobacterium tuberculosis
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 days by microbroth dilution method
Antimycobacterial activity against clinical isolate of Mycobacterium tuberculosis TN675 assessed as intracellular ATP level after 5 days by luminescence assay
Antimycobacterial activity against Mycobacterium tuberculosis TN913 assessed as intracellular ATP level after 5 days by luminescence assay
Antimycobacterial activity against clinical isolate Mycobacterium tuberculosis TN994 assessed as intracellular ATP level after 5 days by luminescence assay
Antimycobacterial activity against Mycobacterium tuberculosis TN1008 assessed as intracellular ATP level after 5 days by luminescence assay
Antimycobacterial activity against Mycobacterium tuberculosis TN1037 assessed as intracellular ATP level after 5 days by luminescence assay
Antimycobacterial activity against Mycobacterium tuberculosis TN1040 assessed as intracellular ATP level after 5 days by luminescence assay
Antimycobacterial activity against Mycobacterium tuberculosis TN1051 assessed as intracellular ATP level after 5 days by luminescence assay
Antimycobacterial activity against Mycobacterium tuberculosis TN1082 assessed as intracellular ATP level after 5 days by luminescence assay
Antimycobacterial activity against Mycobacterium tuberculosis TN2351 assessed as intracellular ATP level after 5 days by luminescence assay
Antimycobacterial activity against Mycobacterium tuberculosis TN2524 assessed as intracellular ATP level after 5 days by luminescence assay
Antimycobacterial activity against Mycobacterium tuberculosis TN3183 assessed as intracellular ATP level after 5 days by luminescence assay
Antimycobacterial activity against Mycobacterium tuberculosis TN3979 assessed as intracellular ATP level after 5 days by luminescence assay
Antimycobacterial activity against Mycobacterium tuberculosis TN4259 assessed as intracellular ATP level after 5 days by luminescence assay
Antimycobacterial activity against Mycobacterium tuberculosis AH9584 assessed as intracellular ATP level after 5 days by luminescence assay
Antimycobacterial activity against Mycobacterium tuberculosis BE11677 assessed as intracellular ATP level after 5 days by luminescence assay
Antimycobacterial activity against Mycobacterium tuberculosis E8133 assessed as intracellular ATP level after 5 days by luminescence assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by resazurin microtiter plate assay
Antimycobacterial activity against Mycobacterium tuberculosis W4 assessed as intracellular ATP level after 5 days by luminescence assay
"Antimycobacterial activity against rifampin, streptomycin, ethambutol, ethionamide, kanamycin and ciprofloxacin-resistant Mycobacterium tuberculosis TN565 assessed as intracellular ATP level after 5 days by luminescence assay"
"Antimycobacterial activity against isoniazid, rifampin, streptomycin, ethambutol, ethionamide and kanamycin-resistant Mycobacterium tuberculosis TN576 assessed as intracellular ATP level after 5 days by luminescence assay"
"Antimycobacterial activity against isoniazid, streptomycin, ethambutol and pyrazinamide-resistant Mycobacterium tuberculosis TN702 assessed as intracellular ATP level after 5 days by luminescence assay"
"Antimycobacterial activity against isoniazid, rifampin, ethambutol and pyrazinamide-resistant Mycobacterium tuberculosis TN715 assessed as intracellular ATP level after 5 days by luminescence assay"
"Antimycobacterial activity against isoniazid, rifampin, streptomycin, ethambutol and ethionamide-resistant Mycobacterium tuberculosis TN768 assessed as intracellular ATP level after 5 days by luminescence assay"
"Antimycobacterial activity against isoniazid, rifampin and ethambutol-resistant Mycobacterium tuberculosis TN772 assessed as intracellular ATP level after 5 days by luminescence assay"
"Antimycobacterial activity against isoniazid, streptomycin and ethambutol-resistant Mycobacterium tuberculosis TN1195 assessed as intracellular ATP level after 5 days by luminescence assay"
Antimycobacterial activity against isoniazid and rifampin-resistant Mycobacterium tuberculosis TN1314 assessed as intracellular ATP level after 5 days by luminescence assay
"Antimycobacterial activity against isoniazid, rifampin, streptomycin, ethambutol, ethionamide, kanamycin and ciprofloxacin-resistant Mycobacterium tuberculosis TN1618 assessed as intracellular ATP level after 5 days by luminescence assay"
"Antimycobacterial activity against isoniazid, rifampin, streptomycin and ethambutol-resistant Mycobacterium tuberculosis TN1811 assessed as intracellular ATP level after 5 days by luminescence assay"
"Antimycobacterial activity against isoniazid, rifampin, streptomycin, ethambutol and capreomycin-resistant Mycobacterium tuberculosis TN2557 assessed as intracellular ATP level after 5 days by luminescence assay"
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as intracellular ATP level after 5 days by luminescence assay
Antituberculosis activity against Mycobacterium tuberculosis H37Ra ATCC 25177 after 6 days using alamar blue dye by broth microdilution assay
"Antimycobacterial activity against Mycobacterium tuberculosis isolate 80,014 expressing rpoB Arg529Lys and Leu530Met mutant gene by resazurin microtiter assay"
Antimycobacterial activity against Mycobacterium tuberculosis isolate 364 expressing rpoB Ser522Leu mutant gene by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis isolate 343 expressing rpoB Asp516Val mutant gene by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis isolate 352 expressing rpoB Asp516Leu and Phe514Phe double mutant gene by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis isolate 363 expressing rpoB Asp516Val mutant gene by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis isolate 344 expressing rpoB Ser522Leu mutant gene by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis isolate 309 expressing rpoB His526Arg mutant gene by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 expressing wild-type rpoB gene by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis isolate 349 expressing rpoB mutant gene by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis isolate 307 expressing rpoB Ser531Leu mutant gene by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis isolate 353 expressing wild-type rpoB gene by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis isolate 311 expressing rpoB mutant gene by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis isolate 361 expressing wild-type rpoB gene by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis isolate 359 expressing wild-type rpoB gene by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by alamar blue assay
Antimycobacterial activity against multiple drug-resistant Mycobacterium tuberculosis isolate T113 by alamar blue assay
Antituberculosis activity against Mycobacterium tuberculosis H37Rv by twofold serial dilution method
Antituberculosis activity against multidrug-resistant Mycobacterium tuberculosis isolate Spec. 192 by twofold serial dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra by green fluorescent protein microplate assay
Antituberculosis activity against drug-sensitive Mycobacterium tuberculosis isolate Spec. 210 by twofold serial dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 days by Resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 45 days
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis by two fold agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by two fold agar dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 to 11 days by microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by microbroth dilution-resazurin assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 harboring pFCA-lux AB gene measured under anaerobic condition after 11 days by luminescence analysis
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 harboring pFCA-lux AB gene measured under aerobic condition after 8 days by luminescence analysis
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 days by resazurin assay
Antitubercular activity against Multidrug-resistant Mycobacterium tuberculosis after 7 days by resazurin assay
Antituberculosis activity against Mycobacterium tuberculosis H37Rv after 7 to 14 days by twofold serial broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by ten-fold serial dilution method
Antituberculosis activity against Mycobacterium tuberculosis H37Rv ATCC 27294
Antituberculosis activity against Mycobacterium tuberculosis isolate A
Antituberculosis activity against isoniazid-resistant Mycobacterium tuberculosis isolate B
Antituberculosis activity against isoniazid-resistant Mycobacterium tuberculosis isolate C
"Antituberculosis activity against isoniazid-, rifampin-resistant Mycobacterium tuberculosis isolate D"
"Antituberculosis activity against isoniazid-, rifampin-,streptomycin-resistant Mycobacterium tuberculosis isolate E"
"Antituberculosis activity against isoniazid-, rifampin-,ethambutol-resistant Mycobacterium tuberculosis isolate F"
"Antituberculosis activity against isoniazid-, rifampin-,ethambutol-resistant Mycobacterium tuberculosis isolate G"
"Antituberculosis activity against isoniazid-, rifampin-, amikacin-, OLF-resistant Mycobacterium tuberculosis isolate H"
"Antituberculosis activity against isoniazid-, rifampin-,kanamycin-,OLF-resistant Mycobacterium tuberculosis isolate I"
"Antituberculosis activity against isoniazid-, rifampin-, amikacin-, OLF-resistant Mycobacterium tuberculosis isolate J"
Antitubercular activity against multi-drug-resistant Mycobacterium tuberculosis H37Rv clinical isolate after 28 days by 10 fold serial dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv CNCTC My 331/88 after 14 days by microdilution panel method
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis MYC5165 after 6 days by MTT assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 6 days by MTT assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 days by microplate alamar blue assay
Antituberculosis activity against Mycobacterium tuberculosis H37Rv by REMA method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv 331/88 after 14 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv 331/88 after 21 days
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 5 days by microplate Alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra after 16 to 24 hrs by alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 16 to 24 hrs by alamar blue assay
Antimycobacterial activity against ethionamide-resistant Mycobacterium tuberculosis H37Rv ATCC 35830 after 16 to 24 hrs by alamar blue assay
Antimycobacterial activity against p-aminosalicylic acid-resistant Mycobacterium tuberculosis H37Rv ATCC 35821 after 16 to 24 hrs by alamar blue assay
Antimycobacterial activity against pyrazinamide-resistant Mycobacterium tuberculosis H37Rv ATCC 35828 after 16 to 24 hrs by alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis after 3 days by Alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by two-fold serial dilution method
Antibacterial activity against non-replicating Mycobacterium tuberculosis H37Rv by low oxygen recovery assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 5 to 7 days under anaerobic condition by microplate dilution assay
Antimycobacterial activity against drug-susceptible Mycobacterium tuberculosis H37Rv measured 24 hrs post dose by microplate alamar blue assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate 44 from Chinese tuberculosis patient measured 24 hrs post dose by microplate alamar blue assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate 83 from Chinese tuberculosis patient measured 24 hrs post dose by microplate alamar blue assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate 164 from Chinese tuberculosis patient measured 24 hrs post dose by microplate alamar blue assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate 431 from Chinese tuberculosis patient measured 24 hrs post dose by microplate alamar blue assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis isolate 926 from Chinese tuberculosis patient measured 24 hrs post dose by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 days by resazurin microtitre assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv grown in glycerol-alanine-salts media
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv grown in iron-deficient glycerol-alanine-salts media
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 28 days
"Antitubercular activity against isoniazid, rifampicin and ethambutol-resistant Mycobacterium tuberculosis clinical isolate after 28 days by agar dilution method"
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 1 days by radiometric growth assay
Antituberculosis activity against Mycobacterium tuberculosis H37Rv by BACTEC MGIT method
Antituberculosis activity against Mycobacterium tuberculosis H37Rv by Lowenstein-Jensen method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 25177after 21 days by BACTEC MGIT 960 method
Antitubercular activity against multi-drug resistant Mycobacterium tuberculosis after 21 days by BACTEC MGIT 960 method
Antitubercular activity against extensively drug-resistant Mycobacterium tuberculosis after 21 days by BACTEC MGIT 960 method
Bactericidal activity against Mycobacterium tuberculosis
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by microplate alamar blue assay
Antibacterial activity against non-replicating Mycobacterium tuberculosis H37Rv ATCC 27294 by low oxygen recovery assay
Antibacterial activity against isoniazid-resistant Mycobacterium tuberculosis H37Rv by microplate alamar blue assay
Antibacterial activity against rifampicin-resistant Mycobacterium tuberculosis H37Rv by microplate alamar blue assay
Antibacterial activity against Mycobacterium bovis BCG by microplate alamar blue assay
Antimicrobial activity against Mycobacterium bovis BCG under aerobic condition for 7 days by MTT assay
Antimicrobial activity against Mycobacterium bovis BCG under dormancy-inducing hypoxic condition for 14 days by MTT assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by MABA method
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 by microbroth dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by agar dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by BACTEC method
Antimycobacterial activity against Mycobacterium bovis BCG after 2 weeks by spot culture growth inhibition assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 2 weeks by spot culture growth inhibition assay
Growth inhibition of Mycobacterium tuberculosis H37Rv
Antibacterial activity against Mycobacterium tuberculosis H37Rv by microbroth dilution method
Antibacterial activity against drug-resistant Mycobacterium tuberculosis 164 by microbroth dilution method
Antibacterial activity against drug-resistant Mycobacterium tuberculosis 926 by microbroth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis My 331/88 after 14 days by micromethod
Antimycobacterial activity against Mycobacterium tuberculosis My 331/88 after 21 days by micromethod
Antitubercular activity against Mycobacterium tuberculosis H37Rv in GAS medium after 4 days by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv in 7H12 medium after 4 days by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv in 7H12 medium incubated for 10 days in anaerobic condition followed by incubation for 48 hrs in aerobic condition by low oxygen recovery assay
Antimycobacterial activity against Mycobacterium bovis BCG
Antitubercular activity against Mycobacterium tuberculosis after 7 to 14 days by microbroth dilution technique
Antimycobacterial activity against Mycobacterium tuberculosis assessed as growth inhibition after 5 days by MABA/resazurin assay
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis ATCC 35822 after 7 days by resazurin microtitre assay
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis ATCC 35338 after 7 days by resazurin microtitre assay
Antimycobacterial activity against pan-susceptible Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by resazurin microtitre assay
Antimycobacterial activity against RIF-resistant Mycobacterium tuberculosis
Antimycobacterial activity against INH-resistant Mycobacterium tuberculosis
Antimycobacterial activity against EMB-resistant Mycobacterium tuberculosis
Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate
"Antimycobacterial activity against isoniazid, rifampicin and ethambutol-resistant Mycobacterium tuberculosis at 0.3125 to 5 ug/mL after 7 days by Resazurin assay"
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 at 0.3125 to 5 ug/mL after 7 days by Resazurin assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 at 1 to 100 ug/mL after 7 days by Resazurin assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv expressing GFP
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 2745/09
Antimycobacterial activity against Mycobacterium tuberculosis 90-221387
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis
Antimycobacterial activity against Mycobacterium tuberculosis isolate no. 246
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by liquid microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H242
Antimycobacterial activity against Mycobacterium tuberculosis Erdman by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv under anaerobic condition
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv isolate WC 51/02
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv isolate WC 64/02
Antimycobacterial activity against Mycobacterium tuberculosis isolate CIBIN/UMF 15:19
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by agar dilution method
Antitubercular activity against log phase culture of Mycobacterium tuberculosis H37Rv ATCC 27294 by agar dilution method
Antimicrobial activity against Mycobacterium tuberculosis str. Erdman by MTT assay
Antimicrobial activity against Mycobacterium tuberculosis CDC1551 by MTT assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv by MTT assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by alamar blue susceptibility assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv by Lowenstein and Jensen method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv by BACTEC MGIT method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis by Bactec TB-460 assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 days by Alamar blue assay
Antituberculosis activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 21 days by BACTEC based radiometric respiratory technique
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis by NCCLS agar dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv by NCCLS agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by microdilution alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv measured twice a week for 3 weeks by Ziehl-Neelsen staining
Antitubercular activity against Mycobacterium tuberculosis H37Rv by agar microdilution method
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis H37Rv ATCC 27294 using alamar blue staining by broth microdilution assay
Antimicrobial activity against Mycobacterium tuberculosis by agar dilution method
Antimicrobial activity against INH-resistant Mycobacterium tuberculosis
Antimicrobial activity against Mycobacterium tuberculosis H37Rv infected macrophage model
Antimicrobial activity against Mycobacterium tuberculosis H4
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 7 days by resazurin microplate assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition by BACTEC MGIT method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 21 days by broth dilution assay method
Antituberculosis activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 12 to 28 days by L-J MIC method
Antitubercular activity against Mycobacterium tuberculosis CSU93
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 21 days by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 6 days by resazurin MIC assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition by Lowenstein-Jensen method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 24 hr by BACTEC-460 radiometric susceptibility assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 21 days by broth dilution assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 28 days by Lowenstein-Jensen agar method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 12 to 28 days by Lowenstein and Jensen agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition measured within 10 days by BACTEC MGIT method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 5 days by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv MTCC 200 assessed as growth inhibition by L.J. MIC method
Antitubercular activity against Mycobacterium tuberculosis H37Rv MTCC 200 assessed as growth inhibition by BACTEC MGIT method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv grown on Lowenstein-Jensen solid medium assessed as growth inhibition measured after 4 weeks
Antimycobacterial activity against MDR Mycobacterium tuberculosis grown in MGIT liquid medium assessed as growth inhibition measured after 4 weeks by BACTEC method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv grown in MGIT liquid medium assessed as growth inhibition measured after 4 weeks by BACTEC method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv grown on Lowenstein-Jensen solid medium assessed as growth inhibition incubated with compound dissolved in ethanol/methanol measured after 4 weeks
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv grown on Lowenstein-Jensen solid medium assessed as growth inhibition incubated with compound dissolved in DMSO measured after 4 weeks
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv grown on Lowenstein-Jensen solid medium assessed as growth inhibition incubated with compound dissolved in water measured after 4 weeks
Antimycobacterial activity against Mycobacterium tuberculosis MTCC 300 assessed as growth inhibition after 24 hr by agar well diffusion method
Antitubercular activity against Mycobacterium tuberculosis H37Rv MTCC 200 after 28 days by micro dilution anti-microbial susceptibility test
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis assessed as growth inhibition at 0.3125 to 5 ug/mL after 7 days by resazurin reduction test
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition at 0.3125 to 5 ug/mL after 7 days by resazurin reduction test
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition at 1 to 100 ug/mL after 7 days by resazurin reduction test
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition by secondary screen assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 5 days by microplate Alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 28 days by Lowenstein-Jensen method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 measured every 24 hr by BACTEC 460 radiometric assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 28 days by agar dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv MTCC 300 after 7 days by Alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC27294 assessed as complete cessation of growth
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv CNCTC My 331/88 after 10 to 14 days by microdilution panel method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition by NCCLS agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 7 days by resazurin method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv after 30 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by agar dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv by microdilution alamar Blue broth assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv by BacTiter-Gl Microbial Cell Viability assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition measured every 24 hrs by BACTEC radiosusceptibility assay
Antitubercular activity against Mycobacterium tuberculosis assessed as growth inhibition
Antibacterial activity against Mycobacterium tuberculosis H37Rv after 2 to 3 weeks by broth microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 12 to 28 days by L.J. agar MIC method
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis clinical isolate assessed as growth inhibition after 5 days by MTT assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 5 days by MTT assay
Antitubercular activity Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 4 weeks
Antimicrobial activity against Mycobacterium tuberculosis H37Rv assessed as drug concentration causing =<1% reduction in bacterial growth incubated for 21 to 30 days by proportion method
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 5 days by fluorescence assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv incubated at 37 degC for 14 days in presence of 40% human serum by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv incubated at 37 degC for 7 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition by radiometric BACTEC assay
Antimicrobial activity against compound-sensitive Mycobacterium tuberculosis 2280 by agar dilution method and BACTEC radiometric method
Antimicrobial activity against rifampicin-resistant and INH-resistant Mycobacterium tuberculosis 1678/05 by agar dilution method and BACTEC radiometric method
Antimicrobial activity against rifampicin-resistant and INH-resistant Mycobacterium tuberculosis 2643 by agar dilution method and BACTEC radiometric method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv by BACTEC radiometric method
Antimycobacterial activity against Mycobacterium bovis BCG after 28 days
Antimycobacterial activity against Mycobacterium tuberculosis after 28 days
Antimycobacterial activity against Mycobacterium tuberculosis assessed as growth inhibition
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 43 assessed as growth inhibition after 45 days by Lowenstein-Jensen method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 45 days by Lowenstein-Jensen method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 12 to 28 days by Lowenstein-Jensen method
Antimycobacterial activity against Mycobacterium tuberculosis ATCC 27294
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 treated 5 days post-infection
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by microbroth dilution method
Antitubercular activity against Mycobacterium tuberculosis XDR-1 assessed as growth inhibition after 2 to 3 weeks by broth microdilution method
Antitubercular activity against rifampicin-resistant Mycobacterium tuberculosis assessed as growth inhibition after 2 to 3 weeks by broth microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 2 to 3 weeks by broth microdilution method
Antimicrobial activity against Bacille Calmette-Guerin
Antimycobacterial activity against pyrazinamide-susceptible Mycobacterium tuberculosis ATCC 35801 assessed as growth inhibition after 24 hrs to 2 weeks by microbroth dilution method
Antimycobacterial activity against pyrazinamide-susceptible Mycobacterium tuberculosis ATCC 27294 assessed as growth inhibition after 24 hrs to 2 weeks by microbroth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 14 days by microdilution method
Antituberculosis activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 12 to 28 days by Lowenstein-Jensen method
Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis in presence of clavulanate
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by broth microdilution method
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis assessed as growth inhibition at 0.3125 to 5 ug/mL by resazurin assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition at 0.3125 to 5 ug/mL by resazurin assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition at 1 to 100 ug/mL by resazurin assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by microdilution plate assay
Antitubercular activity against Mycobacterium tuberculosis H37Ra ATCC 25177 by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis after 8 days by micro plate Alamar Blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 to 8 days by microplate alamar blue assay
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis after 6 weeks
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 4 days by microplate Alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition by luminescence-based low oxygen-recovery assay
Antitubecular activity against Mycobacterium tuberculosis H37Pv assessed as growth inhibition after 4 days by microplate Alamar blue assay
Antitubecular activity against Mycobacterium tuberculosis H37Pv assessed as growth inhibition by low oxygen recovery assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by microplate Alamar Blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 12 to 28 days by Lowenstein-Jensen agar method
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 28 days by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 5 days by microplate Alamar Blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 5 days by broth microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 21 days by micro-broth dilution method
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis IC3 assessed as growth inhibition by BACTEC MGIT 960 method
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis IC2 assessed as growth inhibition by BACTEC MGIT 960 method
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis IC1 assessed as growth inhibition by BACTEC MGIT 960 method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition by micro plate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 24 hrs by agar microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as parasite growth inhibition
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as parasite growth inhibition after 7 days by resazurin microtitre assay
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis ATCC 35338 harboring rpoB His-526-Tir gene mutant after 7 days by REMA assay
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis 1896HF harboring inhA mutant after 7 days by REMA assay
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis ATCC 35822 harboring katG mutant after 7 days by REMA assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by REMA assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv expressing inhA G96V mutant assessed as parasite growth inhibition after 7 days by Alamar Blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv expressing inhA M103L mutant assessed as parasite growth inhibition after 7 days by Alamar Blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv expressing inhA M103I mutant assessed as parasite growth inhibition after 7 days by Alamar Blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as parasite growth inhibition after 7 days by Alamar Blue assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv by two-fold serial dilution method
"Antimicrobial activity against streptomycin, isoniazid, rifampicin, ethambutol, pyrazinamide and ethionammide-resistant Mycobacterium tuberculosis clinical isolate by two-fold serial dilution method"
"Antimicrobial activity against streptomycin, isoniazid, rifampicin, ethambutol, pyrazinamide, ethionammide and capreomicinl-resistant Mycobacterium tuberculosis clinical isolate by two-fold serial dilution method"
"Antimicrobial activity against streptomycin, isoniazid, rifampicin and ethambutol-resistant Mycobacterium tuberculosis clinical isolate by two-fold serial dilution method"
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 days by resazurin microtitre assay
Antimycobacterial activity against rifampin/isoniazid-resistant Mycobacterium tuberculosis 43 assessed as growth inhibition after 45 days by Canetti proportional method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 45 days by Canetti proportional method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by MABA assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 after 4 days by MTT assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv under normoxic condition after 7 days by MABA assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv after 3 weeks by broth dilution method
Antitubercular activity against Mycobacterium tuberculosis BCG
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by BacTiter-Glo method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as parasite growth inhibition after 28 days by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 5 days by microplate alamar blue assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv infected in african green monkey Vero cells
Antimicrobial activity against Mycobacterium tuberculosis H37Rv in presence of 10% FBS
Antimicrobial activity against Mycobacterium tuberculosis H37Rv in presence of 4% BSA
Antimicrobial activity against Mycobacterium tuberculosis H37Rv by low oxygen recovery assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv-CV-Lux AB after 10 days by low oxygen recovery assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv after 4 days by microplate Alamar blue assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv after 21 days by micro-broth dilution method
Antimicrobial activity against multi drug-resistant Mycobacterium tuberculosis after 7 days by resazurin assay
"Antimycobacterial activity against isoniazid, rifamycin, streptomycin, ethambutol and ofloxacin, clofazimine-resistant Mycobacterium tuberculosis Praha 4 after 21 days"
"Antimycobacterial activity against isoniazid, rifamycin, streptomycin, ethambutol and ofloxacin, clofazimine-resistant Mycobacterium tuberculosis Praha 4 after 14 days"
Antimycobacterial activity against pyrazinamide-sensitive Mycobacterium tuberculosis
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv CNCTC My 331/88 after 5 days by microplate alamar blue assay
"Antimycobacterial activity against isoniazid, rifamycin, streptomycin, ethambutol, clofazimine, ofloxacin, gentamicin and amikacin-resistant Mycobacterium tuberculosis Praha 131 after 21 days"
"Antimycobacterial activity against isoniazid, rifamycin, streptomycin, ethambutol, clofazimine, ofloxacin, gentamicin and amikacin-resistant Mycobacterium tuberculosis Praha 131 after 14 days"
"Antimycobacterial activity against isoniazid, rifamycin, streptomycin, ethambutol and clofazimine-resistant Mycobacterium tuberculosis Praha 1 after 21 days"
"Antimycobacterial activity against isoniazid, rifamycin, streptomycin, ethambutol and clofazimine-resistant Mycobacterium tuberculosis Praha 1 after 14 days"
"Antimycobacterial activity against isoniazid, rifamycin and streptomycin-resistant Mycobacterium tuberculosis 9449/2006 after 21 days"
"Antimycobacterial activity against isoniazid, rifamycin and streptomycin-resistant Mycobacterium tuberculosis 9449/2006 after 14 days"
"Antimycobacterial activity against isoniazid, rifampicin, rifabutin, streptomycin and ethambutol-resistant Mycobacterium tuberculosis 234/2005 after 21 days"
"Antimycobacterial activity against isoniazid, rifampicin, rifabutin, streptomycin and ethambutol-resistant Mycobacterium tuberculosis 234/2005 after 14 days"
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 16 to 24 hrs by microplate-Alamar Blue assay
Antitubercular activity against recombinant Mycobacterium tuberculosis H37Rv ATCC 27294 expressing Vibrio harveyii luciferase gene with acetamidase promoter assessed as reduction of metabolic recovery after 10 days by low-oxygen recovery assay
Antitubercular activity against capreomycin-resistant Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 16 to 24 hrs by microplate-Alamar Blue assay
Antitubercular activity against moxifloxacin-resistant Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 16 to 24 hrs by microplate-Alamar Blue assay
Antitubercular activity against rifampin-resistant Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 16 to 24 hrs by microplate-Alamar Blue assay
Antitubercular activity against isoniazid-resistant Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 16 to 24 hrs by microplate-Alamar Blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv My 331/88 after 21 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv My 331/88 after 14 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition in presence of GAST minimal media
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition in presence of 7H9 nutrient-rich media
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 harboring DprE1 C387G mutant assessed as growth inhibition after 5 days by microdilution method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 harboring DprE1 C387S mutant assessed as growth inhibition after 5 days by microdilution method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 overexpressing DprE1 assessed as growth inhibition after 5 days by microdilution method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 5 days by microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 5 days by microplate Alamar Blue assay
Antimycobacterial activity against isoniazid and rifampicin-resistant Mycobacterium tuberculosis MTB985 clinical isolate by MTT assay
Antimycobacterial activity against isoniazid and rifampicin-resistant Mycobacterium tuberculosis MTB411 clinical isolate by MTT assay
Antimycobacterial activity against isoniazid and rifampicin-resistant Mycobacterium tuberculosis UT544 clinical isolate by MTT assay
Antimycobacterial activity against isoniazid and rifampicin-resistant Mycobacterium tuberculosis MTB4000 clinical isolate by MTT assay
Antimycobacterial activity against isoniazid and rifampicin-resistant Mycobacterium tuberculosis MTB2556 clinical isolate by MTT assay
Antimycobacterial activity against streptomycin-resistant Mycobacterium tuberculosis H37Rv ATCC 35820 by MTT assay
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis H37Rv ATCC 35822 by MTT assay
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis H37Rv ATCC 35838 by MTT assay
Antimycobacterial activity against ethambutol-resistant Mycobacterium tuberculosis H37Rv ATCC 35837 by MTT assay
"Antimycobacterial activity against streptomycin, isoniazid, rifampicin, ethambutol and pirazynamide-susceptible Mycobacterium tuberculosis H37Rv ATCC 27294 by MTT assay"
Antimicrobial activity against ofloxacin-resistant Mycobacterium tuberculosis H37Rv SRI 4000 assessed as growth inhibition after 7 days by broth microdilution assay
Antimicrobial activity against rifampin-resistant Mycobacterium tuberculosis H37Rv SRI 1367 assessed as growth inhibition after 7 days by broth microdilution assay
Antimicrobial activity against isoniazid-resistant Mycobacterium tuberculosis H37Rv SRI 1369 assessed as growth inhibition after 7 days by broth microdilution assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv SRI 1345 assessed as growth inhibition after 7 days by broth microdilution assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv SRI 1345 after 7 days by broth microdilution assay
Antimycobacterial activity against ofloxacin-resistant Mycobacterium tuberculosis H37Rv SRI 4000 after 7 days by broth microdilution assay
Antimycobacterial activity against rifampin-resistant Mycobacterium tuberculosis H37Rv SRI 1367 after 7 days by broth microdilution assay
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis H37Rv SRI 1369 after 7 days by broth microdilution assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv by BACTEC radiometric assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv after 5 days by microplate Alamar Blue assay
Antimicrobial activity against Mycobacterium tuberculosis ATCC 27294 by microplate Alamar Blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 2 to 3 weeks by broth microdilution assay
Antitubercular activity against Mycobacterium tuberculosis infected in human THP1 cells assessed as growth inhibition after 5 days by luciferase reporter gene assay
Antitubercular activity against wild type Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as growth inhibition after 6 days by resazurin dye-based assay
Antibacterial activity against Mycobacterium tuberculosis NHN382 clinical isolate harboring Kat G S315t mutant assessed as parasite growth inhibition after 6 days by microplate Alamar Blue assay
Antibacterial activity against Mycobacterium tuberculosis TN587 clinical isolate harboring Kat G 3315T mutant assessed as parasite growth inhibition after 6 days by microplate Alamar Blue assay
Antibacterial activity against Mycobacterium tuberculosis W210 clinical isolate assessed as parasite growth inhibition after 6 days by microplate Alamar Blue assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as parasite growth inhibition after 6 days by microplate Alamar Blue assay
Antitubercular activity against extensive drug-resistant Mycobacterium tuberculosis clinical isolate 7 assessed as growth inhibition by microdilution method
Antitubercular activity against extensive drug-resistant Mycobacterium tuberculosis clinical isolate 6 assessed as growth inhibition by microdilution method
Antitubercular activity against extensive drug-resistant Mycobacterium tuberculosis clinical isolate 5 assessed as growth inhibition by microdilution method
Antitubercular activity against extensive drug-resistant Mycobacterium tuberculosis clinical isolate 4 assessed as growth inhibition by microdilution method
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis clinical isolate 3 assessed as growth inhibition by microdilution method
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis clinical isolate 2 assessed as growth inhibition by microdilution method
Antitubercular activity against isoniazid-resistant Mycobacterium tuberculosis H37RV clinical isolate 1 assessed as growth inhibition by microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37RV ATCC 27294 assessed as growth inhibition after 3 to 11 days by microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition by 2-fold dilution assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by two-fold serial dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by two-fold serial dilution method in presence of efflux pump inhibitor verapamil
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 infected in mouse J774 cells assessed as intracellular killing after 48 hrs by colony formation assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis clinical isolates by broth dilution method
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis clinical isolates by broth dilution method
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis clinical isolates by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by broth dilution method
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 2 weeks by spot culture growth inhibition assay
Antibacterial activity against Mycobacterium tuberculosis H37Ra
"Antimycobacterial activity against streptomycin, ethambutol, kanamycin, isoniazid, rifabutin, rifampicin, levofloxacin, and ciprofloxacin-resistant Mycobacterium tuberculosis LV19 by microbroth dilution method"
"Antimycobacterial activity against isoniazid, rifampicin, and rifabutin-resistant Mycobacterium tuberculosis LV2 by microbroth dilution method"
Antimycobacterial activity against Mycobacterium tuberculosis LV54 by microbroth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by microbroth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv expressing luciferase assessed as growth inhibition after 6 days by luminometry
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv expressing luciferase assessed as growth inhibition preincubated with liver S9 fraction for 30 mins followed by incubation with parasite and measured after 6 days by luminometry
Antimycobacterial activity against Mycobacterium tuberculosis Beijing 17919 expressing luciferase assessed as growth inhibition after 6 days by luminometry
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv expressing luciferase infected in mouse J774A1 cells assessed as inhibition of replication measured after 1 to 4 days by luminescence assay
Antibacterial activity against 1 ug/ml Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 7 days by microtiter plate assay
Antibacterial activity against 0.5 ug/ml Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 7 days by microtiter plate assay
Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 741 assessed as growth inhibition after 7 days by microtiter plate assay
Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 753 assessed as growth inhibition after 7 days by microtiter plate assay
Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 758 assessed as growth inhibition after 7 days by microtiter plate assay
Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 760 assessed as growth inhibition after 7 days by microtiter plate assay
Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 821 assessed as growth inhibition after 7 days by microtiter plate assay
Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 930 assessed as growth inhibition after 7 days by microtiter plate assay
Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 1237 assessed as growth inhibition after 7 days by microtiter plate assay
Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 1256 assessed as growth inhibition after 7 days by microtiter plate assay
Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 1259 assessed as growth inhibition after 7 days by microtiter plate assay
Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 1288 assessed as growth inhibition after 7 days by microtiter plate assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 7 days by microtiter plate assay
Antimicrobial activity against Mycobacterium tuberculosis by BACTEC radiometric assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition by serial dilution method
Antimicrobial activity against Mycobacterium tuberculosis ATCC 9360 by tube dilution method
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 up to 2 weeks by HT-SPOTi assay
Antimycobacterial activity against replicating form of Mycobacterium tuberculosis infected in African green monkey Vero cells assessed as growth inhibition
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 7 days incubation by Alamar Blue staining-based broth microdilution assay
Antimicrobial activity against Mycobacterium tuberculosis ATCC 27294
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition by standard microdilution method
"Antitubercular activity against 1-ethyl-3-(6-(pyrimidin-5-yl)-5-((tetrahydrofuran-3-yl)methoxy)thiazolo[5,4-b]pyridin-2-yl)urea-resistant Mycobacterium tuberculosis H37Rv clone 8.1 harboring DNA gyraseB ATP domain Ala92Ser mutant assessed as growth inhibition by standard microdilution method"
"Antitubercular activity against 1-ethyl-3-(6-(pyrimidin-5-yl)-5-((tetrahydrofuran-3-yl)methoxy)thiazolo[5,4-b]pyridin-2-yl)urea-resistant Mycobacterium tuberculosis H37Rv clone 8.2 harboring DNA gyraseB ATP domain Ala92Ser mutant assessed as growth inhibition by standard microdilution method"
Antimicrobial activity against Mycobacterium tuberculosis H37Rv incubated for 7 days measured after 28 days by resazurin microplate reduction assay
Antimicrobial activity against nonreplicating streptomycin-starved Mycobacterium tuberculosis 18b at 1 ug/ml incubated for 7 days measured after 28 days by resazurin microplate reduction assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv incubated for 7 days measured after 28 days by resazurin microplate reduction assay in presence of MK-4
Antimicrobial activity against Mycobacterium tuberculosis after 7 to 21 days by microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by BACTEC 960 assay
Antimycobacterial activity against rifampicin and isoniazid-resistant Mycobacterium tuberculosis 43 assessed as growth inhibition
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 45 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 5 days by microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 2 to 3 weeks by turbidometry
Antimycobacterial activity against Mycobacterium tuberculosis Beijing (E-47/94) assessed as growth inhibition after 2 to 3 weeks by turbidometry
Antimycobacterial activity against Mycobacterium tuberculosis D-211 assessed as growth inhibition after 2 to 3 weeks by turbidometry
Antimycobacterial activity against streptomycin-resistant Mycobacterium tuberculosis 136570 assessed as growth inhibition after 2 to 3 weeks by turbidometry
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis 912253 assessed as growth inhibition after 2 to 3 weeks by turbidometry
Antimycobacterial activity against rifampin-resistant Mycobacterium tuberculosis 19000 assessed as growth inhibition after 2 to 3 weeks by turbidometry
Antimycobacterial activity against ethambutol-resistant Mycobacterium tuberculosis 17003 assessed as growth inhibition after 2 to 3 weeks by turbidometry
Antimycobacterial activity against ofloxacin-resistant Mycobacterium tuberculosis 12119 assessed as growth inhibition after 2 to 3 weeks by turbidometry
Antimycobacterial activity against wild type Mycobacterium tuberculosis H37Rv assessed as growth inhibition by resazurin assay
Antimycobacterial activity against Mycobacterium tuberculosis overexpressing DprE1 assessed as growth inhibition by resazurin assay
Antimycobacterial activity against BTZ043-resistant Mycobacterium tuberculosis harboring DprE1 C-G mutant assessed as growth inhibition by resazurin assay
Antimycobacterial activity against BTZ043-resistant Mycobacterium tuberculosis harboring DprE1 C-S mutant assessed as growth inhibition by resazurin assay
"Antimycobacterial activity against 3-cyclopropyl-1-phenyl-5-((3-(trifluoromethyl)benzylamino)-methyl)-1H-pyrazolo[3,4-b]pyridin-6(7H)-one-resistant Mycobacterium tuberculosis clone 8.1 assessed as growth inhibition by resazurin assay"
"Antimycobacterial activity against 3-cyclopropyl-1-phenyl-5-((3-(trifluoromethyl)benzylamino)-methyl)-1H-pyrazolo[3,4-b]pyridin-6(7H)-one-resistant Mycobacterium tuberculosis clone 8.2 assessed as growth inhibition by resazurin assay"
"Antimycobacterial activity against 3-cyclopropyl-1-phenyl-5-((3-(trifluoromethyl)benzylamino)-methyl)-1H-pyrazolo[3,4-b]pyridin-6(7H)-one-resistant Mycobacterium tuberculosis clone 8.3 assessed as growth inhibition by resazurin assay"
Antitubercular activity against Mycobacterium tuberculosis H37Rv clinical isolate harboring katG S315T mutant by BACTEC 960 assay
Antibacterial activity against Mycobacterium tuberculosis assessed as growth inhibition in presence of 16 uM nicotinic acid hydrazide
Antibacterial activity against Mycobacterium tuberculosis assessed as growth inhibition in absence of 16 uM nicotinic acid hydrazide
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition by two-fold serial dilution method
Antibacterial activity against Mycobacterium tuberculosis assessed as growth inhibition
Antibacterial activity against Mycobacterium tuberculosis using acidic culture media at pH 5.9 assessed as growth inhibition
Antibacterial activity against Mycobacterium tuberculosis H37Ra by gradient plate test
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 to 8 days by BACTEC 12B method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 harboring DprE1 OE mutant assessed as growth inhibition after 5 days by microdilution method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 harboring DprE1 Y314H mutant assessed as growth inhibition after 5 days by microdilution method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 harboring DprE1 Rv1937/F426C mutant assessed as growth inhibition after 5 days by microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 infected in human THP1 cells assessed as reduction in CFU after 21 to 28 days
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 days by microdilution method
Antimycobacterial activity against wild-type Mycobacterium tuberculosis H37Rv ATCC 27294 after 16 to 18 days by BACTEC 7H12B microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 5 days by standard microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis over expressing DprE1 after 5 days by standard microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis over expressing InhA after 5 days by standard microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis over expressing TopA after 5 days by standard microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis over expressing PimA after 5 days by standard microdilution method
Antimycobacterial activity against BTZ043-resistant Mycobacterium tuberculosis over expressing DprE1 C387S mutant after 5 days by standard microdilution method
Antimycobacterial activity against TMC207R-resistant Mycobacterium tuberculosis clone 8.1 over expressing DprE1 mutant after 5 days by standard microdilution method
Antimycobacterial activity against moxifloxacin-resistant Mycobacterium tuberculosis clone 4.1 over expressing DprE1 mutant after 5 days by standard microdilution method
"Antimycobacterial activity against 2-oxo-1-(2-(4-((3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-6-yl)methylamino)piperidin-1-yl)ethyl)-1,2-dihydroquinoline-7-carbonitrile-resistant Mycobacterium tuberculosis harboring DNA gyraseA A74V mutant"
"Antimycobacterial activity against 5-(((3S,4R)-3-Fluoro-1-(2-(7-methoxy-2-oxo-1,5-naphthyridin-1(2H)-yl)ethyl)piperidin-4-ylamino)methyl)-2-methylnicotinonitrile-resistant Mycobacterium tuberculosis harboring DNA gyraseA D89N mutant"
Antimycobacterial activity against moxifloxacin-resistant Mycobacterium tuberculosis harboring DNA gyraseA G88N mutant
Antimycobacterial activity against Mycobacterium tuberculosis over expressing DprE1 Y314H mutant after 5 days by standard microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv in GAS medium by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv in 7H12 medium by microplate alamar blue assay
Antituberculosis activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth after 45 days
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 in GAST/Fe medium after 1 week by broth microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 in GAST/Fe medium after 2 weeks by broth microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 in 7H9/ADC/Tween medium after 1 week by broth microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 in 7H9/ADC/Tween medium after 2 weeks by broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by Lowenstein-Jensen slope method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as compound level causing less than 2% growth after 7 days by serial dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by MABA method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv after 7 days by MABA assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 days by REMA resazurin microtiter assay
Antitubercular activity against Mycobacterium tuberculosis H37Ra after 7 days by REMA resazurin microtiter assay
Antitubercular activity against Mycobacterium tuberculosis isolate 29/10 after 7 days by REMA resazurin microtiter assay
Antitubercular activity against Mycobacterium tuberculosis isolate 439/11 after 7 days by REMA resazurin microtiter assay
Antitubercular activity against Mycobacterium tuberculosis isolate 756/10 after 7 days by REMA resazurin microtiter assay
Antituberculosis activity against Mycobacterium tuberculosis H37Rv RM1 IS6110 at nt 801 mutant assessed as complete growth inhibition after 5 days
Antituberculosis activity against Mycobacterium tuberculosis H37Rv RM2 GT deletion at 175 to 176 mutant assessed as complete growth inhibition after 5 days
Antituberculosis activity against Mycobacterium tuberculosis H37Rv RM7 C115W mutant assessed as complete growth inhibition after 5 days
Antitubercular activity against Mycobacterium tuberculosis isolate 778/10 after 7 days by REMA resazurin microtiter assay
Antitubercular activity against Mycobacterium tuberculosis isolate 917/10 after 7 days by REMA resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by microplate Alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra after 7 days by microplate Alamar blue assay
Antimycobacterial activity against Ethionamide-resistant Mycobacterium tuberculosis H37Rv ATCC 35830 after 7 days by microplate Alamar blue assay
Antimycobacterial activity against p-Aminosalicylic acid-resistant Mycobacterium tuberculosis H37Rv ATCC 35821 after 7 days by microplate Alamar blue assay
Antimycobacterial activity against pyrazinamide-resistant Mycobacterium tuberculosis H37Rv ATCC 35828 after 7 days by microplate Alamar blue assay
Antimicrobial activity against Mycobacterium tuberculosis Spec. 192 by two-fold serial dilution method
Antimicrobial activity against Mycobacterium tuberculosis Spec. 210 by two-fold serial dilution method
Antimicrobial activity against multi-drug resistant Mycobacterium tuberculosis LAM-1 strain clinical isolate assessed as growth reduction by BACTEC_MGIT_960-TB detection system
Antitubercular activity against drug-sensitive Mycobacterium tuberculosis
Antitubercular activity against drug-resistant Mycobacterium tuberculosis
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 5 days by MABA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 days by Resazurin micro titer assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 234/2005 after 7 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 234/2005 after 14 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 9449/2007 after 7 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 8666/2010 after 7 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 8666/2010 after 14 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis Praha 1 after 7 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis Praha 1 after 14 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis Praha 4 after 7 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis Praha 4 after 14 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis Praha 131 after 7 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis Praha 131 after 14 days by micromethod
Antibacterial activity against Mycobacterium tuberculosis H37Rv after 5 days by microplate Alamar Blue assay
Antituberculosis activity against Mycobacterium tuberculosis H37Rv after 7 days by serial two fold dilution method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294
"Antimicrobial activity against 2-oxo-1-(2-(4-((3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-6-yl)methylamino)piperidin-1-yl)ethyl)-1,2-dihydroquinoline-7-carbonitrile resistant Mycobacterium tuberculosis H37Rv ATCC 27294 containing DNA gyrase A74V mutant"
"Antimicrobial activity against 5-(((3S,4R)-3-fluoro-1-(2-(7-methoxy-2-oxo-1,5-naphthyridin-1(2H)-yl)ethyl)piperidin-4-ylamino)methyl)-2-methylnicotinonitrile resistant Mycobacterium tuberculosis H37Rv ATCC 27294 containing DNA gyrase D89N mutant"
Antimicrobial activity against moxicillin resistant Mycobacterium tuberculosis H37Rv ATCC 27294 containing DNA gyrase G88N mutant
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 10 days by microbroth dilution method
Antimycobacterial activity against rifampin- and Isoniazid- resistant Mycobacterium tuberculosis Beijing harboring Ser 531-Leu 315 rpoB mutant and Ser-Thr katG mutant after 10 days by microbroth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 28 days by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv 331/88 assessed as complete growth inhibition after 14 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv 331/88 assessed as complete growth inhibition after 21 days
Antitubercular activity Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 5 days by MABA method
Antitubercular activity Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 30 days by agar microdilution method
Anti-tubercular activity against Mycobacterium tuberculosis H37Rv by resazurin microtitre assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv by microbroth dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 4 weeks
Antimicrobial activity against Mycobacterium tuberculosis mc2 6020 incubated for 16 hrs by alamar blue assay
Antimicrobial activity against wild-type Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 5 days by microdilution method
Antimicrobial activity against Mycobacterium tuberculosis clinical isolate assessed as growth inhibition after 5 days by microdilution method
"Antimicrobial activity against isoniazid, rifampin and ethambutol-resistant Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 5 days by microdilution method"
Antimicrobial activity against Mycobacterium tuberculosis assessed as growth inhibition after 5 days by microdilution method
Antimicrobial activity against Mycobacterium tuberculosis overexpressing DprE1 assessed as growth inhibition after 5 days by microdilution method
Antitubercular activity against Mycobacterium tuberculosis ATCC 27294 in high iron condition after 5 days by Alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis ATCC 27294 in 7H9 medium after 5 days by Alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis ATCC 27294 in low iron condition after 5 days by Alamar blue assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by microplate alamar blue assay method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv CNCTC My 331/88 after 10 to 14 days by AlamarBlue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv CNCTC My 331/88 in Middlebrook 7H9 broth after 5 days by AlamarBlue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition by microdilution AlamarBlue broth assay
Antimicrobial activity against Mycobacterium tuberculosis H37Ra after 5 days by serial macrobroth dilution method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by two-fold agar dilution method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by two-fold agar dilution method in presence of verapamil
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by two-fold agar dilution method in presence of piperine
Antimicrobial activity against extensively drug-resistant Mycobacterium tuberculosis XDR-TB after 28 days by two-fold agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by two-fold serial dilution assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by two-fold serial dilution assay in presence of 8 mg/mL piperine efflux pump inhibitor
"Antimycobacterial activity against isoniazid, rifampicin, ofloxacin and kanamycin-resistant Mycobacterium tuberculosis H37Rv ATCC 27294 clinical isolate after 28 days by two-fold serial dilution assay in presence of 8 mg/mL piperine efflux pump inhibitor"
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv My 331/88 assessed as microbial growth inhibition incubated for 14 days
Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis Praha 131 assessed as microbial growth inhibition incubated for 14 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 5 days by resazurin-based microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition in presence of 2.5 mg/ml clavulanate
Antitubercular activity against XDR clinical isolates Mycobacterium tuberculosis H37Rv assessed as growth inhibition in presence of 2.5 mg/ml clavulanate
Antitubercular activity against drug-resistant Mycobacterium tuberculosis clinical isolates assessed as growth inhibition
Antitubercular activity against drug-susceptible Mycobacterium tuberculosis clinical isolates assessed as growth inhibition
Antimycobacterial activity against isoniazid and rifampicin resistant Mycobacterium tuberculosis 11277 by MABA method
Antimycobacterial activity against isoniazid and rifampicin resistant Mycobacterium tuberculosis 6133 by MABA method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv incubated for 48 hrs by microdilution broth method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as reduction in bacterial growth incubated for 7 days under 7H12 medium by MABA method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as reduction in bacterial growth incubated for 7 days under GAS medium by MABA method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of mycobacterial growth after 7 days by REMA method
Antitubercular activity against Mycobacterium tuberculosis assessed as growth inhibition after 24 hrs by standard microdilution method
Antimycobacterial activity against replicating Mycobacterium tuberculosis propagated at 37 degC with 20% O2 and 5% CO2
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv 331/88 after 14 days by microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv 331/88 after 21 days by microdilution method
"Antimycobacterial activity against INH, RIF, rifabutin, streptomycin, ethambutol, ofloxacin-resistant Mycobacterium tuberculosis 7357/1998 after 14 days by microdilution method"
"Antimycobacterial activity against INH, RIF, rifabutin, streptomycin, ethambutol, ofloxacin-resistant Mycobacterium tuberculosis 7357/1998 after 21 days by microdilution method"
"Antimycobacterial activity against INH, RIF, rifabutin, streptomycin-resistant Mycobacterium tuberculosis 9449/2006 after 14 days by microdilution method"
"Antimycobacterial activity against INH, RIF, rifabutin, streptomycin-resistant Mycobacterium tuberculosis 9449/2006 after 21 days by microdilution method"
"Antimycobacterial activity against INH, RIF, rifabutin, streptomycin, ethambutol, ofloxacin-resistant Mycobacterium tuberculosis 234/2005 after 14 days by microdilution method"
"Antimycobacterial activity against INH, RIF, rifabutin, streptomycin, ethambutol, ofloxacin-resistant Mycobacterium tuberculosis 234/2005 after 21 days by microdilution method"
"Antimycobacterial activity against INH, RIF, rifabutin, streptomycin, ethambutol, clofazimine-resistant Mycobacterium tuberculosis Praha 1 after 14 days by microdilution method"
"Antimycobacterial activity against INH, RIF, rifabutin, streptomycin, ethambutol, clofazimine-resistant Mycobacterium tuberculosis Praha 1 after 21 days by microdilution method"
"Antimycobacterial activity against INH, RIF, rifabutin, streptomycin, ethambutol, ofloxacin, clofazimine-resistant Mycobacterium tuberculosis Praha 4 after 14 days by microdilution method"
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as inhibition of microbial proliferation
Antimycobacterial activity against Mycobacterium tuberculosis assessed as inhibition of microbial proliferation after 6 days by cell titer blue reagent based assay
"Antimycobacterial activity against INH, RIF, rifabutin, streptomycin, ethambutol, ofloxacin, clofazimine-resistant Mycobacterium tuberculosis Praha 4 after 21 days by microdilution method"
"Antimycobacterial activity against INH, RIF, rifabutin, streptomycin, ethambutol, ofloxacin, gentamicin, amikacin-resistant Mycobacterium tuberculosis Praha 131 after 14 days by microdilution method"
"Antimycobacterial activity against INH, RIF, rifabutin, streptomycin, ethambutol, ofloxacin, gentamicin, amikacin-resistant Mycobacterium tuberculosis Praha 131 after 21 days by microdilution method"
"Antimicrobial activity against isoniazid and rifampin resistant Mycobacterium tuberculosis after 21 days at 37 degC in presence of 1-(4-(4-(1H-pyrrol-1-yl)phenyl)piperazin-1-yl)-4-(5-(3,5-difluorobenzyl)-1-(2-fluorobenzyl)-2-oxo-1,2-dihydropyridin-3-yl)-2-hydroxybut-2-ene-1,4-dione by agar dilution drug susceptibility assay"
Antimicrobial activity against isoniazid and rifampin resistant Mycobacterium tuberculosis after 21 days at 37 degC in presence of PA-824 by agar dilution drug susceptibility assay
Antimicrobial activity against isoniazid and rifampin resistant Mycobacterium tuberculosis after 21 days at 37 degC by agar dilution drug susceptibility assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as complete inhibition of proliferation
Bacteriostatic activity against Mycobacterium bovis BCG after 7 days by Alamar Blue assay
Tuberculostatic activity against Mycobacterium tuberculosis Spec. 210 by two-fold classical test-tube method
Tuberculostatic activity against Mycobacterium tuberculosis Spec. 192 by two-fold classical test-tube method
Tuberculostatic activity against Mycobacterium tuberculosis H37Rv by two-fold classical test-tube method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 7 days by microplate alamar blue assay method
Antimycobacterial activity against extensively drug resistant Mycobacterium tuberculosis
Antibacterial activity against multidrug-resistant Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by agar dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 days by broth microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294/XDR-TB incubated for 28 days by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated at 37 degC for 4 weeks
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis H37Rv by agar dilution method
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis by agar dilution method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv after 24 hrs by two-fold broth microdilution method
"Antimycobacterial activity against rifampin,isoniazid-resistant Mycobacterium tuberculosis expressing rpoB/katG mutant after 10 days by microbroth dilution method"
Antimicrobial activity against Mycobacterium tuberculosis H37Rv after 16 to 20 hrs by two-fold microdilution broth method
Antimicrobial activity against isoniazid-resistant Mycobacterium tuberculosis Who-185 after 16 to 20 hrs by two-fold microdilution broth method
Antimicrobial activity against rifampicin-resistant Mycobacterium tuberculosis Who-185 after 16 to 20 hrs by two-fold microdilution broth method
Antimicrobial activity against Mycobacterium tuberculosis 3688023 after 16 to 20 hrs by two-fold microdilution broth method
Antimicrobial activity against Mycobacterium tuberculosis 37892293 after 16 to 20 hrs by two-fold microdilution broth method
Antimicrobial activity against pyrazinamide-resistant Mycobacterium tuberculosis BCG(SI) after 16 to 20 hrs by two-fold microdilution broth method
Anti-mycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of microbial growth incubated for 5 days by MABA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial growth after 4 weeks by two-fold dilution technique
"Antitubercular activity against isoniazid, rifampin, streptomycin, ethambutol, amikacin, ofloxacin, kanamycin-susceptible Mycobacterium tuberculosis assessed as inhibition of bacterial growth after 4 weeks by two-fold dilution technique"
Antitubercular activity against isoniazid-resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth after 4 weeks by two-fold dilution technique
Antitubercular activity against rifampin and isoniazid-resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth after 4 weeks by two-fold dilution technique
"Antitubercular activity against rifampin, isoniazid and streptomycin-resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth after 4 weeks by two-fold dilution technique"
"Antitubercular activity against rifampin, isoniazid and ethambutol-resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth after 4 weeks by two-fold dilution technique"
"Antitubercular activity against rifampin, isoniazid, amikacin and ofloxacin-resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth after 4 weeks by two-fold dilution technique"
"Antitubercular activity against rifampin, isoniazid, kanamycin and ofloxacin-resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth after 4 weeks by two-fold dilution technique"
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth after 5 days by Microplate Alamar Blue Assay
Antimycobacterial activity against GFP expressing Mycobacterium tuberculosis H37Ra assessed as microbial growth inhibition incubated at 37 degC for 7 days by fluorescence based assay
Antibacterial activity against Mycobacterium tuberculosis T1538 under aerobic condition after 7 days by MTT assay
Antibacterial activity against Mycobacterium tuberculosis T1413 under aerobic condition after 7 days by MTT assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv under aerobic condition after 7 days by MTT assay
Antibacterial activity against Mycobacterium bovis BCG under hypoxic condition after 14 days by MTT assay
Antibacterial activity against Mycobacterium bovis BCG under aerobic condition after 7 days by MTT assay
Antimycobacterial activity against Mycobacterium bovis BCG after 7 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days
Antimicrobial activity against Mycobacterium tuberculosis H37Rv grown in GAS medium without ferric ammonium citrate at pH 6.6 incubated for 10 to 14 days by broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition by Alamar Blue staining-based broth microdilution assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 3 days by broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 7 days by microdilution method
"Antimycobacterial activity against 6-((1-(2-(7-chloro-2-oxo-1,8-naphthyridin-1(2H)-yl)ethyl)piperidin-4-ylamino)methyl)-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one resistant Mycobacterium tuberculosis H37Rv harboring DNA gyraseA A74V mutant incubated for 7 days by microdilution method"
"Antimycobacterial activity against 1-(2-(4-((5-chloro-6-methylpyridin-3-yl)methylamino)piperidin-1-yl)ethyl)-7-fluoro-1,5-naphthyridin-2(1H)-one resistant Mycobacterium tuberculosis H37Rv harboring DNA gyraseA D89N mutant incubated for 7 days by microdilution method"
Antimycobacterial activity against moxifloxacin resistant Mycobacterium tuberculosis H37Rv harboring DNA gyraseA G88N mutant incubated for 7 days by microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 21 days by microbroth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 21 days by microbroth dilution method in presence of 3 ug/ml efflux pump inhibitor reserpine
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 21 days by microbroth dilution method in presence of 40 ug/ml efflux pump inhibitor verapamil
Antitubercular activity against Mycobacterium tuberculosis H37Ra after 7 days by microplate alamar blue assay
Antitubercular activity against fluorescent reporter strain of Mycobacterium tuberculosis H37Rv after 5 days by fluorescence assay
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis UAl3495 after 7 days by autoluminescent assay
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis UAlP7 after 7 days by autoluminescent assay
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis UAl4768 after 7 days by autoluminescent assay
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis UAlP163 after 7 days by autoluminescent assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by serial dilution method
Antimycobacterial activity against multidrug-resistance Mycobacterium tuberculosis A8 after 28 days by serial dilution method
Antimycobacterial activity against INH/RIF/rifabutine/streptomycin-resistance Mycobacterium tuberculosis 9449/2006 after 14 days by microbroth dilution method
Antimycobacterial activity against INH/RIF/rifabutine/streptomycin-resistance Mycobacterium tuberculosis 9449/2006 after 21 days by microbroth dilution method
Antimycobacterial activity against INH/RIF/rifabutine/streptomycin/ethambutol/ofloxacin/gentamicin/amikacin-resistance Mycobacterium tuberculosis Praha 131 after 14 days by microbroth dilution method
Antimycobacterial activity against INH/RIF/rifabutine/streptomycin/ethambutol/ofloxacin/gentamicin/amikacin-resistance Mycobacterium tuberculosis Praha 131 after 21 days by microbroth dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 days by microplate Alamar Blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 days by spectrophotometry
Antimycobacterial activity against Mycobacterium tuberculosis TN675 after 5 days by spectrophotometry
Antimycobacterial activity against Mycobacterium tuberculosis TN913 after 5 days by spectrophotometry
Antimycobacterial activity against Mycobacterium tuberculosis TN994 after 5 days by spectrophotometry
Antimycobacterial activity against Mycobacterium tuberculosis TN1008 after 5 days by spectrophotometry
Antimycobacterial activity against Mycobacterium tuberculosis TN1037 after 5 days by spectrophotometry
Antimycobacterial activity against Mycobacterium tuberculosis TN1040 after 5 days by spectrophotometry
Antimycobacterial activity against Mycobacterium tuberculosis TN1051 after 5 days by spectrophotometry
Antimycobacterial activity against Mycobacterium tuberculosis TN1082 after 5 days by spectrophotometry
Antimycobacterial activity against Mycobacterium tuberculosis TN2351 after 5 days by spectrophotometry
Antimycobacterial activity against Mycobacterium tuberculosis TN2524 after 5 days by spectrophotometry
Antimycobacterial activity against Mycobacterium tuberculosis TN3183 after 5 days by spectrophotometry
Antimycobacterial activity against Mycobacterium tuberculosis TN3979 after 5 days by spectrophotometry
Antimycobacterial activity against Mycobacterium tuberculosis TN4259 after 5 days by spectrophotometry
Antimycobacterial activity against Mycobacterium tuberculosis AH9584 after 5 days by spectrophotometry
Antimycobacterial activity against Mycobacterium tuberculosis BE11677 after 5 days by spectrophotometry
Antimycobacterial activity against Mycobacterium tuberculosis E8133 after 5 days by spectrophotometry
Antimycobacterial activity against Mycobacterium tuberculosis W4 after 5 days by spectrophotometry
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis TN565 after 5 days by spectrophotometry
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis TN576 after 5 days by spectrophotometry
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis TN702 after 5 days by spectrophotometry
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis TN715 after 5 days by spectrophotometry
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis TN768 after 5 days by spectrophotometry
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis TN772 after 5 days by spectrophotometry
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis TN1195 after 5 days by spectrophotometry
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis TN1314 after 5 days by spectrophotometry
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis TN1618 after 5 days by spectrophotometry
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis TN1811 after 5 days by spectrophotometry
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis TN2557 after 5 days by spectrophotometry
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 25618
Antimycobacterial activity against p-aminosalicylic acid/isonicotinic acid hydrazide/etambutol/rifampicin-resistant Mycobacterium tuberculosis Spec. 210
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis Spec. 192
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 25618 under aerobic condition after 5 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra after 7 days by alamar blue dye assay
Antimycobacterial activity against Mycobacterium tuberculosis in 7H12 medium by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis in GAS medium by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition incubated for 7 days by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis after 5 days by microplate Alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of cell growth after 5 days by microplate alamar blue assay
Antituberculosis activity against Mycobacterium tuberculosis H37Rv MTCC 300 after 4 weeks by Lowenstein-Jensen medium method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 days by microplate alamar blue assay
Antitubercular activity against dormant phase Mycobacterium tuberculosis H37Ra ATCC 25177 incubated for 12 days by XTT reduction menadione assay
Antituberculosis activity against multi-drug resistant Mycobacterium tuberculosis
Antimicrobial activity against nonreplicating Mycobacterium tuberculosis 18b by resazurin microtiter assay
Antimicrobial activity against rifamycin-resistant Mycobacterium tuberculosis by resazurin microtiter assay
Antimicrobial activity against multidrug-resistant Mycobacterium tuberculosis by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 days by microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 2 to 3 weeks by turbidity assay
Antimycobacterial activity against INH-resistant Mycobacterium tuberculosis after 2 to 3 weeks by turbidity assay
Antimycobacterial activity against streptomycin-resistant Mycobacterium tuberculosis after 2 to 3 weeks by turbidity assay
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis after 2 to 3 weeks by turbidity assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by alamar blue assay
Antitubercular activity against multi drug resistant Mycobacterium tuberculosis H37Rv after 5 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv CNCTC My 331/88 incubated for 10 to 14 days by microplate alamar blue assay
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis 7357/1998 after 14 days by microplate dilution method
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis 7357/1998 after 21 days by microplate dilution method
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis 234/2005 after 14 days by microplate dilution method
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis 234/2005 after 21 days by microplate dilution method
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis 9449/2007 after 14 days by microplate dilution method
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis 9449/2007 after 21 days by microplate dilution method
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis 8666/2010 after 14 days by microplate dilution method
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis 8666/2010 after 21 days by microplate dilution method
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis Praha 1 after 14 days by microplate dilution method
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis Praha 1 after 21 days by microplate dilution method
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis Praha 4 after 14 days by microplate dilution method
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis Praha 4 after 21 days by microplate dilution method
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis Praha 131 after 14 days by microplate dilution method
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis Praha 131 after 21 days by microplate dilution method
Antibacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by resazurin microplate assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 7 days by microbroth dilution method
Antitubercular activity against Mycobacterium tuberculosis BCG after 7 days by alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 14 days by broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 21 days by broth microdilution method
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis after 14 days by broth microdilution method
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis after 21 days by broth microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 4 weeks
Antitubercular activity against multi drug resistant Mycobacterium tuberculosis isolate 1 assessed as growth inhibition after 4 weeks
Antitubercular activity against multi drug resistant Mycobacterium tuberculosis isolate 2 assessed as growth inhibition after 4 weeks
Antimycobacterium activity against Mycobacterium tuberculosis H37Rv after 48 hrs by Resazurin microtiter assay
Antituberculosis activity against isoniazid-sensitive Mycobacterium tuberculosis H37Rv by microdilution method
Antituberculosis activity against isoniazid-resistant Mycobacterium tuberculosis CN-40 by microdilution method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by alamar blue assay
Anti-tubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294T after 7 days by mircodilution method
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as isoniazid MIC at 16 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as isoniazid MIC at 8 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as isoniazid MIC at 4 ug/ml after 7 days by microdilution checkerboard
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as isoniazid MIC at 2 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as isoniazid MIC at 1 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as isoniazid MIC at 0.5 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as isoniazid MIC at 0.25 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as isoniazid MIC at 0.12 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as isoniazid MIC at 64 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as isoniazid MIC at 32 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as isoniazid MIC at 128 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as isoniazid MIC at 256 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as rifampin MIC at 16 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as rifampin MIC at 8 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as rifampin MIC at 4 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as rifampin MIC at 2 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as rifampin MIC at 1 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as rifampin MIC at 0.5 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as rifampin MIC at 0.25 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as rifampin MIC at 0.12 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as rifampin MIC at 64 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as rifampin MIC at 32 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as rifampin MIC at 128 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as rifampin MIC at 256 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as amikacin MIC at 16 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as amikacin MIC at 8 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as amikacin MIC at 4 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as amikacin MIC at 2 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as amikacin MIC at 1 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as amikacin MIC at 0.5 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as amikacin MIC at 0.25 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as amikacin MIC at 0.12 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as amikacin MIC at 64 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as amikacin MIC at 32 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as amikacin MIC at 128 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as amikacin MIC at 256 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as ofloxacin MIC at 16 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as ofloxacin MIC at 8 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as ofloxacin MIC at 4 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as ofloxacin MIC at 2 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as ofloxacin MIC at 1 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as ofloxacin MIC at 0.5 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as ofloxacin MIC at 0.25 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as ofloxacin MIC at 0.12 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as ofloxacin MIC at 64 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as ofloxacin MIC at 32 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as ofloxacin MIC at 128 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as ethidium bromide MIC at 16 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as ethidium bromide MIC at 8 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as ethidium bromide MIC at 4 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as ethidium bromide MIC at 2 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as ethidium bromide MIC at 1 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as ethidium bromide MIC at 0.5 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as ethidium bromide MIC at 0.25 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as ethidium bromide MIC at 0.12 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as ethidium bromide MIC at 64 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as ethidium bromide MIC at 32 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as ethidium bromide MIC at 128 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as ethidium bromide MIC at 256 ug/ml after 7 days by microdilution checkerboard assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294T assessed as ofloxacin MIC at 256 ug/ml after 7 days by microdilution checkerboard assay
Antimycobacterial activity against nutrient starved Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial load for 7 days measured after 28 days by microplate reader analysis
Antimicrobial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 5 days by fluorescence analysis
Antitubercular activity against Mycobacterium tuberculosis H37Ra ATCC 25177 by XTT Reduction Menadione Assay
Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate assessed as growth inhibition after 5 days by microplate Alamar blue assay
Antimycobacterial activity against extensively drug resistant Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 5 days by fluorescence analysis
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 25618 after 2 weeks
Antimycobacterial activity against Mycobacterium bovis BCG after 2 weeks
Antimycobacterial activity against Mycobacterium bovis BCG overexpressing InhA after 2 weeks
Antimycobacterial activity against isoniazid resistant Mycobacterium tuberculosis H37Rv clinical isolate 2 harboring InhA promoter C-15T mutant
Antimycobacterial activity against isoniazid resistant Mycobacterium tuberculosis H37Rv clinical isolate 3 harboring InhA promoter C-15T mutant
Antimycobacterial activity against isoniazid resistant Mycobacterium tuberculosis H37Rv clinical isolate 6 harboring InhA promoter C-15T mutant
Antimycobacterial activity against isoniazid resistant Mycobacterium tuberculosis H37Rv clinical isolate 1 harboring katG S315T mutant
Antimycobacterial activity against isoniazid resistant Mycobacterium tuberculosis H37Rv clinical isolate 4 harboring katG S315T mutant
Antimycobacterial activity against isoniazid resistant Mycobacterium tuberculosis H37Rv clinical isolate 5 harboring katG S315T mutant
Antimycobacterial activity against isoniazid resistant Mycobacterium tuberculosis H37Rv clinical isolate 7 harboring katG S315T mutant
Antitubercular activity against active state Mycobacterium tuberculosis H37Ra assessed as viable cells after 8 days by XTT reduction menadione assay
Antitubercular activity against dormant state Mycobacterium tuberculosis H37Ra assessed as viable cells after 12 days by XTT reduction menadione assay
Antituberculosis activity against Mycobacterium tuberculosis H37Rv in glycerol-alanine salts medium incubated for 4 days by Microplate Alamar Blue assay
Antituberculosis activity against Mycobacterium tuberculosis H37Rv in 7H12 medium incubated for 4 days by Microplate Alamar Blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv mc26206 incubated for 96 hrs by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis incubated for 96 hrs by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by 2-fold broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by microdilution method
Antituberculosis activity against Mycobacterium tuberculosis H37Rv after 2 to 4 weeks by Lowensteine-Jensen method
Antitubercular activity against Mycobacterium tuberculosis after 7 days by microplate Alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis preincubated for 7 days under anaeorobic conditions followed by recovery for 28 hrs by Low-Oxygen-Recovery Assay
Antitubercular activity against Mycobacterium tuberculosis H37Ra infected in African green monkey Vero cells measured daily for 8 days by green fluorescent protein microplate assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv cultured in 7H12 medium after 4 days by microplate Alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv cultured in GAS medium after 4 days by microplate Alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Ra ATCC 25177 incubated for 40 mins by XTT Reduction Menadione Assay
Antimicrobial activity against non-replicating Mycobacterium tuberculosis H37Rv SRI 1345 assessed as inhibition of visual growth incubated for 7 days under anaerobic condition by low oxygen recovery assay
Antitubercular activity against dormant Mycobacterium tuberculosis H37Ra after 12 days by XTT-Menadione assay
Antitubercular activity against dormant Mycobacterium bovis BCG after 12 days by nitrate reductase assay
Tuberculostatic activity against Mycobacterium tuberculosis H37Rv assessed as induction of penetration size stunting incubated for 10 days by vertical diffusion method
Tuberculostatic activity against multi-drug resistant Mycobacterium tuberculosis isolates assessed as induction of penetration size stunting incubated for 10 days by vertical diffusion method
Antitubercular activity against Mycobacterium tuberculosis H37Rv measured after 7 days under aerobic condition
Antitubercular activity against fluoroquinolone-resistant Mycobacterium tuberculosis H37Rv isolate 1 by two-fold serial dilution method
Antitubercular activity against rifampicin-resistant Mycobacterium tuberculosis H37Rv isolate 2 by two-fold serial dilution method
Antitubercular activity against rifampicin-resistant Mycobacterium tuberculosis H37Rv isolate 1 by two-fold serial dilution method
Antitubercular activity against isoniazid-resistant Mycobacterium tuberculosis H37Rv isolate 2 by two-fold serial dilution method
Antitubercular activity against isoniazid-resistant Mycobacterium tuberculosis H37Rv isolate 1 by two-fold serial dilution method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv expressing bacterial luciferase measured after 10 days under hypoxia condition by LORA assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv measured after 5 days under aerobic condition by two-fold serial dilution method
Antimicrobial activity against p-aminosalicylic acid/isonicotinic acid hydrazide/etambutol/rifampicin sensitive Mycobacterium tuberculosis Spec. 192 by classical test tube method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv by classical test tube method
Antimicrobial activity against p-aminosalicylic acid/isonicotinic acid hydrazide/etambutol/rifampicin resistant Mycobacterium tuberculosis Spec. 210 by classical test tube method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 7 days by BacTiter-Glo cell viability assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv SRI 1345 after 7 days
Antimicrobial activity against isoniazid resistant Mycobacterium tuberculosis SRI 1369 after 7 days
Antimicrobial activity against rifampicin resistant Mycobacterium tuberculosis SRI 1367 after 7 days
Antimicrobial activity against ofloxacin resistant Mycobacterium tuberculosis SRI 4000 after 7 days
Antimycobacterial activity against Mycobacterium tuberculosis mc'2-7000x assessed as inhibition of mycobacterial growth
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATTC 27294 assessed as inhibition of mycobacterial growth incubated for 7 days
Antimycobacterial activity against drug-resistant Mycobacterium tuberculosis isolate MDR1 assessed as inhibition of mycobacterial growth incubated for 9 days
Antimycobacterial activity against drug-resistant Mycobacterium tuberculosis isolate MDR2 assessed as inhibition of mycobacterial growth incubated for 9 days
Antitubercular activity against Mycobacterium tuberculosis clinical isolate by BACTEC 460 TB method
Antitubercular activity against Mycobacterium tuberculosis after 24 hrs by microplate Alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 3 days by microplate Alamar Blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by BACTEC method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 10 days by micro broth dilution method
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis harbouring Beijing genotype with combination of mutations of Ser 53-Leu 315 and Ser-Thr in rpoB and katG genes after 10 days by micro broth dilution method
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth after 7 days by resazurin assay
Antibacterial activity against isoniazid-resistant Mycobacterium tuberculosis RS-032 clinical isolate harboring katG S315T mutant assessed as reduction in bacterial growth after 7 days by resazurin assay
Antibacterial activity against multidrug-resistant Mycobacterium tuberculosis PE-003 clinical isolate harboring inhA C(-15)T mutant assessed as reduction in bacterial growth after 7 days by resazurin assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as reduction in bacterial growth after 6 days by resazurin assay
Antibacterial activity against isoniazid-resistant Mycobacterium tuberculosis RS-036 clinical isolate harboring inhA C(-15)T mutant assessed as reduction in bacterial growth after 7 days by resazurin assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv in 7H12 medium by microplate alamar blue assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv in GAS medium by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by agar dilution technique
Antibacterial activity against Mycobacterium tuberculosis H37Rv under iron-deficient condition after 10 to 14 days by broth microdilution method
Antibacterial activity against Mycobacterium tuberculosis H37Ra after 7 days by resazurin dye based fluorescence assay
Antibacterial activity against Mycobacterium tuberculosis BSG001 incubated overnight by microbroth-dilution method
Antibacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 after 7 days by two-fold serial dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25197 after 7 days by resazurin microtiter assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of visible growth after 7 days by microbroth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis under aerobic condition after 7 days by microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 24 hrs by microbroth dilution method
Antimycobacterial activity against rifampin and isoniazid resistant-Mycobacterium tuberculosis Beijing harboring Ser 531 to Leu 315 and Ser to Thr in rpoB and katG genes mutation after 24 hrs by microbroth dilution method
Antimycobacterial activity against active stage of Mycobacterium tuberculosis H37Ra ATCC 25177 measured on day 8 by XTT reduction menadione assay
Antimycobacterial activity against dormant stage of Mycobacterium tuberculosis H37Ra ATCC 25177 measured on day 12 by XTT reduction menadione assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by two-fold agar dilution method
Antibacterial activity against Mycobacterium tuberculosis H37Ra ATCC 2517 by two fold serial dilution method
Antibacterial activity against ofloxacin-resistant Mycobacterium tuberculosis by two fold serial dilution method
Antibacterial activity against rifampin/isoniazid-resistant Mycobacterium tuberculosis CSU 45 SRI 1377 by two fold serial dilution method
Antibacterial activity against actively replicative Mycobacterium tuberculosis H37Rv measured after 7 days by MABA assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 5 days by microplate alamar blue assay
AntiMycobacterium tuberculosis activity 2-week 7H9/glucose/BSA/Tx  MIC (uM)
AntiMycobacterium tuberculosis activity 1-week 7H9/DPPC/cholesterol/BSA/Tx MIC (uM)
AntiMycobacterium tuberculosis activity 2-week 7H9/DPPC/cholesterol/BSA/Tx MIC (uM)
AntiMycobacterium tuberculosis activity 1-week GAST/Fe MIC (uM)
AntiMycobacterium tuberculosis activity 2-week GAST/Fe MIC (uM)
AntiMycobacterium tuberculosis activity 1-week 7H9/ADC/Tw MIC (uM)
AntiMycobacterium tuberculosis activity 2-week 7H9/ADC/Tw MIC (uM)
AntiMycobacterium tuberculosis activity 1-week 7H9/cholesterol/BSA/Tx  MIC (uM)
AntiMycobacterium tuberculosis activity 2-week Alamar Blue 7H9/ADC/Tw MIC (uM)
AntiMycobacterium tuberculosis activity 1-week 7H9/glucose/BSA/Tx  MIC (uM)
AntiMycobacterium tuberculosis activity 2-week Alamar Blue 7H9/cholesterol/BSA/Tx MIC (uM)
AntiMycobacterium tuberculosis activity day 21 MIC99 in 7H9/2.5mM butyrate/pH6/0.1mM nitrite MIC99 (uM)
Antibacterial activity against Mycobacterium tuberculosis MTCC 300 after 7 days by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv measured daily for 8 days by GFP-based fluorescence assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by MABA
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 6 days by resazurin assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv in 1000 bacteria inoculated agar plate
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv in 100000 bacteria inoculated agar plate
Antitubercular activity against Mycobacterium tuberculosis H37Rv by Alamar blue assay
Antibacterial activity against Mycobacterium tuberculosis H37Ra expressing pSMTB1 luciferase reporter gene measured after 7 days by serial dilution assay
Antimycobacterial activity against isoniazid/rifampicin-resistant Mycobacterium tuberculosis isolate 11168 after 7 days by microplate alamar blue assay
Antimycobacterial activity against isoniazid/rifampicin-resistant Mycobacterium tuberculosis isolate 9160 after 7 days by microplate alamar blue assay
Antitubercular activity against active stage Mycobacterium tuberculosis H37Ra measured after 8 days by XTT assay
Antitubercular activity against dormant stage Mycobacterium tuberculosis H37Ra measured after 12 days by XTT assay
Antitubercular activity against Mycobacterium tuberculosis H37Ra transfected with TYOK plasmid assessed as relative light units after 4 days by selectable marker-free autoluminescent assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition by Alamar-Blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 days by micro plate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra measured after 7 days by alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as reduction in 2 log10 bacterial colonies measured after 14 to 21 days by agar dilution method
"Antimycobacterial activity against isoniazid, streptomycin and ethambutol resistant Mycobacterium tuberculosis clinical isolate 01;104 assessed as reduction in 2 log10 bacterial colonies measured after 14 to 21 days by agar dilution method"
"Antimycobacterial activity against rifampicin, streptomycin and ethambutol resistant Mycobacterium tuberculosis clinical isolate 01;005 assessed as reduction in 2 log10 bacterial colonies measured after 14 to 21 days by agar dilution method"
Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 01;111 assessed as reduction in 2 log10 bacterial colonies measured after 14 to 21 days by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 01;087 assessed as reduction in 2 log10 bacterial colonies measured after 14 to 21 days by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 01;092 assessed as reduction in 2 log10 bacterial colonies measured after 14 to 21 days by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 01;095 assessed as reduction in 2 log10 bacterial colonies measured after 14 to 21 days by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 01;064 assessed as reduction in 2 log10 bacterial colonies measured after 14 to 21 days by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 01;057 assessed as reduction in 2 log10 bacterial colonies measured after 14 to 21 days by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 01;001 assessed as reduction in 2 log10 bacterial colonies measured after 14 to 21 days by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis measured after 5 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis incubated for 7 days by alamar blue assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 25618 after 8 to 9 days by BacT/Alert MP bottle assay
Antibacterial activity against isoniazid/rifampin-resistant Mycobacterium tuberculosis after 8 to 9 days by BacT/Alert MP bottle assay
Antibacterial activity against rifampin-resistant Mycobacterium tuberculosis after 8 to 9 days by BacT/Alert MP bottle assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv measured after 5 days by MTT dye based two-fold microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis isolate 51 measured after 5 days by MTT dye based two-fold microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis isolate 164 measured after 5 days by MTT dye based two-fold microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis isolate 304 measured after 5 days by MTT dye based two-fold microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis isolate 598 measured after 5 days by MTT dye based two-fold microdilution method
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis isolate 110 measured after 5 days by MTT dye based two-fold microdilution method
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis isolate 277 measured after 5 days by MTT dye based two-fold microdilution method
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis isolate 300 measured after 5 days by MTT dye based two-fold microdilution method
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis isolate 925 measured after 5 days by MTT dye based two-fold microdilution method
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis isolate 958 measured after 5 days by MTT dye based two-fold microdilution method
Antimycobacterial activity against isoniazid resistant Mycobacterium tuberculosis isolate 277b measured after 5 days by MTT dye based two-fold microdilution method
Antimycobacterial activity against isoniazid resistant Mycobacterium tuberculosis isolate 620 measured after 5 days by MTT dye based two-fold microdilution method
Antimycobacterial activity against isoniazid/streptomycin resistant Mycobacterium tuberculosis isolate 396 measured after 5 days by MTT dye based two-fold microdilution method
Antimycobacterial activity against isoniazid/streptomycin resistant Mycobacterium tuberculosis isolate 681 measured after 5 days by MTT dye based two-fold microdilution method
Antimycobacterial activity against isoniazid/streptomycin resistant Mycobacterium tuberculosis isolate 780 measured after 5 days by MTT dye based two-fold microdilution method
Antimycobacterial activity against isoniazid/streptomycin resistant Mycobacterium tuberculosis isolate 914 measured after 5 days by MTT dye based two-fold microdilution method
Antimycobacterial activity against rifampicin/streptomycin resistant Mycobacterium tuberculosis isolate 675 measured after 5 days by MTT dye based two-fold microdilution method
Antimycobacterial activity against rifampicin/isoniazid/pyrazinamide resistant Mycobacterium tuberculosis isolate 122 measured after 5 days by MTT dye based two-fold microdilution method
Antimycobacterial activity against rifampicin/isoniazid/pyrazinamide resistant Mycobacterium tuberculosis isolate 501 measured after 5 days by MTT dye based two-fold microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 measured after 10 days by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv My 331/88 after 14 days by micromethod
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv My 331/88 after 21 days by micromethod
Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis 234/2005 after 14 days by micromethod
Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis 234/2005 after 21 days by micromethod
Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis 9449/2007 after 14 days by micromethod
Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis 9449/2007 after 21 days by micromethod
Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis 242/2015 after 14 days by micromethod
Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis Praha 1 after 14 days by micromethod
Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis 242/2015 after 21 days by micromethod
Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis Praha 1 after 21 days by micromethod
Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis Praha 4 after 14 days by micromethod
Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis Praha 4 after 21 days by micromethod
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as cell growth inhibition by microbroth dilution assay
Antimycobacterial activity against dormant Mycobacterium bovis BCG ATCC 35743 after 12 days by neutral red dye based two-fold dilution method
Antimycobacterial activity against dormant Mycobacterium tuberculosis H37Ra ATCC 25177 after 12 days by XTT dye based two-fold dilution method
Antimycobacterial activity against Mycobacterium tuberculosis MC2 7000 by microplate alamar blue assay
Antitubercular activity against dormant stage of Mycobacterium tuberculosis H37Ra ATCC 25177 infected in human THP1 cells after 12 days by nitrate reductase assay
Antitubercular activity against active stage of Mycobacterium tuberculosis H37Ra ATCC 25177 infected in human THP1 cells after 8 days by nitrate reductase assay
Antitubercular activity against dormant stage of Mycobacterium tuberculosis H37Ra ATCC 25177 after 12 days by XTT reduction menadione assay
Antitubercular activity against active stage of Mycobacterium tuberculosis H37Ra ATCC 25177 after 8 days by XTT reduction menadione assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv 331/88 measured after 14 days by micromethod
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv 331/88 measured after 21 days by micromethod
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by REMA
Antimycobacterial activity against patient-derived isoniazid/rifampicin/kanamycin-resistant Mycobacterium tuberculosis 2067 harboring rpoB H526R mutant/ahpC T10 mutant after 7 days by REMA
Antimycobacterial activity against patient-derived strepromycin/isoniazid-resistant Mycobacterium tuberculosis 5227 harboring katG S315T mutant/ahpC A10 mutant after 7 days by REMA
Antimycobacterial activity against patient-derived strepromycin/ethionamide/isoniazid-resistant Mycobacterium tuberculosis 5307 harboring inhA T15 mutant after 7 days by REMA
Antimycobacterial activity against patient-derived multidrug-resistant Mycobacterium tuberculosis 7106 harboring rpoB S531L mutant/katG S315T mutant after 7 days by REMA
Antibacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by microplate alamar blue assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 7357/1998 after 14 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis Praha 1 after 21 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis Praha 4 after 21 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis Praha 131 after 21 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 234/2005 after 21 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 7357/1998 after 21 days by micromethod
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 8666/2010 after 21 days by micromethod
Antimycobacterial activity against Mycobacterium tuberculosis after 14 days
Antimycobacterial activity against Mycobacterium tuberculosis by broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis MDR_CHUV by resazurin reduction microplate assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by resazurin reduction microplate assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv expressing GFP after 7 days
Antimycobacterial activity against Mycobacterium tuberculosis PE-003 clinical isolate after 7 days by resazurin reduction microplate assay
Antimycobacterial activity against Mycobacterium tuberculosis CDCT-4 (1105/09) clinical isolate after 7 days by resazurin reduction microplate assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days in presence of isoniazid by resazurin reduction microplate assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days in presence of rifampin by resazurin reduction microplate assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days in presence of ethambutol by resazurin reduction microplate assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days in presence of ethionamide by resazurin reduction microplate assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days in presence of moxifloxacin by resazurin reduction microplate assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days in presence of streptomycin by resazurin reduction microplate assay
Antimycobacterial activity against isoniazid/rifampicin/ethambutol-resistant Mycobacterium tuberculosis clinical isolate after 4 days by Alamar blue assay
Antimycobacterial activity against isoniazid/rifampicin/ethambutol-sensitive Mycobacterium tuberculosis H37Rv after 4 days by Alamar blue assay
Antimycobacterial activity against isoniazid/rifampicin/kanamycin/streptomycin-resistant Mycobacterium tuberculosis by microplate Alamar Blue assay
Antimycobacterial activity against isoniazid/rifampicin/kanamycin/capreomycin-resistant Mycobacterium tuberculosis by microplate Alamar Blue assay
Antimycobacterial activity against isoniazid/rifampicin/kanamycin/streptomycin/ofloxacin/moxifloxacin/levofloxacin-resistant Mycobacterium tuberculosis by microplate Alamar Blue assay
Antimycobacterial activity against isoniazid/rifampicin/streptomycin-resistant Mycobacterium tuberculosis by microplate Alamar Blue assay
Antimycobacterial activity against isoniazid/rifampicin-resistant Mycobacterium tuberculosis by microplate Alamar Blue assay
Antimycobacterial activity against clinical isolates of multidrug resistant/extensively drug resistant Mycobacterium tuberculosis Praha 1 after 14 days by micromethod
Antimycobacterial activity against clinical isolates of multidrug resistant/extensively drug resistant Mycobacterium tuberculosis Praha 1 after 21 days by micromethod
Antimycobacterial activity against clinical isolates of multidrug resistant/extensively drug resistant Mycobacterium tuberculosis Praha 4 after 14 days by micromethod
Antimycobacterial activity against clinical isolates of multidrug resistant/extensively drug resistant Mycobacterium tuberculosis Praha 4 after 21 days by micromethod
Antimycobacterial activity against clinical isolates of multidrug resistant/extensively drug resistant Mycobacterium tuberculosis Praha 131 after 14 days by micromethod
Antimycobacterial activity against clinical isolates of multidrug resistant/extensively drug resistant Mycobacterium tuberculosis Praha 131 after 21 days by micromethod
Antimycobacterial activity against clinical isolates of multidrug resistant/extensively drug resistant Mycobacterium tuberculosis 9449/2007 after 14 days by micromethod
Antimycobacterial activity against clinical isolates of multidrug resistant/extensively drug resistant Mycobacterium tuberculosis 9449/2007 after 21 days by micromethod
Antimycobacterial activity against clinical isolates of multidrug resistant/extensively drug resistant Mycobacterium tuberculosis 234/2005 after 14 days by micromethod
Antimycobacterial activity against clinical isolates of multidrug resistant/extensively drug resistant Mycobacterium tuberculosis 234/2005 after 21 days by micromethod
Antimycobacterial activity against clinical isolates of multidrug resistant/extensively drug resistant Mycobacterium tuberculosis 7357/1998 after 14 days by micromethod
Antimycobacterial activity against clinical isolates of multidrug resistant/extensively drug resistant Mycobacterium tuberculosis 7357/1998 after 21 days by micromethod
Antimycobacterial activity against clinical isolates of multidrug resistant/extensively drug resistant Mycobacterium tuberculosis 8666/2010 after 14 days by micromethod
Antimycobacterial activity against clinical isolates of multidrug resistant/extensively drug resistant Mycobacterium tuberculosis 8666/2010 after 21 days by micromethod
Antibacterial activity against wild type Mycobacterium tuberculosis H37Rv after 14 days
Antibacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by resazurin microdilution assay
Antimycobacterial activity against Mycobacterium tuberculosis after 7 days under aerobic condition by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis under hypoxic condition by LORA
Antimicrobial activity against Mycobacterium tuberculosis H37Rv after 6 days by resazurin dye based method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv after 6 days in presence of efflux pump inhibitor verapamil by resazurin dye based method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv after 6 days in presence of efflux pump inhibitor PAbetaN by resazurin dye based method
Antimicrobial activity against Mycobacterium tuberculosis harboring Tap efflux pump deletion mutant after 6 days by resazurin dye based method
Antimicrobial activity against Mycobacterium tuberculosis harboring Mmr efflux pump deletion mutant after 6 days by resazurin dye based method
Anti-tubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days under aerobic condition by microplate alamar blue assay
Anti-tubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 10 days under hypoxic condition by low-oxygen recovery assay
Antibacterial activity against Mycobacterium bovis BCG grown in 7H9 medium after 6 days by resazurin-based fluorescent method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv after 7 days by resazurin microtiter assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 24 hrs by micro broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv MC2-6206 after 8 days by resazurin microtiter based colorimetric assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in microbial growth incubated for 5 days by CLSI protocol based assay
Antitubercular activity against isoniazid resistant Mycobacterium tuberculosis H37Rv harboring KAtG Y155 deletion mutant after 5 days
Antitubercular activity against Mycobacterium tuberculosis H37Ra harboring pTYOK in UAIRa broth culture assessed as concentration required to reduce relative luminescence unit to <10% measured after 4 days by autoluminescence assay
Antitubercular activity against isoniazid resistant Mycobacterium tuberculosis ATCC 35822 after 5 days
Antitubercular activity against rifampicin resistant Mycobacterium tuberculosis H37Rv harboring rpoB S522L mutant after 5 days
Antitubercular activity against rifampicin resistant Mycobacterium tuberculosis ATCC 35828 after 5 days
Antitubercular activity against fluoroquinolone resistant Mycobacterium tuberculosis H37Rv harboring gyrB D94N mutant after 5 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 25618 after 6 days by resazurin dye based assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by Resazurin microtitre assay
Antitubercular activity against rifampicin-resistant Mycobacterium tuberculosis ATCC 35338 harboring His-526-Tir mutation in rpoB gene after 7 days by Resazurin microtitre assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 25618 after 6 days by resazurin dye based assay
Antitubercular activity against clinical isolates of Mycobacterium tuberculosis by broth microdilution assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 grown under Middlebrook 7H9 broth after 2 weeks by microscopic analysis
Antitubercular activity against Mycobacterium tuberculosis H37Rv incubated for 7 days under anaerobic condition measured by broth microdilution method
Antitubercular activity against NRP-2 stage of Mycobacterium tuberculosis H37Rv ATCC 27294 grown under glycerol free dubos broth after 7 days by microscopic analysis
Antibacterial activity against multidrug-resistant Mycobacterium tuberculosis
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of mycobacterial growth incubated for 2 weeks by MABA method
Antimycobacterial activity against isoniazid/rifampicin/ethambutol-resistant Mycobacterium tuberculosis G122 assessed as inhibition of mycobacterial growth incubated for 2 weeks by MABA method
Antimycobacterial activity against isoniazid/rifampicin/streptomycin-resistant Mycobacterium tuberculosis G133 assessed as inhibition of mycobacterial growth incubated for 2 weeks by MABA method
Antitubercular activity against Mycobacterium tuberculosis H37RV after 16 to 24 hrs under aerobic condition by MABA assay
Antitubercular activity against Mycobacterium tuberculosis H37RV under hypoxic condition by LORA assay
Antimycobacterial activity against Mycobacterium tuberculosis Erdman ATCC 35801 by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 303 by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 1889 by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 35829 by broth dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 10 days by tube dilution method
Antimycobacterial activity against Bovin sensitive Mycobacterium tuberculosis measured after six weeks
Antimycobacterial activity against human sensitive Mycobacterium tuberculosis measured after six weeks
Antimycobacterial activity against human resistant Mycobacterium tuberculosis measured after six weeks
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 measured after 5 to 8 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by serial dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 10 to 12 days by serial dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by NCCLS method
Antimycobacterial activity against Mycobacterium tuberculosis Academia by serial dilution method
Antimycobacterial activity against Mycobacterium tuberculosis 331/88 after 14 to 21 days by micromethod
Antitubercular activity against Mycobacterium tuberculosis H37Ra ATCC 25177 after 4 weeks by Agar-based proportion Assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by two fold dilution method
Antimycobacterial activity against isoniazid/rifampicin/ethambutol-resistant Mycobacterium tuberculosis 09710 by two fold dilution method
Antitubercular activity against Mycobacterium tuberculosis by microdilution method
Antitubercular activity against isoniazid/rifampicin/fluoroquinolone-resistant Mycobacterium tuberculosis
Antitubercular activity against Mycobacterium tuberculosis H37Ra by GFP based microplate assay
Antimycobacterial activity against Mycobacterium tuberculosis RCMB 010126 clinical isolate after 7 days by MABA
Antitubercular activity against Mycobacterium tuberculosis INH-R1 harboring katG Y155 truncated mutant after 5 days by fluorescence-based assay
Antitubercular activity against Mycobacterium tuberculosis INH-R2 ATCC 35822 after 5 days by fluorescence-based assay
Antitubercular activity against Mycobacterium tuberculosis RIF-R1 harboring rpoB S522L mutant after 5 days by fluorescence-based assay
Antitubercular activity against Mycobacterium tuberculosis RIF-R2 ATCC 35828 after 5 days by fluorescence-based assay
Antitubercular activity against Mycobacterium tuberculosis FQ-R1 harboring gyrB D94N mutant after 5 days by fluorescence-based assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 days measured under aerobic conditions by fluorescence-based assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 expressing luxABCDE operon incubated for 10 days under hypoxic conditions followed by incubation under aerobic conditions for 28 hrs by LORA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv by Lowensteine-Jensen method
Antitubercular activity against Mycobacterium tuberculosis spec.210
Antitubercular activity against Mycobacterium tuberculosis spec.192
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in in mycobacterial growth incubated for 5 days by MTT assay
Antimycobacterial activity against Mycobacterium tuberculosis MDR-TB
Antimycobacterial activity against Mycobacterium tuberculosis XDR-TB
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by Alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 10 days under low oxygen condition followed by second incubation under aerobic condition for 28 hrs by LORA
Antitubercular activity against Mycobacterium tuberculosis H37Rv measured after 7 days under aerobic condition by alamar blue assay
Antibacterial activity against isonizaid/rifampicin/streptomycin/ethambutol-resistant Mycobacterium tuberculosis isolate FJ05195 after 18 hrs by agar dilution method
Antibacterial activity against isonizaid/rifampicin/streptomycin/ethambutol-resistant Mycobacterium tuberculosis isolate FJ05436 after 18 hrs by agar dilution method
Antibacterial activity against isonizaid/rifampicin-resistant Mycobacterium tuberculosis isolate FJ05120 after 18 hrs by agar dilution method
Antibacterial activity against Mycobacterium tuberculosis isolate FJ05060 after 18 hrs by agar dilution method
Antibacterial activity against Mycobacterium tuberculosis isolate FJ05349 after 18 hrs by agar dilution method
Antibacterial activity against Mycobacterium tuberculosis H37Rv after 18 hrs by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial growth incubated for 28 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by broth dilution assay
Antimycobacterial activity against Mycobacterium tuberculosis after 5 days by MABA
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 72 hrs by alamar blue dye-based broth dilution assay
Antimycobacterial activity against INH resistant Mycobacterium tuberculosis after 72 hrs by alamar blue dye-based broth dilution assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by MABA
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 12 to 28 days by Lowenstein and Jensen method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by BACTEC method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv measured after 1 week by resazurin assay
Antimycobacterial activity against isoniazid/rifampicin/ethambutol-resistant Mycobacterium tuberculosis after 3 days by rapid direct susceptibility test
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 3 days by rapid direct susceptibility test
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 25618 after 7 days by resazurin dye based assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by resazurin dye based two-fold dilution assay
Antimycobacterial activity against Mycobacterium tuberculosis ATCC 25177 after 5 days by Alamar blue based CLSI method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 21 days
Antimycobacterial activity against INH/RIF/rifabutine/STM resistant Mycobacterium tuberculosis 9449/2006 after 14 days
Antimycobacterial activity against INH/RIF/rifabutine/STM resistant Mycobacterium tuberculosis 9449/2006 after 21 days
Antimycobacterial activity against INH/RIF/rifabutine/STM/EMB/clofazimine resistant Mycobacterium tuberculosis Praha 1 after 14 days
Antimycobacterial activity against INH/RIF/rifabutine/STM/EMB/clofazimine resistant Mycobacterium tuberculosis Praha 1 after 21 days
Antimycobacterial activity against INH/RIF/rifabutine/STM/EMB/OFX/clofazimine resistant Mycobacterium tuberculosis Praha 4 after 14 days
Antimycobacterial activity against INH/RIF/rifabutine/STM/EMB/OFX/clofazimine resistant Mycobacterium tuberculosis Praha 4 after 21 days
Antimycobacterial activity against INH/RIF/rifabutine/STM/EMB resistant Mycobacterium tuberculosis 234/2005 after 14 days
Antimycobacterial activity against INH/RIF/rifabutine/STM/EMB resistant Mycobacterium tuberculosis 234/2005 after 21 days
Antimycobacterial activity against INH/RIF/rifabutine/STM/EMB/OFX/gentamicin/amikacin resistant Mycobacterium tuberculosis Praha 131 after 14 days
Antimycobacterial activity against INH/RIF/rifabutine/STM/EMB/OFX/gentamicin/amikacin resistant Mycobacterium tuberculosis Praha 131 after 21 days
Antitubercular activity against dormant stage of Mycobacterium tuberculosis H37Ra ATCC 25177 after 12 days by XRMA
Antitubercular activity against active stage of Mycobacterium tuberculosis H37Ra ATCC 25177 after 8 days by XRMA
Antitubercular activity against multidrug-resistant dormant stage of Mycobacterium tuberculosis H37Ra after 12 days by XRMA
Antitubercular activity against multidrug-resistant active stage of Mycobacterium tuberculosis H37Ra after 8 days by XRMA
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by resazurin dye based assay
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis isolate CDCT10 harboring rpoB/katG mutant gene after 7 days by resazurin dye based assay
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis isolate CDCT16 harboring rpoB/katG/inhA mutant gene after 7 days by resazurin dye based assay
Antitubercular activity against isoniazid/ethambutol-resistant Mycobacterium tuberculosis isolate CDCT27 harboring katG mutant gene after 7 days by resazurin dye based assay
Antitubercular activity against Mycobacterium tuberculosis isolate CDCT28 harboring rpoB mutant gene after 7 days by resazurin dye based assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by Two-fold serial dilution assay
Antimycobacterial activity against Mycobacterium bovis BCG in low iron containing medium
Antimycobacterial activity against Mycobacterium bovis BCG in 7H9 medium
Antibacterial activity against replicative stage Mycobacterium tuberculosis H37Rv after 7 days by MABA
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 days under aerobic condition
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 10 days under low oxygen condition followed by incubation under aerobic condition for 28 hrs by LORA
Antitubercular activity against isoniazid-resistant Mycobacterium tuberculosis H37Rv INH-R1 harboring katG Y155 mutant after 5 days
Antitubercular activity against rifampicin-resistant Mycobacterium tuberculosis H37Rv RIF-R1 harboring rpoB S522L mutant after 5 days
Antitubercular activity against fluoroquinolone-resistant Mycobacterium tuberculosis H37Rv harboring gyrB D94N mutant after 5 days
Antitubercular activity against isoniazid-resistant Mycobacterium tuberculosis INH-R2 ATCC 35822 after 5 days
Antitubercular activity against rifampicin-resistant Mycobacterium tuberculosis H37Rv RIF-R2 ATCC 35828 after 5 days
Antibacterial activity against Mycobacterium tuberculosis H37Rv after 1 week by MABA
Antibacterial activity against Mycobacterium tuberculosis H37Rv after 1 week in presence of efflux pump inhibitor piperine by MABA
Antibacterial activity against Mycobacterium tuberculosis H37Rv after 1 week in presence of efflux pump inhibitor verapamil by MABA
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25197 assessed as reduction in bacterial growth incubated for 7 days by resazurin microtiter assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 using 7H9/ADC/Tween medium after 1 week in absence of guanine and presence of anhydrotetracycline by Alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis SRMV2.6 harboring IMPDH2 Y487C mutant using 7H9/ADC/Tween medium after 1 week in absence of guanine by Alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 using GAST/Fe medium after 1 week in absence of guanine by broth microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 using GAST/Fe medium after 1 week in presence of guanine by broth microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 using 7H9/ADC/Tween medium after 1 week in absence of guanine by broth microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 using 7H9/ADC/Tween medium after 1 week in presence of guanine by broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 2 weeks by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv measured after 1 week
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv measured after 2 weeks
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv harboring cyd deletion mutant measured after 2 weeks by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis MC2 7000
Antimycobacterial activity against Mycobacterium tuberculosis MC2 6230
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 days by MABA
Antitubercular activity against Mycobacterium tuberculosis H37Rv by broth microdilution Alamar blue assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv in presence of 0.15 ng/ml anhydrotetracycline-induced guaB2 gene silencing by alamar blue assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv in presence of 0.31 ng/ml anhydrotetracycline-induced guaB2 gene silencing by alamar blue assay
Antitubercular activity against isoniazid and rifampicin-resistant Mycobacterium tuberculosis T113/09 harboring katG and rpoB mutant after 5 days by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis SR 2571/0215 harboring katG mutant after 5 days by microplate alamar blue assay
Antitubercular activity against wild-type isoniazid-resistant Mycobacterium tuberculosis harboring katG mutant after 5 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 10 days by MABA
Antimycobacterial activity against MDR Mycobacterium tuberculosis isolate 591 after 15 days by MABA
Antimycobacterial activity against Mycobacterium tuberculosis ATCC 35828
Antimycobacterial activity against Mycobacterium tuberculosis ATCC 35820
Antimycobacterial activity against Mycobacterium tuberculosis ATCC 35822
Antimycobacterial activity against Mycobacterium tuberculosis ATCC 35837
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by MABA
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by serial dilution assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv in logarithmic phase
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv in hypoxia-induced latent phase
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 5 days by MABA
Antimycobacterial activity against non-replicating Mycobacterium tuberculosis
Antitubercular activity against Mycobacterium tuberculosis H37Rv harboring GFP measured after 7 days by fluorescence assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by broth microdilution assay
Antimycobacterial activity against active form of Mycobacterium tuberculosis H37Rv measured after 7 days by alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv measured after 6 days by resazurin assay
Antibacterial activity against Mycobacterium tuberculosis after 7 days by Alamar Blue assay
Antibacterial activity against Mycobacterium tuberculosis ATCC 27294 after 7 days by broth microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by MABA
Antitubercular activity against Mycobacterium tuberculosis H37Rv expressing DsRed using 7H9-Ty-5BT medium after 6 days by 2-fold serial dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv expressing DsRed using 7H9-Ty-10BT medium after 6 days by 2-fold serial dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by BacTiter-Glo microbial cell viability assay
Antimycobacterial activity against wild type Mycobacterium bovis BCG harboring pATB45 after 48 hrs by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium bovis BCG harboring pATB45::inhA after 48 hrs by resazurin microtiter assay
Antitubercular activity against rifampicin-resistant Mycobacterium tuberculosis after 21 days by two fold agar dilution method
Antitubercular activity against rifampicin-sensitive Mycobacterium tuberculosis after 21 days by two fold agar dilution method
Antibacterial activity against multidrug resistant Mycobacterium tuberculosis ATTC 27294 by Alamar Blue assay
Antitubercular activity against replicating Mycobacterium tuberculosis H37Rv by Alamar Blue assay
Antitubercular activity against non-replicating Mycobacterium tuberculosis H37Rv after 10 days by low oxygen recovery assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv by serial dilution assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by Alamar Blue assay
Antibacterial activity against multidrug resistant Mycobacterium tuberculosis after 7 days by two fold dilution assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by two fold dilution assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 days by MABA method
Antitubercular activity against multi-drug resistant Mycobacterium tuberculosis
Antibacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 after 7 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by Alamar blue assay
Antimycobacterial activity against isoniazid/rifampicin-resistant Mycobacterium tuberculosis isolate 16995 after 7 days by Alamar blue assay
Antimycobacterial activity against isoniazid/rifampicin-resistant Mycobacterium tuberculosis isolate 16833 after 7 days by Alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 6 days under shaking condition by resazurin dye based fluorescence assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by BACTEC 460 radiometric method
Antitubercular activity against rifampicin-resistant Mycobacterium tuberculosis H37Rv harboring RpoB S522L mutant
Antitubercular activity against isoniazid-resistant Mycobacterium tuberculosis H37Rv harboring katG Y155 mutant
Antitubercular activity against fluoroquinolone-resistant Mycobacterium tuberculosis H37Rv harboring gyrA D94N mutant
Antibacterial activity against Mycobacterium tuberculosis H37Rv measured after 5 days by resazurin-dye based microplate assay
Antibacterial activity against non-replicating Mycobacterium tuberculosis H37Rv harboring pFCA-luxAB preincubated for 10 days under anaerobic condition followed by incubation under ambient gaseous condition for 28 hrs by LORA
Antimycobacterial activity against kanamycin-resistant Mycobacterium tuberculosis H37Rv ATCC 3582
Antimycobacterial activity against ethionamide-resistant Mycobacterium tuberculosis H37Rv ATCC 35830
Antimycobacterial activity against ethambutol-resistant Mycobacterium tuberculosis H37Rv ATCC 35837
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis H37Rv ATCC 35822
Antimycobacterial activity against p-aminosalicyclic acid-resistant Mycobacterium tuberculosis H37Rv ATCC 35821
Antimycobacterial activity against streptomycin-resistant Mycobacterium tuberculosis H37Rv ATCC 35820
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis H37Rv ATCC 35828
Antimycobacterial activity against ofloxacin-resistant Mycobacterium tuberculosis H37Rv ATCC 35828
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis H37Rv INH-R1 harboring katG Y155 truncated mutant
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis H37Rv RIF-R1 harboring rpoB S522L mutant
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis H37Rv ATCC 35822 INH-R2
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis H37Rv ATCC 35828 RIF-R2
Antimycobacterial activity against fluoroquinolone-resistant Mycobacterium tuberculosis H37Rv FQ-R1 harboring unidentified mutation
Antimycobacterial activity against streptomycin-resistant Mycobacterium tuberculosis H37Rv ATCC 35820 by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 5 days by MABA method
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 after 7 days by Alamar Blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Ra ATCC 25177 after 7 days by resazurin microtiter assay
Antimycobacterial activity against replicating Mycobacterium tuberculosis H37Rv incubated for 1 week by MABA method
Antimycobacterial activity against replicating Mycobacterium tuberculosis H37Rv incubated for 1 week in presence of verapamil by MABA method
Antimycobacterial activity against replicating Mycobacterium tuberculosis H37Rv incubated for 1 week in presence of piperine by MABA method
Antitubercular activity against Mycobacterium tuberculosis after 6 days by resazurin-based fluorescence assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 14 days by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated in dark for 5 days by Alamar Blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Ra after 5 days by luminescence assay
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis isolate R7 after 7 days by microplate alamar blue assay
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis isolate P91 after 7 days by microplate alamar blue assay
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis isolate P103 after 7 days by microplate alamar blue assay
Antimycobacterial activity against ethionamide-resistant Mycobacterium tuberculosis ATCC 35830 by resazurin dye based fluorimetric method
Antimycobacterial activity against ethambutol-resistant Mycobacterium tuberculosis ATCC 35837 by resazurin dye based fluorimetric method
Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis clinical isolate
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis clinical isolate
Antimycobacterial activity against drug-susceptible Mycobacterium tuberculosis clinical isolate
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 measured after 7 days by microplate alamar blue assay
Antimycobacterial activity against kanamycin-resistant Mycobacterium tuberculosis ATCC 35827 by resazurin dye based fluorimetric method
Antimycobacterial activity against p-aminosalicyclic acid-resistant Mycobacterium tuberculosis ATCC 35821 by resazurin dye based fluorimetric method
Antimycobacterial activity against streptomycin-resistant Mycobacterium tuberculosis ATCC 35820 by resazurin dye based fluorimetric method
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis H37Rv by resazurin dye based fluorimetric method
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 2 weeks by broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by pesto blue-dye based broth microdilution assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 7106 harboring rpoB S531L/katG S315T mutation after 7 days by resazurin microtitre plate assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 5023 harboring rpoB S531L/katG S315T mutation mutation after 7 days by resazurin microtitre plate assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 2712 harboring rpoB S531L/katG I335V/ahpC T10 mutation after 7 days by resazurin microtitre plate assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by resazurin microtitre plate assay
Antimycobacterial activity against ethambutol/isoniazid/rifampicin-resistant Mycobacterium tuberculosis incubated for 7 days by rapid direct susceptibility test
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 7 days by rapid direct susceptibility test
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv MC2 6206 by CLSI method
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 to 14 days in presence of middlebrook 7H9/BSA medium by two fold serial dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 to 14 days in presence of GAST medium by two fold serial dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 to 14 days in presence of middlebrook GBSA or DBSA medium by two fold serial dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 to 14 days in presence of middlebrook 7H9/BSA/Tyloxapol/butyrate/sodium nitrite medium by two fold serial dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 to 14 days in presence of middlebrook 7H9/BSA/Tyloxapol/cholesterol medium by two fold serial dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv harboring cydC::aph mutant after 7 to 14 days in presence of middlebrook 7H9/ADC medium by two fold serial dilution method
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 10 days by GFP based fluorescence assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 16 hrs
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 11 days by serial dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 10 to 12 days by double serial dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 10 to 12 days by vertical diffusion method
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 1 week by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as parasite growth inhibition measured after 7 days incubation by microplate alamar blue assay
Antitubercular activity against multidrug resistant Mycobacterium tuberculosis isolate 11168 assessed as parasite growth inhibition measured after 7 days incubation by microplate alamar blue assay
Antitubercular activity against multidrug resistant Mycobacterium tuberculosis isolate 9160 assessed as parasite growth inhibition measured after 7 days incubation by microplate alamar blue assay
Antitubercular activity against clinical drug sensitive Mycobacterium tuberculosis K14b00DS after 14 days in presence of middlebrook 7H9/BSA medium by eleven fold serial dilution method
Antitubercular activity against multi-drug resistant Mycobacterium tuberculosis K26b00MR after 14 days in presence of middlebrook 7H9/BSA medium by eleven fold serial dilution method
Antitubercular activity against multi-drug resistant Mycobacterium tuberculosis K29b00MR after 14 days in presence of middlebrook 7H9/BSA medium by eleven fold serial dilution method
Antitubercular activity against multi-drug resistant Mycobacterium tuberculosis K22b00MR after 14 days in presence of middlebrook 7H9/BSA medium by eleven fold serial dilution method
Antitubercular activity against multi-drug resistant Mycobacterium tuberculosis K25b00MR after 14 days in presence of middlebrook 7H9/BSA medium by eleven fold serial dilution method
Antitubercular activity against serine beta-lactamase producing Mycobacterium tuberculosis H37Rv after 14 days in presence of Chol/BSA medium by eleven fold serial dilution method
Antitubercular activity against serine beta-lactamase producing Mycobacterium tuberculosis H37Rv after 14 days in presence of Glu/BSA medium by eleven fold serial dilution method
Antitubercular activity against serine beta-lactamase producing Mycobacterium tuberculosis H37Rv after 14 days in presence of DPPC/BSA medium by eleven fold serial dilution method
Antitubercular activity against serine beta-lactamase producing Mycobacterium tuberculosis H37Rv after 14 days in presence of Glu/Cas medium by eleven fold serial dilution method
Antitubercular activity against serine beta-lactamase producing Mycobacterium tuberculosis H37Rv after 14 days in presence of DPCC/Cas medium by eleven fold serial dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv incubated for 6 days by resazurin dye based fluorescence assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial cell growth incubated for 14 days by broth dilution method
Antitubercular activity against Mycobacterium tuberculosis RCMB 010126 after 7 days by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis RCMB 010126 clinical isolate after 4 days by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 15 days by turbidometric method
Antitubercular activity against rifampicin-resistant Mycobacterium tuberculosis after 7 days by resazurin dye based colorimetric assay
Antitubercular activity against isoniazid-resistant Mycobacterium tuberculosis after 7 days by resazurin dye based colorimetric assay
Antitubercular activity against streptomycin-resistant Mycobacterium tuberculosis after 7 days by resazurin dye based colorimetric assay
Antitubercular activity against kanamycin-resistant Mycobacterium tuberculosis after 7 days by resazurin dye based colorimetric assay
Antitubercular activity against moxifloxacin-resistant Mycobacterium tuberculosis after 7 days by resazurin dye based colorimetric assay
Antitubercular activity against d-cycloserine-resistant Mycobacterium tuberculosis after 7 days by resazurin dye based colorimetric assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 after 7 days by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv mc2 6206 after 7 days by resazurin microtiter assay
Antimycobacterial activity against multidrug (INH and RIF)-resistant Mycobacterium tuberculosis clinical isolate 1 assessed as inhibition of bacterial growth incubated for 7 days by rapid direct susceptibility test technique
"Antimycobacterial activity against multidrug (ethambutol, INH and RIF)-resistant Mycobacterium tuberculosis clinical isolate 2 assessed as inhibition of bacterial growth incubated for 7 days by rapid direct susceptibility test technique"
Antitubercular activity against Mycobacterium tuberculosis H37Ra after 8 days by visual analysis
Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis H37Rv measured after 7 days by resazurin dye-based assay
Antimycobacterial activity against patient-derived multidrug-resistant Mycobacterium tuberculosis 2712 measured after 7 days by resazurin dye-based assay
Antimycobacterial activity against patient-derived multidrug-resistant Mycobacterium tuberculosis 5023 measured after 7 days by resazurin dye-based assay
Antimycobacterial activity against patient-derived multidrug-resistant Mycobacterium tuberculosis 7106 measured after 7 days by resazurin dye-based assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv reduction in bacterial multiplication incubated for 7 days by luminometric assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by broth microdilution method
Antitubercular activity against streptomycin/isoniazid/ethambutol resistant Mycobacterium tuberculosis isolate 1097 after 7 days by resazurin microtiter assay
Antitubercular activity against rifampicin resistant Mycobacterium tuberculosis isolate 952 after 7 days by resazurin microtiter assay
Antitubercular activity against Mycobacterium tuberculosis isolate 1567 after 7 days by resazurin microtiter assay
Antitubercular activity against Mycobacterium tuberculosis isolate 1535 after 7 days by resazurin microtiter assay
Antitubercular activity against ciprofloxacin resistant Mycobacterium tuberculosis isolate 600 after 7 days by resazurin microtiter assay
Antitubercular activity against Mycobacterium tuberculosis isolate 1657 after 7 days by resazurin microtiter assay
Antitubercular activity against multidrug resistant Mycobacterium tuberculosis isolate 1120 after 7 days by resazurin microtiter assay
Antitubercular activity against multidrug resistant Mycobacterium tuberculosis isolate 571 after 7 days by resazurin microtiter assay
Antitubercular activity against isoniazid/ethambutol resistant Mycobacterium tuberculosis isolate 368 after 7 days by resazurin microtiter assay
Antitubercular activity against streptomycin resistant Mycobacterium tuberculosis isolate 157 after 7 days by resazurin microtiter assay
Antitubercular activity against streptomycin resistant Mycobacterium tuberculosis isolate 204 after 7 days by resazurin microtiter assay
Antitubercular activity against streptomycin resistant Mycobacterium tuberculosis isolate 203 after 7 days by resazurin microtiter assay
Antitubercular activity against rifampicin/ethambutol resistant Mycobacterium tuberculosis isolate 1726 after 7 days by resazurin microtiter assay
Antitubercular activity against Mycobacterium tuberculosis isolate 147 after 7 days by resazurin microtiter assay
Antitubercular activity against Mycobacterium tuberculosis isolate 1777 after 7 days by resazurin microtiter assay
Antitubercular activity against Mycobacterium tuberculosis isolate 1574 after 7 days by resazurin microtiter assay
Antitubercular activity against Mycobacterium tuberculosis isolate 231 after 7 days by resazurin microtiter assay
Antitubercular activity against multidrug resistant Mycobacterium tuberculosis isolate 7 after 7 days by resazurin microtiter assay
Antitubercular activity against multidrug resistant Mycobacterium tuberculosis isolate 512 after 7 days by resazurin microtiter assay
Antitubercular activity against ciprofloxacin resistant Mycobacterium tuberculosis isolate 1670 after 7 days by resazurin microtiter assay
Antitubercular activity against isoniazid resistant Mycobacterium tuberculosis isolate 1358 after 7 days by resazurin microtiter assay
Antimicrobial activity against autoluminescent Mycobacterium tuberculosis H37Ra assessed as test compound concentration causing ratio of drug treated RLU/untreated RLU less than 10% measured every day up to 6 days by luminometric method
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 6 days by alamar blue reagent based assay
Antimycobacterial activity against miltidrug-resistant Mycobacterium tuberculosis
Antimycobacterial activity against Mycobacterium tuberculosis isolate 11168 after 4 days by microplate Alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis isolate 19810 after 4 days by microplate Alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis isolate 19806 after 4 days by microplate Alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis isolate 19805 after 4 days by microplate Alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis isolate 19863 after 4 days by microplate Alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis isolate 19675 after 4 days by microplate Alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis isolate 19769 after 4 days by microplate Alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis isolate 19874 after 4 days by microplate Alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis isolate 19852 after 4 days by microplate Alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis isolate 19809 after 4 days by microplate Alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 4 days by microplate Alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv by MABA
Antitubercular activity against Mycobacterium tuberculosis H37Rv by LORA
Antitubercular activity against Mycobacterium tuberculosis H37Rv measured after 1 week by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra UAlRa incubated for 6 days by luminescence based assay
Antimycobacterial activity against Mycobacterium tuberculosis K2
Antimycobacterial activity against Mycobacterium tuberculosis K12
Antimycobacterial activity against Mycobacterium tuberculosis K16
Antimycobacterial activity against Mycobacterium tuberculosis K18
Antimycobacterial activity against Mycobacterium tuberculosis K4
Antimycobacterial activity against Mycobacterium tuberculosis K5
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as reduction in microbial growth after 7 days by alamar blue assay
Antibacterial activity against multidrug resistant Mycobacterium tuberculosis
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial cell growth incubated for 8 days measured under aerobic MABA conditions by alamar blue staining based assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial cell growth incubated for 11 days measured under anaerobic LORA condition by luminescence assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as reduction in bacterial cell viability incubated for 7 days by microplate alamar blue assay
Antimycobacterial activity against multidrug resistance Mycobacterium tuberculosis 16883 clinical isolate assessed as reduction in bacterial cell viability incubated for 7 days by microplate alamar blue assay
Antitubercular activity against resistant Mycobacterium tuberculosis TDR harboring inhA Promoter (c-15 t) mutant
Antitubercular activity against resistant Mycobacterium tuberculosis TDR harboring inhA Promoter (c-15 t)/Ser94Ala mutant
Antitubercular activity against resistant Mycobacterium tuberculosis TDR harboring inhA Promoter (c-15 t)/IIe21Thr mutant
Antitubercular activity against resistant Mycobacterium tuberculosis Bangladesh isolate harboring inhA Promoter (c-15 t)
Antitubercular activity against resistant Mycobacterium tuberculosis Bangladesh isolate harboring inhA Promoter (c-15 t)/IIe21Thr mutant
Antitubercular activity against resistant Mycobacterium tuberculosis Bangladesh isolate harboring inhA Promoter (c-15 t)/Ser94Ala mutant
Antitubercular activity against resistant Mycobacterium tuberculosis harboring embCAB Met306IIe/Val mutant
Antitubercular activity against resistant Mycobacterium tuberculosis harboring embCAB Gly406Asp/Ala mutant
Antitubercular activity against resistant Mycobacterium tuberculosis harboring rrs A1401G mutant
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 25618
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 35838
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 35822
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 35837
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 35820
Antitubercular activity against Mycobacterium tuberculosis Kurono ATCC 35812
Antitubercular activity against Mycobacterium tuberculosis by radiometric analysis
Antitubercular activity against multidrug resistant Mycobacterium tuberculosis
Antitubercular activity against Mycobacterium tuberculosis XDR
Antimycobacterial activity against Mycobacterium tuberculosis extracellular forms assessed as inhibition of microbial growth
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of microbial growth incubated for 6 days by alamar blue resazurin assay
Antimycobacterial activity against Mycobacterium tuberculosis 2-RM1 expressing ethA frameshift mutant assessed as inhibition of microbial growth incubated for 6 days by alamar blue resazurin assay
Antimycobacterial activity against Mycobacterium tuberculosis 3-RM1 expressing mymA mutant assessed as inhibition of microbial growth incubated for 6 days by alamar blue resazurin assay
Antimycobacterial activity against Mycobacterium tuberculosis Rv3083::Tn expressing mymA mutant assessed as inhibition of microbial growth incubated for 6 days by alamar blue resazurin assay
Antimycobacterial activity against Mycobacterium tuberculosis SG2 expressing ethA and mymA mutant assessed as inhibition of microbial growth incubated for 6 days by alamar blue resazurin assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv in liquid medium
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial cell growth by resazurin reduction method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv overexpressing DprE1 assessed as reduction in bacterial cell growth
Antimycobacterial activity against BTZ043-resistant Mycobacterium tuberculosis H37Rv harbouring DprE1 C387G mutant assessed as reduction in bacterial cell growth
"Antimycobacterial activity against 1,4-azaindole resistant Mycobacterium tuberculosis H37Rv harbouring DprE1 Y314H mutant assessed as reduction in bacterial cell growth"
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv harbouring DprE1 Y314S mutant assessed as reduction in bacterial cell growth
Antimycobacterial activity against BTZ043-resistant Mycobacterium tuberculosis H37Rv harbouring DprE1 C387S mutant assessed as reduction in bacterial cell growth
Antitubercular activity against replicating Mycobacterium tuberculosis H37Rv assessed as growth inhibition measured after 7 days incubation by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as bacterial growth inhibition incubated for 5 days by standard microdilution method
"Antitubercular activity against isoniazid, streptomycin, ethionamide and ethambutol resistant Mycobacterium tuberculosis isolate 1 assessed as growth inhibition"
Antitubercular activity against isoniazid and ethionamide resistant Mycobacterium tuberculosis isolate 2 assessed as growth inhibition
"Antitubercular activity against isoniazid, streptomycin and rifampicin resistant Mycobacterium tuberculosis isolate 3 assessed as growth inhibition"
Antitubercular activity against isoniazid and rifampicin resistant Mycobacterium tuberculosis isolate 4 assessed as growth inhibition
Antitubercular activity against isoniazid and ethionamide resistant Mycobacterium tuberculosis isolate 5 assessed as growth inhibition
"Antitubercular activity against isoniazid, streptomycin and ethionamide resistant Mycobacterium tuberculosis isolate 6 assessed as growth inhibition"
"Antitubercular activity against isoniazid, streptomycin, ethionamide, ethambutol and rifampicin resistant Mycobacterium tuberculosis isolate 7 assessed as growth inhibition"
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis incubated for 7 days by rapid direct susceptibility test
Antimycobacterial activity against multidrug (isoniazid and rifampicin) resistant Mycobacterium tuberculosis 1 incubated for 7 days by rapid direct susceptibility test
Antimycobacterial activity against multidrug (isoniazid and rifampicin) resistant Mycobacterium tuberculosis 2 incubated for 7 days by rapid direct susceptibility test
Antimycobacterial activity against GFP-fused Mycobacterium tuberculosis H37Rv by resazurin dye-based micro-broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after overnight incubation by REMA method
Antimycobacterial activity against GFP-fused Mycobacterium tuberculosis H37Rv after 7 days by fluorescence assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 24 hrs by REMA method
Antimycobacterial activity against recombinant GFP-fused Mycobacterium tuberculosis H37Rv after 10 days by resazurin dye-based assay
Antimycobacterial activity against Mycobacterium tuberculosis after 5 days by turbidity assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv after 7 days by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 6 days by AlphaLISA assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv by time-kill assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 cultured in medium containing 7H9/glucose/BSA/Tyloxapol assessed as reduction in bacterial growth incubated for 7 days by Alamar blue reagent based assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 cultured in medium containing 7H9/glucose/BSA/Tyloxapol assessed as reduction in bacterial growth incubated for 14 days by Alamar blue reagent based assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 cultured in medium containing 7H9/DPPC/ cholesterol/BSA/Tyloxapol assessed as reduction in bacterial growth incubated for 7 days by Alamar blue reagent based assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 cultured in medium containing 7H9/DPPC/ cholesterol/BSA/Tyloxapol assessed as reduction in bacterial growth incubated for 14 days by Alamar blue reagent based assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 cultured in medium containing 7H9/glucose/casitone/Tyloxapol assessed as reduction in bacterial growth incubated for 7 days by Alamar blue reagent based assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 cultured in medium containing 7H9/glucose/casitone/Tyloxapol assessed as reduction in bacterial growth incubated for 14 days by Alamar blue reagent based assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 cultured in media containing 7H9/DPPC/casitone/Tyloxapol assessed as reduction in bacterial growth incubated for 7 days by Alamar blue reagent based assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 cultured in media containing 7H9/DPPC/casitone/Tyloxapol assessed as reduction in bacterial growth incubated for 14 days by Alamar blue reagent based assay
Antitubercular activity against multi drug resistant Mycobacterium tuberculosis isolate 1
Antitubercular activity against multi drug resistant Mycobacterium tuberculosis isolate 2
Antitubercular activity against multi drug resistant Mycobacterium tuberculosis isolate 3
Antitubercular activity against multi drug resistant Mycobacterium tuberculosis isolate 4
Antitubercular activity against multi drug resistant Mycobacterium tuberculosis isolate 5
Antitubercular activity against multi drug resistant Mycobacterium tuberculosis isolate 6
Antitubercular activity against multi drug resistant Mycobacterium tuberculosis isolate 7
Antitubercular activity against extensively drug resistant Mycobacterium tuberculosis isolate 8
Antitubercular activity against extensively drug resistant Mycobacterium tuberculosis isolate 9
Antitubercular activity against extensively drug resistant Mycobacterium tuberculosis isolate 10
Antitubercular activity against extensively drug resistant Mycobacterium tuberculosis isolate 11
Antimycobacterial against GFP-transfected Mycobacterium tuberculosis H37Rv assessed as reduction in GFP protein expression and measured every 2 days for 12 days
Antibacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by resazurin dye-based assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv transfected with pMV261 empty vector after 7 days by resazurin dye-based assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv over expressing InhA after 7 days by resazurin dye-based assay
Antimycobacterial activity against Mycobacterium tuberculosis MC2 7000 after 6 days by alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by rapid direct susceptibility test
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 09710 by rapid direct susceptibility test
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 3 to 7 days by rapid direct susceptibility test
Antimycobacterial activity against isoniazid/rifampicin/ethambutol-resistant Mycobacterium tuberculosis after 3 to 7 days by rapid direct susceptibility test
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis after 3 to 7 days by rapid direct susceptibility test
Antibacterial activity against non-replicating Mycobacterium tuberculosis H37Rv after 5 days under hypoxic condition by resazurin dye-based fluorescence assay
Antibacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 measured after 1 week
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 25618 after 6 days by resazurin dye-based fluorescence assay
Antibacterial activity against Mycobacterium tuberculosis over expressing DprE1 after 6 days by resazurin dye-based fluorescence assay
Antimycobacterial activity against Mycobacterium tuberculosis MC2 6230 assessed as reduction in cell viability incubated for 5 days by resazurin based method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated fro 96 hrs
Antimycobacterial activity against Mycobacterium tuberculosis incubated for 7 days by resazurin dye based assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 days by MABA
Anti-mycobacterial activity against Mycobacterium tuberculosis H37Rv
Anti-mycobacterial activity against isoniazid and rifampicin-resistant Mycobacterium tuberculosis
Antimycobacterial against Mycobacterium tuberculosis H37Rv incubated for 7 days by MABA assay
Antimycobacterial against Mycobacterium tuberculosis
Antitubercular activity against Mycobacterium tuberculosis H37Rv incubated for 7 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 5 days under aerobic condition by fluorescence assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as reduction in mycobacterial growth incubated for 5 days by MABA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv measured after 7 days by alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv measured after 7 days under aerobic condition by resazurin dye based assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 6 days by resazurin dye based fluorescence assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis assessed as complete inhibition of bacterial growth incubated for 7 days by rapid direct susceptibility test
Antimycobacterial activity against drug-susceptible Mycobacterium tuberculosis H37Rv assessed as complete inhibition of bacterial growth incubated for 7 days by rapid direct susceptibility test
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of parasite growth incubated for 6 days by REMA method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by micro plate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC27294 measured after 2-3 weeks by agar dilution SPOTi assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 days by resazurin dye based assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv incubated for 42 days by Lowensteine-Jensen method
Antimycobacterial activity against isoniazid resistant Mycobacterium tuberculosis H37Rv ATCC 27294 measured after 7 days by resazurin microtiter assay
Antimycobacterial activity against isoniazid resistant Mycobacterium tuberculosis ATCC 35822 after 7 days by resazurin microtiter assay
Antimycobacterial activity against isoniazid resistant Mycobacterium tuberculosis measured after 7 days by resazurin microtiter assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv incubated for 5 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by Alamar Blue staining-based broth microdilution assay
Antibiofilm activity against Mycobacterium bovis BCG after 5 weeks
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by Alamar Blue assay
Antitubercular activity against multidrug resistant Mycobacterium tuberculosis isolate 2
Antitubercular activity against multidrug resistant Mycobacterium tuberculosis isolate 1
Antibacterial activity against drug-resistant Mycobacterium tuberculosis isolate 1 after 7 days by resazurin microtiter assay
Antibacterial activity against drug-resistant Mycobacterium tuberculosis isolate 2 after 7 days by resazurin microtiter assay
Antibacterial activity against drug-resistant Mycobacterium tuberculosis isolate 3 after 7 days by resazurin microtiter assay
Antibacterial activity against drug-resistant Mycobacterium tuberculosis isolate 4 after 7 days by resazurin microtiter assay
Antibacterial activity against drug-resistant Mycobacterium tuberculosis isolate 5 after 7 days by resazurin microtiter assay
Antibacterial activity against Mycobacterium tuberculosis after 20 hrs by NCCLS-based two-fold broth dilution method
Antibacterial activity against Mycobacterium tuberculosis Kurono
Antibacterial activity against Mycobacterium tuberculosis JCM 6384
Antimycobacterial activity against Mycobacterium tuberculosis in absence of tryptophan by Alamar Blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 6 days by resazurin dye based fluorescence assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 2 weeks in presence of GAST-Fe medium
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 2 weeks in presence of 7H9/ADC medium
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 2 weeks in presence of 7H9/glucose medium
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 2 weeks in presence of 7H9/DPPC medium
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra ITM-M006710 after 48 hr by resazurin dye based microdilution method
Antimycobacterial activity against multi drug resistant Mycobacterium tuberculosis 7357/1998 after 14 days
Antimycobacterial activity against multi drug resistant Mycobacterium tuberculosis 7357/1998 after 21 days
Antimycobacterial activity against multi drug resistant Mycobacterium tuberculosis 9449/2006 after 14 days
Antimycobacterial activity against multi drug resistant Mycobacterium tuberculosis 9449/2006 after 21 days
Antimycobacterial activity against multi drug resistant Mycobacterium tuberculosis 8666/2010 after 14 days
Antimycobacterial activity against multi drug resistant Mycobacterium tuberculosis 8666/2010 after 21 days
Antimycobacterial activity against multi drug resistant Mycobacterium tuberculosis 234/2005 after 14 days
Antimycobacterial activity against multi drug resistant Mycobacterium tuberculosis 234/2005 after 21 days
Antimycobacterial activity against multi drug resistant Mycobacterium tuberculosis Praha 1 after 14 days
Antimycobacterial activity against multi drug resistant Mycobacterium tuberculosis Praha 1 after 21 days
Antimycobacterial activity against multi drug resistant Mycobacterium tuberculosis Praha 4 after 14 days
Antimycobacterial activity against multi drug resistant Mycobacterium tuberculosis Praha 4 after 21 days
Antimycobacterial activity against XDR Mycobacterium tuberculosis Praha 131 after 14 days
Antimycobacterial activity against XDR Mycobacterium tuberculosis Praha 131 after 21 days
Antibacterial activity against Mycobacterium tuberculosis H37Rv by resazurin dye-based assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv by MABA
Antibacterial activity against Mycobacterium tuberculosis H37Rv after 5 days
Antibacterial activity against Mycobacterium tuberculosis CNCTC My 331/88
Antimycobacterial activity against isoniazid/rifampicin-resistant Mycobacterium tuberculosis isolate 16995 after 7 days by microplate alamar blue assay
Antimycobacterial activity against isoniazid/rifampicin-resistant Mycobacterium tuberculosis isolate 16833 after 7 days by microplate alamar blue assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv after 5 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth incubated for 2 weeks in 7H9/glucose media by 2-fold serial dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth incubated for 2 weeks in 7H9/DPPC media by 2-fold serial dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 days by Alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 days by alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 6 days by alamar blue assay
Antitubercular activity against isoniazid/ethionamide resistant Mycobacterium tuberculosis isolate 1 after 7 days
Antitubercular activity against isoniazid/ethionamide resistant Mycobacterium tuberculosis isolate 2 after 7 days
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis isolate 3 after 7 days
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis isolate 4 after 7 days
Antitubercular activity against isoniazid/rifampicin resistant Mycobacterium tuberculosis isolate 5 after 7 days
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis isolate 6 after 7 days
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis isolate 7 after 7 days
Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis isolate 8 after 7 days
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 days by Resazurin microtitre assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 1 to 2 weeks
Antitubercular activity against oxygen-deprived Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 5 days under aerobic conditions by LOR assay
Antitubercular activity against oxygen-deprived Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition preincubated for 10 days under anaerobic conditions followed by incubation under aerobic conditions for 28 hrs by LOR assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv FQ-R1 harboring gyrB D94N mutant after 5 days
Antitubercular activity against Mycobacterium tuberculosis H37Rv RIF-R2 ATCC 35828 after 5 days
Antitubercular activity against Mycobacterium tuberculosis H37Rv RIF-R1 harboring nrpoB S522L mutant after 5 days
Antitubercular activity against Mycobacterium tuberculosis H37Rv INH-R2 ATCC 35822 after 5 days
Antitubercular activity against Mycobacterium tuberculosis H37Rv INH-R1 harboring katG Y155 mutant after 5 days
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition under aerobic conditions after 5 days by dual read-out fluorescence assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition in aerobic conditions by dual read out fluorescence assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 days by broth macrodilution assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv by radiometric assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by agar dilution assay
Antituberculosis activity against Mycobacterium tuberculosis H37Rv after 5 days by MABA method
Antibacterial activity against Mycobacterium tuberculosis 607
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 5 days by alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis Erdman
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv measured after 28 days by Lowensteine-Jensen method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25197 assessed as inhibition of bacterial cell growth incubated for 7 days by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial cell growth incubated for 7 days by resazurin microtiter assay
Antimycobacterial activity against Isoniazid-resistant Mycobacterium tuberculosis ATCC 35822 assessed as inhibition of bacterial cell growth incubated for 7 days by resazurin microtiter assay
Antimycobacterial activity against Pyrazinamide-resistant Mycobacterium tuberculosis ATCC 35828 assessed as inhibition of bacterial cell growth incubated for 7 days by resazurin microtiter assay
Antimycobacterial activity against Rifampicin-resistant Mycobacterium tuberculosis ATCC 35838 assessed as inhibition of bacterial cell growth incubated for 7 days by resazurin microtiter assay
Antimycobacterial activity against Streptomycin-resistant Mycobacterium tuberculosis ATCC 35820 assessed as inhibition of bacterial cell growth incubated for 7 days by resazurin microtiter assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 7 days by resazurin assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv by microbroth dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Ra measured for 5 days by resazurin dye-based assay
Antibacterial activity against multidrug-resistant Mycobacterium tuberculosis M22 after 9 days by inverted microscopic analysis
Antibacterial activity against multidrug-resistant Mycobacterium tuberculosis M23 after 9 days by inverted microscopic analysis
Antibacterial activity against multidrug-resistant Mycobacterium tuberculosis P887 after 9 days by inverted microscopic analysis
Antibacterial activity against extensively drug resistant Mycobacterium tuberculosis X24 after 9 days by inverted microscopic analysis
Antibacterial activity against extensively drug resistant Mycobacterium tuberculosis X59 after 9 days by inverted microscopic analysis
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by microplate alamar blue method
Antibacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by resazurin dye-based fluorescence assay
Antitubercular activity against Mycobacterium tuberculosis measured after 48 hrs by luminescence based serial dilution method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv incubated for 10 days by microbroth dilution method
Antimicrobial activity against rifampin and isoniazid resistant Mycobacterium tuberculosis Beijing harboring rpoB Ser 531-Leu 315 and katC Ser-Thr mutant incubated for 10 days by microbroth dilution method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 7 days by microplate Alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth incubated for 7 days by resazurin dye based assay
Antimycobacterial activity against Mycobacterium tuberculosis 3614 harbouring wild type KatG and InhA Ile21Thr mutant assessed as reduction in bacterial growth incubated for 7 days by resazurin dye based assay
Antimycobacterial activity against Mycobacterium tuberculosis 19 harbouring KatG Ser315Thr mutant and wild type InhA assessed as reduction in bacterial growth incubated for 7 days by resazurin dye based assay
Antimycobacterial activity against Mycobacterium tuberculosis 73A harbouring KatG Ser315Thr mutant and wild type InhA assessed as reduction in bacterial growth incubated for 7 days by resazurin dye based assay
Antimycobacterial activity against Mycobacterium tuberculosis 91 harbouring KatG Ser315Thr mutant and wild type InhA assessed as reduction in bacterial growth incubated for 7 days by resazurin dye based assay
Antimycobacterial activity against Mycobacterium tuberculosis BRF45 harbouring KatG Ser315Thr mutant and wild type InhA assessed as reduction in bacterial growth incubated for 7 days by resazurin dye based assay
Antimycobacterial activity against Mycobacterium tuberculosis BRF57 harbouring KatG Ser315Thr mutant and wild type InhA assessed as reduction in bacterial growth incubated for 7 days by resazurin dye based assay
Antimycobacterial activity against Mycobacterium tuberculosis BRF14 harbouring KatG Ser315Thr mutant and wild type InhA assessed as reduction in bacterial growth incubated for 7 days by resazurin dye based assay
Antimycobacterial activity against Mycobacterium tuberculosis BRF16 harbouring KatG Ser315Thr mutant and wild type InhA assessed as reduction in bacterial growth incubated for 7 days by resazurin dye based assay
Antimycobacterial activity against Mycobacterium tuberculosis 71A harbouring KatG Ser315Thr mutant and wild type InhA assessed as reduction in bacterial growth incubated for 7 days by resazurin dye based assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 6 days by resazurin dye-based colorimetric method
Antibacterial activity against Mycobacterium tuberculosis assessed as reduction in microbial growth
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by BACTEC radiometric growth assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 7 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in microbial growth after 7 days by alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth incubated for 7 days by resazurin based assay
Antimycobacterial activity against multidrug resistance Mycobacterium tuberculosis CCM11.1 assessed as reduction in bacterial growth incubated for 7 days by resazurin based assay
Antimycobacterial activity against multidrug resistance Mycobacterium tuberculosis CCM10.1 assessed as reduction in bacterial growth incubated for 7 days by resazurin based assay
Antimycobacterial activity against Mycobacterium bovis BCG assessed as reduction in bacterial growth incubated for 48 hrs by HT-SPOTi assay
Antimycobacterial activity against Mycobacterium tuberculosis drug resistant clinical isolates
Antitubercular activity against Mycobacterium tuberculosis harboring mmpL3
Antimycobacterial activity against Mycobacterium tuberculosis clinical isolates
"Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as reduction in mycolic acids synthesis after 8 hrs in presence of [1, 2-14C]-acetate by TLC analysis"
Antimycobacterial activity against Mycobacterium tuberculosis expressing DprE1
Antimycobacterial activity against Mycobacterium tuberculosis expressing WecA
Antimycobacterial activity against multi drug-resistant Mycobacterium tuberculosis expressing WecA
Antimycobacterial activity against Mycobacterium tuberculosis expressing Rv1258c efflux pump
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra after 7 to 8 days by MABA assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv expressing LeuRS
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv overexpressing DprE1
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as reduction in bacterial growth incubated for 5 hrs by alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis assessed as reduction in bacterial growth by microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis assessed as reduction in bacterial growth incubated for 21 days by REMA assay
Antitubercular activity against Mycobacterium tuberculosis mc2 6230 assessed as inhibition of bacterial growth incubated for 7 days by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth by MABA assay
Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis G122 incubated for 5 days by alamar blue based colorimetric assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 5 days by alamar blue based colorimetric assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as reduction in microbial growth by broth dilution method
Antitubercular activity against autoluminescent Mycobacterium tuberculosis H37Rv assessed as reduction in microbial growth by two-fold serial dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as reduction in microbial growth incubated for 1 week by MTT assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as reduction in microbial growth incubated for 5 to 7 days by inverted plate count method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as reduction in microbial growth incubated
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 cultured in 7H12 media assessed as reduction in bacterial growth incubated for 7 days by resazurin dye fluorescence based assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 cultured in GAS media assessed as reduction in bacterial growth incubated for 7 days by resazurin dye fluorescence based assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in microbial growth incubated for 7 days by alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of microbial growth incubated for 5 days by alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as inhibition of microbial growth incubated for 1 week by MABA method
Antitubercular activity against PAS/INH/EMB/RMP-resistant Mycobacterium tuberculosis Spec.210 assessed as inhibition of microbial growth incubated for 1 week by MABA method
Antitubercular activity against Mycobacterium tuberculosis Spec.192 assessed as inhibition of microbial growth incubated for 1 week by MABA method
Antitubercular activity against INH-resistant Mycobacterium tuberculosis Spec.800 harboring InhA promoter mutation assessed as inhibition of microbial growth incubated for 1 week by MABA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as reduction in bacterial growth incubated for 14 days in presence of 1/2 x MIC rifampicin by MABA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as reduction in bacterial growth incubated for 14 days in presence of 1/2 x MIC isoniazid by MABA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as reduction in bacterial growth incubated for 14 days in presence of 1/2 x MIC streptomycin by MABA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as reduction in bacterial growth incubated for 14 days in presence of 1/2 x MIC ethambutol by MABA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as rifampicin MIC incubated for 14 days in presence of rifampicin by MABA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as isoniazid MIC incubated for 14 days in presence of isoniazid by MABA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as streptomycin MIC incubated for 14 days in presence of streptomycin by MABA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as ethambutol MIC incubated for 14 days in presence of ethambutol by MABA method
Antitubercular activity against Mycobacterium tuberculosis Spec.192 assessed as reduction in bacterial growth incubated for 14 days in presence of 1/2 x MIC rifampicin by MABA method
Antitubercular activity against Mycobacterium tuberculosis Spec.192 assessed as reduction in bacterial growth incubated for 14 days in presence of 1/2 x MIC isoniazid by MABA method
Antitubercular activity against Mycobacterium tuberculosis Spec.192 assessed as reduction in bacterial growth incubated for 14 days in presence of 1/2 x MIC streptomycin by MABA method
Antitubercular activity against Mycobacterium tuberculosis Spec.192 assessed as reduction in bacterial growth incubated for 14 days in presence of 1/2 x MIC ethambutol by MABA method
Antitubercular activity against Mycobacterium tuberculosis Spec.192 assessed as rifampicin MIC incubated for 14 days in presence of rifampicin by MABA method
Antitubercular activity against Mycobacterium tuberculosis Spec.192 assessed as isoniazid MIC incubated for 14 days in presence of isoniazid by MABA method
Antitubercular activity against Mycobacterium tuberculosis Spec.192 assessed as streptomycin MIC incubated for 14 days in presence of streptomycin by MABA method
Antitubercular activity against Mycobacterium tuberculosis Spec.192 assessed as ethambutol MIC incubated for 14 days in presence of ethambutol by MABA method
Antitubercular activity against PAS/INH/EMB/RMP-resistant Mycobacterium tuberculosis Spec.210 assessed as reduction in bacterial growth incubated for 14 days in presence of 1/2 x MIC rifampicin by MABA method
Antitubercular activity against PAS/INH/EMB/RMP-resistant Mycobacterium tuberculosis Spec.210 assessed as reduction in bacterial growth incubated for 14 days in presence of 1/2 x MIC isoniazid by MABA method
Antitubercular activity against PAS/INH/EMB/RMP-resistant Mycobacterium tuberculosis Spec.210 assessed as reduction in bacterial growth incubated for 14 days in presence of 1/2 x MIC streptomycin by MABA method
Antitubercular activity against PAS/INH/EMB/RMP-resistant Mycobacterium tuberculosis Spec.210 assessed as reduction in bacterial growth incubated for 14 days in presence of 1/2 x MIC ethambutol by MABA method
Antitubercular activity against PAS/INH/EMB/RMP-resistant Mycobacterium tuberculosis Spec.210 assessed as rifampicin MIC incubated for 14 days in presence of rifampicin by MABA method
Antitubercular activity against PAS/INH/EMB/RMP-resistant Mycobacterium tuberculosis Spec.210 assessed as isoniazid MIC incubated for 14 days in presence of isoniazid by MABA method
Antitubercular activity against PAS/INH/EMB/RMP-resistant Mycobacterium tuberculosis Spec.210 assessed as streptomycin MIC incubated for 14 days in presence of streptomycin by MABA method
Antitubercular activity against PAS/INH/EMB/RMP-resistant Mycobacterium tuberculosis Spec.210 assessed as ethambutol MIC incubated for 14 days in presence of ethambutol by MABA method
Antitubercular activity against INH-resistant Mycobacterium tuberculosis Spec.800 assessed as reduction in bacterial growth incubated for 14 days in presence of 1/2 x MIC rifampicin by MABA method
Antitubercular activity against INH-resistant Mycobacterium tuberculosis Spec.800 assessed as reduction in bacterial growth incubated for 14 days in presence of 1/2 x MIC isoniazid by MABA method
Antitubercular activity against INH-resistant Mycobacterium tuberculosis Spec.800 assessed as reduction in bacterial growth incubated for 14 days in presence of 1/2 x MIC streptomycin by MABA method
Antitubercular activity against INH-resistant Mycobacterium tuberculosis Spec.800 assessed as reduction in bacterial growth incubated for 14 days in presence of 1/2 x MIC ethambutol by MABA method
Antitubercular activity against INH-resistant Mycobacterium tuberculosis Spec.800 assessed as rifampicin MIC incubated for 14 days in presence of rifampicin by MABA method
Antitubercular activity against INH-resistant Mycobacterium tuberculosis Spec.800 assessed as isoniazid MIC incubated for 14 days in presence of isoniazid by MABA method
Antitubercular activity against INH-resistant Mycobacterium tuberculosis Spec.800 assessed as streptomycin MIC incubated for 14 days in presence of streptomycin by MABA method
Antitubercular activity against INH-resistant Mycobacterium tuberculosis Spec.800 assessed as ethambutol MIC incubated for 14 days in presence of ethambutol by MABA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as inhibition of microbial growth by classical test tube method
Antitubercular activity against PAS/INH/EMB/RMP-resistant Mycobacterium tuberculosis Spec.210 assessed as inhibition of microbial growth by classical test tube method
Antitubercular activity against Mycobacterium tuberculosis Spec.192 assessed as inhibition of microbial growth by classical test tube method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 7 days by MABA assay
Antitubercular activity against Mycobacterium tuberculosis H37Ra ATCC 25177 assessed as reduction in microbial growth after 7 days by Alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as reduction in microbial growth by CLSI based broth microdilution method
Antitubercular activity against isoniazid-resistant Mycobacterium tuberculosis clinical isolate measured after 1 week by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth preincubated for 72 hrs followed by phAE202 and Cacl2 addition and measured after 4 hrs by luciferase reporter mycobacterio-phage assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial growth incubated for 7 days by MABA assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial cell growth
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial cell growth measured after 7 days by alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis mc2 6230 assessed as minimum inhibitory concentration required to inhibit 99% of bacterial growth measured after 2 to 3 weeks
Antitubercular activity against Mycobacterium tuberculosis mc2 6230 assessed as minimum inhibitory concentration required to inhibit 99% of bacterial growth incubated for 7 days by two-fold serial dilution method
Antitubercular activity against Mycobacterium tuberculosis mc2 6230 assessed as minimum inhibitory concentration required to inhibit 99% of bacterial growth
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition by MABA relative to control
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 assessed as growth inhibition incubated for 7 days measured after 48 hrs treatment with resazurin by alamarblue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as inhibition of visible bacterial growth by MABA assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra measured up to 7 days
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of microbial growth incubated by measuring turbidity for 5 days by serial microdilution based colorimetric assay
Antimycobacterial activity against Mycobacterium tuberculosis InhA-OE strain assessed as inhibition of microbial growth at 20 uM incubated for 5 days by serial microdilution based colorimetric assay
Antimycobacterial activity against replicating Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 7 days by MABA assay
Antimycobacterial activity against non-replicating Mycobacterium tuberculosis H37Rv expressing pFCA-LuxAB assessed as bacterial growth inhibition incubated for 10 days under anerobic condition by low oxygen recovery assay
Antimycobacterial activity against replicating Mycobacterium tuberculosis H37Ra assessed as inhibition of bacterial growth incubated for 7 days by MABA assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial growth by agar plate dilution method
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis H37Rv ATCC 35822 assessed as inhibition of bacterial growth by agar plate dilution method
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis H37Rv ATCC 35838 assessed as inhibition of bacterial growth by agar plate dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as reduction in bacterial growth by resazurin reduction microplate assay
Antimycobacterial activity against multidrug resistance Mycobacterium tuberculosis CDCT-16 clinical isolates assessed as reduction in bacterial growth by resazurin reduction microplate assay
Antimycobacterial activity against multidrug resistance Mycobacterium tuberculosis CDCT-27 clinical isolates assessed as reduction in bacterial growth by resazurin reduction microplate assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition by MABA
Antitubercular activity against isoniazid/rifampicin multidrug-resistant Mycobacterium tuberculosis FJ05120 clinical isolates assessed as bacterial growth inhibition by MABA
Antitubercular activity against isoniazid/rifampicin/streptomycin/capreomycin/ofloxacin extensively drug-resistant Mycobacterium tuberculosis FJ05195 clinical isolates assessed as bacterial growth inhibition by MABA
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 measured after 7 days by broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth grown under middlebrook 7H9/ADC/Tween medium incubated for 7 days by alamar blue broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth grown under GAST-Fe medium incubated for 7 days by alamar blue broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth grown under middlebrook 7H9/Glucose/BSA/Tyloxapol medium incubated for 7 days by alamar blue broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth grown under middlebrook 7H9/Glucose/Casitone/Tyloxapol medium incubated for 7 days by alamar blue broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth grown under middlebrook 7H9/DPCC/Casitone/Tyloxapol medium incubated for 7 days by alamar blue broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth grown under middlebrook 7H9/DPCC/Cholesterol/BSA/Tyloxapol medium incubated for 7 days by alamar blue broth microdilution method
Antimycobacterial activity against wild-type Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth grown under middlebrook 7H9 medium incubated for 7 days by alamar blue broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv harbouring MpmL3 F255L mutant assessed as inhibition of bacterial growth grown under middlebrook 7H9 medium incubated for 7 to 14 days by alamar blue broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv harbouring MpmL3 F644L mutant assessed as inhibition of bacterial growth grown under middlebrook 7H9 medium incubated for 7 to 14 days by alamar blue broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv harbouring MpmL3 V681 mutant assessed as inhibition of bacterial growth grown under middlebrook 7H9 medium incubated for 7 to 14 days by alamar blue broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv harbouring MpmL3 G596R mutant assessed as inhibition of bacterial growth grown under middlebrook 7H9 medium incubated for 7 to 14 days by alamar blue broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth grown under Glycerol/Alanine/salts/Tween80 medium incubated for 7 days in presence of 12.5 uM ferrous sulphate by alamar blue broth microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 28 days by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth by microdilution alamar blue broth assay
Antitubercular activity against Mycobacterium tuberculosis isolate 12525 incubated for 7 days by microplate alamar blue assay
Antitubercular activity against linezolid-resistant Mycobacterium tuberculosis incubated for 7 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 14 days by resazurin reduction microplate assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 5 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra incubated for 6 days by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 7 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 by two fold dilution technique
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 5 days by two-fold serial dilution method
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition
"Antitubercular activity against isoniazid,streptomycin,rifampicin,ethambutol,para-aminosalicylate,prothionamide,capreomycin-resistant Mycobacterium tuberculosis 14862 assessed as bacterial growth inhibition"
Antitubercular activity against Mycobacterium tuberculosis H37Rv measured after 7 days by MABA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth
"Antitubercular activity against INH, SM, RFP, EMB, RBT, PAS, OLFX-resistant Mycobacterium tuberculosis 13946 assessed as inhibition of bacterial growth"
"Antitubercular activity against INH, SM, RFP, EMB, PAS, Prothionamide 1321, Capreomycin-resistant Mycobacterium tuberculosis 14862 assessed as inhibition of bacterial growth"
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 6 days by MABA assay
"Antitubercular activity against isoniazid, rifampicin, fluoroquinolones-resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth incubated for 6 days by MABA assay"
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth measured after 7 days by resazurin assay
Antitubercular activity against Mycobacterium tuberculosis mc2-7000 assessed as inhibition of bacterial growth incubated for 6 days by MABA assay
Antimycobacterial activity against patient derived Mycobacterium tuberculosis Spec. 210
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of microbial growth incubated for 1 week by alamar blue based assay
Antimycobacterial activity activity against GFP-tagged Mycobacterium tuberculosis H37Rv assessed as inhibition of microbial growth incubated for 5 days by fluorescence assay
Antimycobacterial activity activity against Mycobacterium tuberculosis H37Ra assessed as inhibition of microbial growth incubated for 4 weeks in culture medium at pH 6.8
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 16 hrs
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial growth under GAST medium condition after 7 to 14 days by broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial growth under 7H9 medium condition after 7 to 14 days by broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial growth under 7H9 medium condition after 7 to 14 days in presence of palmitate by broth microdilution method
Antimycobacterial activity against isoniazid/rifampicin/ethambutol/pyrazinamide/streptomycin/kanamycin/para-aminosalicylic acid/prothionamide multidrug-resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth under 7H9 medium condition after 7 to 14 days in presence of tylo-xapol by broth microdilution method
Antimycobacterial activity against isoniazid/rifampicin/ethambutol/pyrazinamide/streptomycin/kanamycin/para-aminosalicylic acid/prothionamide multidrug-resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth under 7H9 medium condition after 7 to 14 days by broth microdilution method
Antimycobacterial activity against isoniazid/rifampicin/ethambutol/pyrazinamide/streptomycin/kanamycin/para-aminosalicylic acid/prothionamide multidrug-resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth under GAST medium condition after 7 to 14 days by broth microdilution method
Antimycobacterial activity against isoniazid/rifampicin/ethambutol/kanamycin/ofloxacin multidrug-resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth under 7H9 medium condition after 7 to 14 days by broth microdilution method
Antimycobacterial activity against isoniazid/rifampicin/ethambutol/kanamycin/ofloxacin multidrug-resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth under GAST medium condition after 7 to 14 days by broth microdilution method
Antimycobacterial activity against isoniazid/rifampicin/ethambutol/para-aminosalicylic acid extensively drug-resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth under 7H9 medium condition after 7 to 14 days by broth microdilution method
Antimycobacterial activity against isoniazid/rifampicin/ethambutol/para-aminosalicylic acid extensively drug-resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth under GAST medium condition after 7 to 14 days by broth microdilution method
Antimycobacterial activity against isoniazid/rifampicin/ethambutol/streptomycin/ofloxacin/para-aminosalicylic acid/prothionamide multidrug-resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth under 7H9 medium condition after 7 to 14 days by broth microdilution method
Antimycobacterial activity against isoniazid/rifampicin/ethambutol/streptomycin/ofloxacin/para-aminosalicylic acid/prothionamide multidrug-resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth under GAST medium condition after 7 to 14 days by broth microdilution method
Antitubercular activity against Mycobacterium tuberculosis mc2 6230 assessed as inhibition of bacterial growth incubated for 7 days by microtiter plate assay
Antitubercular activity against Mycobacterium tuberculosis H37Ra assessed as bacterial growth inhibition
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 measured on 12th day by XTT reduction menadione assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 7 days by resazurin dye based assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by filter paper disc diffusion method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by Lowenstein-Jensen method relative to control
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by Lowenstein-Jensen method
Antimycobacterial activity against Mycobacterium tuberculosis by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC27294 incubated for 7 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by BACTEC radiometric method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 2729411 by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 25618 incubated for 5 days by colorimetric microdilution assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv measured after 11 to 12 days
Antimycobacterial activity against Mycobacterium tuberculosis measured up to 2 weeks
Antimycobacterial activity against Mycobacterium tuberculosis HN878 measured up to 2 weeks
Antimycobacterial activity against Mycobacterium tuberculosis Erdman measured up to 2 weeks
Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis measured up to 2 weeks
Antimycobacterial activity against ethambutol/pyrazinamide/kanamycin/streptomycin/ofloxacin/moxifloxacin/levofloxacin resistant Mycobacterium tuberculosis measured up to 2 weeks
Antimycobacterial activity against extensively drug resistant Mycobacterium tuberculosis measured up to 2 weeks
Antimycobacterial activity against Mycobacterium africanum measured up to 2 weeks
Antimycobacterial activity Mycobacterium bovis BCG measured up to 2 weeks
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra 7131 incubated for 21 days by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv measured after 14 days by test tube dilution technique
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv measured after 21 days by test tube dilution technique
Antimycobacterial activity against Mycobacterium tuberculosis RCMB 010126 measured after 7 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC27294 measured after 28 days by two-fold serial dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by Lowenstein-Jensen agar method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv measured after 12 to 28 days by Lowenstein-Jensen method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 45 days by Lowenstein-Jensen method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 4 weeks
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 incubated for 7 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth incubated for 5 days by MTT assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as reduction in bacterial growth by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 7 days by microplate alamar blue assay
Antimycobacterial activity against multidrug resistance Mycobacterium tuberculosis 16995 clinical isolate incubated for 7 days by microplate alamar blue assay
Antimycobacterial activity against multidrug resistance Mycobacterium tuberculosis 16833 clinical isolate incubated for 7 days by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Ra ATCC 25177 assessed as reduction in bacterial growth after 6 to 8 days by green fluorescent protein microplate assay
Antitubercular activity against Mycobacterium tuberculosis H37Ra assessed as bacterial growth inhibition in the presence of 7H10/OADC medium
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition after 7 days by broth microdilution assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as reduction in bacterial growth incubated for 48 hrs by broth microdilution assay
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis H37Rv ATCC 35822 assessed as inhibition of bacterial growth incubated for 48 hrs by broth microdilution assay
Antimycobacterial activity against ethambutol-resistant Mycobacterium tuberculosis H37Rv ATCC 35837 assessed as inhibition of bacterial growth incubated for 48 hrs by broth microdilution assay
Antimycobacterial activity against Streptomycin-resistant Mycobacterium tuberculosis H37Rv ATCC 35820 assessed as inhibition of bacterial growth incubated for 48 hrs by broth microdilution assay
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis H37Rv ATCC 35838 assessed as inhibition of bacterial growth incubated for 48 hrs by broth microdilution assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 7 days by MABA assay
"Antitubercular activity against isoniazid,streptomycin,rifampicin,ethambutol,para-aminosalicylate,prothionamide,capreomycin-resistant Mycobacterium tuberculosis clinical isolate 14862 assessed as bacterial growth inhibition incubated for 7 days by MABA assay"
"Antitubercular activity against isoniazid,streptomycin,rifampicin,ethambutol, rifabutin, para-aminosalicylat, ofloxacin-resistant Mycobacterium tuberculosis clinical isolate 13946 assessed as inhibition of bacterial growth incubated for 7 days by MABA assay"
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ACTT 25618 assessed as inhibition of visible growth incubated for 7 days by micro plate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Ra assessed as inhibition of bacterial growth by green fluorescent protein based method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 7 days by microplate Alamar blue assay
Antibacterial activity against Mycobacterium bovis BCG transfected with pMV261:Mt-dprE1 assessed as bacterial growth inhibition incubated for 7 days by resazurin assay
Antibacterial activity against Mycobacterium bovis BCG transfected with pMV261:Mt-dprE2 assessed as bacterial growth inhibition incubated for 7 days by resazurin assay
Antibacterial activity against wild type Mycobacterium bovis BCG assessed as bacterial growth inhibition incubated for 7 days by resazurin assay
Antimycobacterial activity against drug susceptible Mycobacterium tuberculosis H37Rv assessed as minimal inhibitory concentration required for complete inhibition of mycobacterial growth incubated for 14 days
Antimycobacterial activity against drug susceptible Mycobacterium tuberculosis H37Rv assessed as minimal inhibitory concentration required for complete inhibition of mycobacterial growth incubated for 21 days
Antimycobacterial activity against multi drug-resistant Mycobacterium tuberculosis praha 1 assessed as minimal inhibitory concentration required for complete inhibition of mycobacterial growth incubated for 14 days
Antimycobacterial activity against multi drug-resistant Mycobacterium tuberculosis praha 1 assessed as minimal inhibitory concentration required for complete inhibition of mycobacterial growth incubated for 21 days
Antimycobacterial activity against multi drug-resistant Mycobacterium tuberculosis praha 4 assessed as minimal inhibitory concentration required for complete inhibition of mycobacterial growth incubated for 14 days
Antimycobacterial activity against multi drug-resistant Mycobacterium tuberculosis praha 4 assessed as minimal inhibitory concentration required for complete inhibition of mycobacterial growth incubated for 21 days
Antimycobacterial activity against multi drug-resistant Mycobacterium tuberculosis praha 131 assessed as minimal inhibitory concentration required for complete inhibition of mycobacterial growth incubated for 14 days
Antimycobacterial activity against multi drug-resistant Mycobacterium tuberculosis praha 131 assessed as minimal inhibitory concentration required for complete inhibition of mycobacterial growth incubated for 21 days
Antimycobacterial activity against multi drug-resistant Mycobacterium tuberculosis 234/2005 assessed as minimal inhibitory concentration required for complete inhibition of mycobacterial growth incubated for 14 days
Antimycobacterial activity against multi drug-resistant Mycobacterium tuberculosis 234/2005 assessed as minimal inhibitory concentration required for complete inhibition of mycobacterial growth incubated for 21 days
Antimycobacterial activity against multi drug-resistant Mycobacterium tuberculosis 9449/2007 assessed as minimal inhibitory concentration required for complete inhibition of mycobacterial growth incubated for 14 days
Antimycobacterial activity against multi drug-resistant Mycobacterium tuberculosis 9449/2007 assessed as minimal inhibitory concentration required for complete inhibition of mycobacterial growth incubated for 21 days
Antimycobacterial activity against multi drug-resistant Mycobacterium tuberculosis 7357/1998 assessed as minimal inhibitory concentration required for complete inhibition of mycobacterial growth incubated for 14 days
Antimycobacterial activity against multi drug-resistant Mycobacterium tuberculosis 7357/1998 assessed as minimal inhibitory concentration required for complete inhibition of mycobacterial growth incubated for 21 days
Antimycobacterial activity against multi drug-resistant Mycobacterium tuberculosis 8666/2010 assessed as minimal inhibitory concentration required for complete inhibition of mycobacterial growth incubated for 14 days
Antimycobacterial activity against multi drug-resistant Mycobacterium tuberculosis 8666/2010 assessed as minimal inhibitory concentration required for complete inhibition of mycobacterial growth incubated for 21 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra carrying pMC261/pVV16 plasmid assessed as bacterial growth inhibition incubated for 28 days by drop dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra overexpressing InhA assessed as bacterial growth inhibition incubated for 28 days by drop dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra overexpressing KatGs-meg assessed as bacterial growth inhibition incubated for 28 days by drop dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial growth in presence of glucose by broth microdilution method
Antibacterial activity againstMycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth in presence of efflux pump inhibitor PAbetaN and glucose incubated for 6 hrs by microdilution assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth in presence of efflux pump inhibitor verapamil and glucose incubated for 6 hrs by microdilution assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv harboring Tap deletion mutant assessed as inhibition of bacterial growth incubated for 6 hrs by microdilution assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv harboring mmr deletion mutant assessed as inhibition of bacterial growth incubated for 6 hrs by microdilution assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth measured by Resazurin microtitre assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis FURG-2 assessed as inhibition of bacterial growth measured by Resazurin microtitre assay
Antimicrobial activity against Mycobacterium tuberculosis MC2 6220 BSL2 assessed as microbial growth inhibition incubated for 16 hrs under aerobic condition by microplate reader assay
Antimicrobial activity against Mycobacterium tuberculosis MC2 6220 BSL2MIC assessed as microbial growth inhibition incubated for 16 hrs under aerobic condition by microplate reader assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 7 days by MABA
"Antitubercular activity against INH, SM, RFP, EMB, RBT, PAS, OLFX-resistant Mycobacterium tuberculosis 13946 assessed as bacterial growth inhibition incubated for 7 days by MABA"
"Antitubercular activity against INH, SM, RFP, EMB, PAS, Prothionamide 1321, Capreomycin-resistant Mycobacterium tuberculosis 14862 assessed as bacterial growth inhibition incubated for 7 days by MABA"
Antitubercular activity against linezolid resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth incubated for 7 days by MABA
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial growth measured after 5 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium bovis BCG assessed as inhibition of visible mycobacterial growth by broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 assessed as inhibition of bacterial growth incubated for 9 days by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial growth incubated for 9 days by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial growth by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv in presence of middlebrook 7H9/ADC/Tw medium by bioluminescence reporter assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv in presence of middlebrook 7H9/glucose/BSA/tyloxapol medium measured after 14 days by bioluminescence reporter assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv in presence of middlebrook 7H9/DPPC/Cholesterol/BSA/Tx medium by bioluminescence reporter assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv in presence of middlebrook 7H9/Cholesterol/BSA/Tx medium by bioluminescence reporter assay
Antimycobacterial activity against Mycobacterium tuberculosis H37RvMA in presence of middlebrook 7H9/glucose/BSA/tyloxapol medium measured for 2 weeks by bioluminescence reporter assay
Antimycobacterial activity against Mycobacterium tuberculosis delta cyd in presence of middlebrook 7H9/glucose/BSA/tyloxapol medium measured for 2 weeks by bioluminescence reporter assay
Antimycobacterial activity against Mycobacterium tuberculosis QcrB A317T mutant in presence of middlebrook 7H9/glucose/BSA/tyloxapol medium measured for 2 weeks by bioluminescence reporter assay
Antimycobacterial activity against Mycobacterium tuberculosis MmpL3 G253E in presence of middlebrook 7H9/glucose/BSA/tyloxapol medium measured for 2 weeks by bioluminescence reporter assay
Antimycobacterial activity against Mycobacterium tuberculosis MmpL3 G758A in presence of middlebrook 7H9/glucose/BSA/tyloxapol medium measured for 2 weeks by bioluminescence reporter assay
Antimycobacterial activity against Mycobacterium tuberculosis DprE1 Y314C in presence of middlebrook 7H9/glucose/BSA/tyloxapol medium measured for 2 weeks by bioluminescence reporter assay
Antimycobacterial activity against Mycobacterium tuberculosis DprE1 P116S in presence of middlebrook 7H9/glucose/BSA/tyloxapol medium measured for 2 weeks by bioluminescence reporter assay
Antimycobacterial activity against Mycobacterium tuberculosis DprE1 T314H in presence of middlebrook 7H9/glucose/BSA/tyloxapol medium measured for 2 weeks by bioluminescence reporter assay
Antimycobacterial activity against Mycobacterium tuberculosis InhA-OE overexpressing H37Rv-LP:fabGl/inhA-c-15t in presence of middlebrook 7H9/glucose/BSA/tyloxapol medium measured for 2 weeks by bioluminescence reporter assay
Antimycobacterial activity against Mycobacterium tuberculosis KatG T198A in presence of middlebrook 7H9/glucose/BSA/tyloxapol medium measured for 2 weeks by bioluminescence reporter assay
Antimycobacterial activity against Mycobacterium tuberculosis EthA C253R in presence of middlebrook 7H9/glucose/BSA/tyloxapol medium measured for 2 weeks by bioluminescence reporter assay
Antimycobacterial activity against drug-susceptible Mycobacterium tuberculosis S2371 by MIGIT method
Antimycobacterial activity against drug-susceptible Mycobacterium tuberculosis S1125 by MIGIT method
Antimycobacterial activity against multi drug-resistant Mycobacterium tuberculosis MD55 by MIGIT method
Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis R88 by MIGIT method
Antimycobacterial activity against multi drug-resistant Mycobacterium tuberculosis R296 by MIGIT method
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis R3027 by MIGIT method
"In vivo antimycobacterial activity against Mycobacterium tuberculosis Erdman pFCA LuxAB strain32 aerosol infected in BALB/c mouse assessed as reduction in lung burden by measuring free concentration at 200 mg/kg, po once a day treatment initiated 7 days after infection for 12 consecutive days"
Antitubercular activity against Mycobacterium tuberculosis H37RvMA incubated for 14 days in GAST/FE medium by Alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37RvMA incubated for 14 days in 7H9/OHADC medium by Alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as reduction in microbial growth under aerobic condition by luminescence analysis
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as reduction in microbial growth under anaerobic condition by luminescence analysis
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv clinical isolates 1 assessed as reduction in bacterial growth incubated for 7 days by resazurin dye based assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv clinical isolates 4 assessed as reduction in bacterial growth incubated for 7 days by resazurin dye based assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv clinical isolates 3 assessed as reduction in bacterial growth incubated for 7 days by resazurin dye based assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv clinical isolates 2 assessed as reduction in bacterial growth incubated for 7 days by resazurin dye based assay
Antimycobacterial activity against Mycobacterium tuberculosis CydA-KO assessed as reduction in bacterial growth incubated for 7 days by resazurin dye based assay
Antimycobacterial activity against Mycobacterium tuberculosis MmpL3 G253E assessed as reduction in bacterial growth incubated for 7 days by resazurin dye based assay
Antimycobacterial activity against Mycobacterium tuberculosis DprE1 C387S assessed as reduction in bacterial growth incubated for 7 days by resazurin dye based assay
Antimycobacterial activity against Mycobacterium tuberculosis QcrB A317T assessed as reduction in bacterial growth incubated for 7 days by resazurin dye based assay
Antibacterial activity against Mycobacterium tuberculosis mc2 6230 assessed as bacterial growth inhibition incubated for 5 days by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis mc2 6230 measured after 7 days
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 24 hrs by MABA assay
Antitubercular activity against Mycobacterium tuberculosis mc2 6230 assessed as inhibition of bacterial growth incubated for 7 days
Antimycobacterial activity against Mycobacterium tuberculosis mc2 6230 assessed as reduction in bacterial growth incubated for 10 days by time-kill kinetics method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as bacterial growth inhibition incubated for 6 days by MTT assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial growth incubated for 2 weeks by spot culture growth inhibition assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 9360 assessed as bacterial growth inhibition incubated for 2 weeks by spot culture growth inhibition assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as bacterial growth inhibition
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as bacterial growth inhibition incubated for 5 days by Alamar blue reagent based assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as bacterial growth inhibition incubated for 7 days by resazurin dye based microtiter assay
Antimycobacterial activity against rifampicin resistant Mycobacterium tuberculosis ATCC 35822 assessed as bacterial growth inhibition incubated for 7 days by resazurin dye based microtiter assay
Antimycobacterial activity against rifampicin resistant Mycobacterium tuberculosis ATCC 35338 assessed as bacterial growth inhibition incubated for 7 days by resazurin dye based microtiter assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as bacterial growth inhibition by radiometry method
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as bacterial growth inhibition cultured in liquid media for 5 days by absorbance based assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as bacterial growth inhibition cultured in solid media incubated for 3 to 4 weeks
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as bacterial growth inhibition incubated for 5 days under normoxic condition by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 assessed as bacterial growth inhibition incubated for 6 days under normoxic condition by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as bacterial growth inhibition incubated for 5 days under hypoxic condition by resazurin microtiter assay
Potentiation of kanamycin-induced antibacterial activity against Mycobacterium tuberculosis K204 assessed as kanamycin MIC incubated for 1 day followed by kanamycin addition for 6 days and by Alamar blue assay
Antibacterial activity against Mycobacterium tuberculosis H37Ra ATCC NRS22 assessed as inhibition of bacterial growth incubated upto 3 weeks hrs by resazurin dye based double-dilution method
Antibacterial activity against Mycobacterium tuberculosis mc2 6230 with Eis C-14T mutation assessed as inhibition of bacterial growth incubated upto 3 weeks hrs by resazurin dye based double-dilution method
Anti-mycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 5 days by alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial growth incubated for 7 days by Presto blue resazurin microtiter plate assay
Antitubercular activity against clinical isolate isoniazid-resistant Mycobacterium tuberculosis ATCC 35822 assessed as inhibition of bacterial growth incubated for 7 days by Presto blue resazurin microtiter plate assay
Antitubercular activity against clinical isolate ethambutol-resistant Mycobacterium tuberculosis ATCC 35837 assessed as inhibition of bacterial growth incubated for 7 days by Presto blue resazurin microtiter plate assay
Antitubercular activity against clinical isolate streptomycin-resistant Mycobacterium tuberculosis ATCC 35820 assessed as inhibition of bacterial growth incubated for 7 days by Presto blue resazurin microtiter plate assay
Antitubercular activity against clinical isolate rifampicin-resistant Mycobacterium tuberculosis ATCC 35838 assessed as inhibition of bacterial growth incubated for 7 days by Presto blue resazurin microtiter plate assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv incubated for 24 hrs and measured by MTT assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of visible growth incubated for 7 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra assessed as inhibition of bacterial growth by microplate alamar blue assay
Antibacterial activity against Mycobacterium tuberculosis incubated for 2 to 3 weeks
Antibacterial activity against Mycobacterium tuberculosis BCG assessed as bacterial growth inhibition
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as mycobacterial growth inhibition by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as mycobacterial growth inhibition by low oxygen recovery assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 10 days under hypoxic condition followed by 28 hrs incubation under normoxic condition by Low-Oxygen-Recovery Assay
Antimycobacterial activity against Mycobacterium tuberculosis Erdman assessed as bacterial growth inhibition
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial growth by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis measured by microbroth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth measured after 24 hrs by turbidity based analysis
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth measured after 7 days by alamar blue dye based microplate analysis
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 7 days by resazurin assay
Antitubercular activity against Multidrug-resistant Mycobacterium tuberculosis clinical isolate PT2 assessed as bacterial growth inhibition incubated for 7 days by resazurin dye based assay
Antitubercular activity against Multidrug-resistant Mycobacterium tuberculosis clinical isolate PT12 assessed as bacterial growth inhibition incubated for 7 days by resazurin dye based assay
Antitubercular activity against Multidrug-resistant Mycobacterium tuberculosis clinical isolate PT20 assessed as bacterial growth inhibition incubated for 7 days by resazurin dye based assay
Antitubercular activity against Multidrug-resistant Mycobacterium tuberculosis qcrB-T313A mutant assessed as bacterial growth inhibition incubated for 7 days by resazurin dye based assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by MABA assay
Antimycobacterial activity against drug-susceptible Mycobacterium tuberculosis H37Rv
Antimycobacterial activity against non-replicating Mycobacterium tuberculosis H37Rv by time kill kinetic assay
Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis
Antibacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 assessed as no visible mycobacterial growth incubated for 7 to 8 days by light microscope based spectrophotometric analysis
Antibacterial activity against Mycobacterium tuberculosis H37Ra assessed as inhibition of bacterial growth incubated for 72 hrs by microbroth dilution method
Antibacterial activity against Mycobacterium tuberculosis measured after 14 days
Antibacterial activity against Mycobacterium tuberculosis incubated for 5 days by Alamar blue staining method
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by broth microdilution based microplate Alamar blue staining method
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 6 weeks by MGIT assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 5 days by Alamar blue staining method
Antibacterial activity against Mycobacterium tuberculosis H37Ra by MABA method
Antitubercular activity against Mycobacterium tuberculosis mc26230 incubated for 7 days
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth
Antibacterial activity against EMB-resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth in presence of Ethionamide
Antibacterial activity against extensively drug-resistant Mycobacterium tuberculosis clinical isolate assessed as inhibition of bacterial growth
Antibacterial activity against multidrug-resistant Mycobacterium tuberculosis clinical isolate assessed as inhibition of bacterial growth
Antibacterial activity against extensively drug-resistant Mycobacterium tuberculosis clinical isolate assessed as inhibition of bacterial growth in presence of SMARt-420
Antibacterial activity against multidrug-resistant Mycobacterium tuberculosis clinical isolate assessed as inhibition of bacterial growth in presence of SMARt-420
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 7 days by microdilution alamar blue method
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 6 days by resazurin dye based fluorescence assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv in human THP-1 cells assessed as bacterial killing by standard broth assay
Antibacterial activity against non-replicating Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 9 days by LORA assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 6 days by resazurin dye based assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 14 to 21 days
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 7 days by resazurin microtiter assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 7 days by by microplate alamar blue assay
Antimycobacterial activity against rifampin resistant Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 7 days by by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis DprE1 C387S assessed as inhibition of bacterial growth incubated for 7 days by by microplate alamar blue assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis clinical isolate HD1 assessed as inhibition of bacterial growth incubated for 7 days by by microplate alamar blue assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis clinical isolate HD2 assessed as inhibition of bacterial growth incubated for 7 days by by microplate alamar blue assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis clinical isolate HD3 assessed as inhibition of bacterial growth incubated for 7 days by by microplate alamar blue assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis clinical isolate HD4 assessed as inhibition of bacterial growth incubated for 7 days by by microplate alamar blue assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis clinical isolate HD5 assessed as inhibition of bacterial growth incubated for 7 days by by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Ra ATCC 25177 assessed as reduction in bacterial growth incubated for 7 days by Alamar blue assay
Antitubercular activity against multi-drug resistant Mycobacterium tuberculosis 16833 assessed as reduction in bacterial growth incubated for 7 days by Alamar blue assay
Antimycobacterial activity against InhA overexpressing Mycobacterium tuberculosis InhA-OE
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 8 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial growth measured after 7 days by resazurin microtitre assay
Antimycobacterial activity against ethambutol-resistant Mycobacterium tuberculosis H37Rv ATCC 35837 assessed as inhibition of bacterial growth incubated for 48 hrs by resazurin microtitre assay
Antimycobacterial activity against Streptomycin-resistant Mycobacterium tuberculosis H37Rv ATCC 35820 assessed as inhibition of bacterial growth incubated for 48 hrs by resazurin microtitre assay
Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis H37Rv ATCC 35838 assessed as inhibition of bacterial growth incubated for 48 hrs by resazurin microtitre assay
Anti-mycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as bacterial growth inhibition incubated for 7 days by resazurin dye based assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition by vertical diffusion method
Anti-mycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 2729415 assessed as bacterial growth inhibition by alamar blue assay
Anti-mycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 7 days by REMA assay
Anti-mycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition incubated for 48 hrs by by alamar blue staining based analysis
Potentiation of isoniazid-induced antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in isoniazid MIC at 250 uM incubated for 48 hrs by by alamar blue staining based analysis
Potentiation of isoniazid-induced antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in isoniazid MIC at 125 uM incubated for 48 hrs by by alamar blue staining based analysis
Antibiotic activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial cell growth by measuring resazurin reduction incubated for 6 days by fluorescence microplate based assay
Antibacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 assessed as bacterial growth inhibition incubated for 7 days by absorbance based analysis
Antibacterial activity against Mycobacterium tuberculosis CDC1551 assessed as bacterial growth inhibition incubated for 5 days by luminescence based analysis
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv measured by MABA assay
Antimycobacterial activity against Mycobacterium tuberculosis 13946 clinical isolate measured by MABA assay
Antimycobacterial activity against Mycobacterium tuberculosis 14862 clinical isolate measured by MABA assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth measured after 8 days by Alamar blue assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth measured after 8 days by Alamar blue reagent based broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth incubated for 15 days by turbidometric method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra assessed as reduction in bacterial growth
Antimycobacterial activity against Mycobacterium tuberculosis kurono assessed as reduction in bacterial colonies incubated for 14 days by colony counting method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial colonies by colony counting method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth by MABA assay
Antimycobacterial activity against Mycobacterium tuberculosis My 331/88 (H37Rv) assessed as reduction in bacterial growth incubated for 14 days by microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth by MABA analysis
Antimycobacterial activity against multi drug resistant Mycobacterium tuberculosis 16833 assessed as reduction in bacterial growth by MABA analysis
Antimycobacterial activity against multi drug resistant Mycobacterium tuberculosis 16995 assessed as reduction in bacterial growth by MABA analysis
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as reduction in bacterial growth incubated for 7 days by MABA analysis
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as reduction in bacterial growth
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth by BACTEC MGIT method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth by agar dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth incubated for 21 days by broth dilution assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as reduction in bacterial growth by MABA analysis
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as reduction in bacterial growth and measured after 21 days by radiometric BACTEC method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as reduction in bacterial growth incubated for 72 hrs by two-fold dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as reduction in bacterial growth by fluorescence based MABA method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth incubated for 6 days by resazurin reduction microplate assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 6 days by Alamar blue staining based assay
Antimycobacterial activity against multi drug-resistant Mycobacterium tuberculosis 565 assessed as bacterial growth inhibition incubated for 6 days by Alamar blue staining based assay
Antimycobacterial activity against multi drug-resistant Mycobacterium tuberculosis 7791 assessed as bacterial growth inhibition incubated for 6 days by Alamar blue staining based assay
Antimycobacterial activity against multi drug-resistant Mycobacterium tuberculosis TN800 assessed as bacterial growth inhibition incubated for 6 days by Alamar blue staining based assay
Antibacterial activity against Mycobacterium tuberculosis incubated for 1 to 2 days in absence of Trp by Alamar blue assays
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as bacterial growth inhibition measured after 48 hrs by broth dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as bacterial growth inhibition measured after 5 days by MABA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as bacterial growth inhibition
Antitubercular activity against Mycobacterium tuberculosis spec. 210 assessed as bacterial growth inhibition
Antitubercular activity against Mycobacterium tuberculosis spec. 192 assessed as bacterial growth inhibition
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition measured after 5 days by MABA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition measured after 7 days by REMA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition measured after 7 days by MABA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as bacterial growth inhibition measured after 7 days by MABA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition measured after 7 days by direct susceptibility assay
Antitubercular activity against multi-drug-resistant Mycobacterium tuberculosis assessed as bacterial growth inhibition measured after 7 days by direct susceptibility assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition by direct susceptibility assay
Antitubercular activity against Mycobacterium tuberculosis mc 2 7000 assessed as bacterial growth inhibition
Antitubercular activity against Mycobacterium tuberculosis mc 2 6230 assessed as bacterial growth inhibition
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as bacterial growth inhibition by agar dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as bacterial growth inhibition measured after 10 days by MABA method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition measured after 18 hrs by twofold agar dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as bacterial growth inhibition measured after 9 days by twofold agar dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition measured after 7 days by broth microdilution assay
Antitubercular activity against dormant stage of Mycobacterium tuberculosis H37Ra ATCC 25177 assessed as bacterial growth inhibition by XTT assay
Antitubercular activity against active stage of Mycobacterium tuberculosis H37Ra ATCC 25177 assessed as bacterial growth inhibition by XTT assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition measured after 24 hrs by agar micro dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition by micro broth dilution assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra incubated for 8 to 12 days by XTT reduction menadione assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv measured by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 6 days by alamar blue dye based broth microdilution assay
Antimycobacterial activity against active stage of Mycobacterium tuberculosis H37Ra ATCC 25177 assessed as minimum inhibitory concentration by XTT assay
Antimycobacterial activity against dormant stage of Mycobacterium tuberculosis H37Ra ATCC 25177 assessed as minimum inhibitory concentration by XTT assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as reduction in microbial growth in GAST media
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth by fluorescence based analysis
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth in the presence of resazurin reduction under microplate alamarBlue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv incubated for 14 days in GAST/FE medium by Alamar blue assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv resistant isoniazid by CLSI broth microdilution method
Antibacterial activity against Mycobacterium tuberculosis H37Rv resistant rifampicin by CLSI broth microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv infected in THP-1 cells assessed as intracellular bacterial growth measured over 6 days
Antibacterial activity against Mycobacterium tuberculosis H37Rv in the presence of ATP synthase
Antibacterial activity against drug resistant Mycobacterium tuberculosis H37Rv in the presence of ATP synthase
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition in presence of ATP
Antibacterial activity against Mycobacterium tuberculosis H37Rv overexpressed in ATP synthase
Antimycobacterial activity against Mycobacterium tuberculosis assessed as growth inhibition incubated for 7 days by microplate alamar blue bioassay
Antibacterial activity against aged non-growing Mycobacterium tuberculosis
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 assessed as inhibition of bacterial growth incubated for 12 days by Alamar Blue based fluorescence analysis
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 7 to 10 days by Alamar Blue staining based analysis
Antitubercular activity against INH/RIF-resistant Mycobacterium tuberculosis clinical isolate M6 assessed as inhibition of bacterial growth incubated for 7 to 10 days by Alamar Blue staining based analysis
Antitubercular activity against INH/RIF-resistant Mycobacterium tuberculosis clinical isolate M7 assessed as inhibition of bacterial growth incubated for 7 to 10 days by Alamar Blue staining based analysis
Antitubercular activity against INH/RIF-resistant Mycobacterium tuberculosis clinical isolate M15 assessed as inhibition of bacterial growth incubated for 7 to 10 days by Alamar Blue staining based analysis
Antitubercular activity against INH/RIF-resistant Mycobacterium tuberculosis clinical isolate M34 assessed as inhibition of bacterial growth incubated for 7 to 10 days by Alamar Blue staining based analysis
Antitubercular activity against INH/RIF-sensitive Mycobacterium tuberculosis clinical isolate S17 assessed as inhibition of bacterial growth incubated for 7 to 10 days by Alamar Blue staining based analysis
Antitubercular activity against INH/RIF-sensitive Mycobacterium tuberculosis clinical isolate S23 assessed as inhibition of bacterial growth incubated for 7 to 10 days by Alamar Blue staining based analysis
Antibacterial activity against Mycobacterium tuberculosis assessed as inhibition of LPS biosynthesis
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth incubated for 7 days by dye based assay
Antimycobacterial activity against Mycobacterium tuberculosis ATCC 25618 extracellular forms assessed as inhibition of microbial growth
Antimycobacterial activity against Mycobacterium tuberculosis InhA S94A assessed as reduction in bacterial growth
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as inhibition of bacterial growth incubated for 2 days by CLSI protocol based broth microdilution method
Antibacterial activity multi-drug resistant Mycobacterium tuberculosis H37Rv ATCC 35822 assessed as inhibition of bacterial growth incubated for 2 days by CLSI protocol based broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv CNCTC My 331/88 assessed as bacterial growth inhibition incubated for 5 days by resazurin dye based assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 5 days by REMA assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 7 days by REMA assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 2 days by resazurin-based assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth by incubated for 7 days by resazurin dye based broth microdilution method
Antitubercular activity against Mycobacterium tuberculosis assessed as bacterial growth inhibition
Antitubercular activity against Mycobacterium tuberculosis H37Ra assessed as inhibition of bacterial growth incubated for 28 days by microbroth dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 21 hrs by REMA assay
Antibacterial activity against Mycobacterium tuberculosis Erdman
Antibacterial activity against extensively drug-resistant Mycobacterium tuberculosis 5
Antibacterial activity against multi drug-resistant Mycobacterium tuberculosis 365
Antibacterial activity against Mycobacterium tuberculosis H37Rv incubated for 7 days by resazurin dye based broth microdilution assay
Anti-tubercular activity against Mycobacterium tuberculosis H37Rv strain
Antitubercular activity against Mycobacterium tuberculosis H37Rv MTCC-200
Antimycobacterial activity against Mycobacterium tuberculosis incubated for 7 days by MABA assay
Antitubercular activity against Mycobacterium tuberculosis H37 Rv ATCC 27294 incubated for 7 days by Alamar blue assay
Antibacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 assessed as bacterial growth inhibition by XTT Reduction Menadione Assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv strain assessed as bacterial growth inhibition incubated for 7 days by Resazurin Microtiter Assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 strain assessed as bacterial growth inhibition by MABA Assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv MTCC 200 strain assessed as bacterial growth inhibition
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 cultured in GAST/Fe media assessed as inhibition of bacterial growth incubated for 7 days
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 cultured in 7H9/ADC/Tw media assessed as inhibition of bacterial growth incubated for 7 days
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 cultured in 7H9/DPPC/casitone/Tx media assessed as inhibition of bacterial growth incubated for 7 days
Antibacterial activity against Mycobacterium tuberculosis assessed as bacterial growth inhibition
Antibacterial activity against Mycobacterium tuberculosis H37RV ATCC 27294 assessed as bacterial growth inhibition
Antibacterial activity against Mycobacterium tuberculosis H37Rv MTCC 300 assessed as bacterial growth inhibition by alamar blue assay
Antibacterial activity against Mycobacterium tuberculosis assessed as bacterial growth inhibition by HTS assay
Antibacterial activity against Mycobacterium tuberculosis MmpL3 assessed as bacterial growth inhibition by HTS assay
Antibacterial activity against wild type Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 6 days by HTS assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 6 days by resazurin staining based assay
Antibacterial activity against wild type Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition
Antibacterial activity against wild type Mycobacterium tuberculosis H37Rv infected in BALB/c mouse assessed as bacterial growth inhibition po administrated for 5 days a week via gavage for 4 weeks
Antibacterial activity against wild type Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition by alamar blue staining based assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv infected in human THP-1 cells assessed as bacterial growth inhibition
Antibacterial activity against Mycobacterium tuberculosis H37Rv (ATCC 27294) assessed as bacterial growth inhibition by MABA assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv (ATCC 27294) assessed as bacterial growth inhibition incubated for 7 days by MABA assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth by microplate alamar blue assay
Antitubercular activity against Multidrug-resistant Mycobacterium tuberculosis H37Rv assessed as reduction in microbial growth by broth dilution method
Antitubercular activity against Mycobacterium tuberculosis 103471 assessed as reduction in bacterial growth
Antitubercular activity against replicating Mycobacterium tuberculosis H37Rv
Antitubercular activity against non-replicating Mycobacterium tuberculosis H37Rv
Antitubercular activity against replicating Mycobacterium tuberculosis bacilli
Antitubercular activity against non replicating Mycobacterium tuberculosis bacilli by low oxygen recovery assay
Antitubercular activity against low oxygen adapted Mycobacterium tuberculosis H37Rv
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv measured after 21 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by test tube dilution technique
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv measured after 8 to 9 days
Antimycobacterial activity against multi drug resistant Mycobacterium tuberculosis measured after 8 to 9 days
Antimycobacterial activity against drug resistant Mycobacterium tuberculosis measured after 8 to 9 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv measured after 7 days
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv measured after 5 mins by MABA assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 2794
Antimycobacterial activity against isoniazid resistant Mycobacterium tuberculosis clinical isolate incubated for 7 days by resazurin microtitre assay
"Antimycobacterial activity against isoniazid, rifampicin, ethambutol, pyrazinamide, capreomycin, and ethionamide resistant Mycobacterium tuberculosis clinical isolate incubated for 7 days by resazurin microtitre assay"
"Antimycobacterial activity against isoniazid, rifampicin, ethambutol, pyrazinamide, streptomycin, capreomycin, amikacin, kanamycin, ofloxacin, and ethionamide resistant Mycobacterium tuberculosis clinical isolate incubated for 7 days by resazurin microtitre assay"
"Antimycobacterial activity against isoniazid, streptomycin, ethambutol and ethionamide resistant Mycobacterium tuberculosis clinical isolate A"
Antimycobacterial activity against isoniazid and ethionamide resistant Mycobacterium tuberculosis clinical isolate B
"Antimycobacterial activity against isoniazid, streptomycin, and rifampicin resistant Mycobacterium tuberculosis clinical isolate C"
Antimycobacterial activity against isoniazid and ethionamide resistant Mycobacterium tuberculosis clinical isolate E
"Antimycobacterial activity against isoniazid, streptomycin and ethionamide resistant Mycobacterium tuberculosis clinical isolate F"
"Antimycobacterial activity against isoniazid, streptomycin, rifampicin, ethambutol, ethionamide and ofloxacin resistant Mycobacterium tuberculosis clinical isolate H"
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 5 days by alamar blue assay
Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth by alamar blue assay
Antimycobacterial activity against extensively-resistant Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth by alamar blue assay
Antitubercular activity against active stage of Mycobacterium tuberculosis H37Ra
Antitubercular activity against dormant stage of Mycobacterium tuberculosis H37Ra
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth by resazurin dye based fluorescence analysis
Antitubercular activity against Mycobacterium tuberculosis H37Rv by resazurin microtitre assay
Antitubercular activity against multidrug resistant Mycobacterium tuberculosis clinical isolate 1 by resazurin microtitre assay
Antitubercular activity against multidrug resistant Mycobacterium tuberculosis clinical isolate 2 by resazurin microtitre assay
Antitubercular activity against multidrug resistant Mycobacterium tuberculosis clinical isolate 3 by resazurin microtitre assay
Antitubercular activity against multidrug resistant Mycobacterium tuberculosis clinical isolate 4 by resazurin microtitre assay
Antitubercular activity against multidrug resistant Mycobacterium tuberculosis clinical isolate 5 by resazurin microtitre assay
Antitubercular activity against multidrug resistant Mycobacterium tuberculosis clinical isolate 6 by resazurin microtitre assay
Antitubercular activity against multidrug resistant Mycobacterium tuberculosis clinical isolate 7 by resazurin microtitre assay
Antitubercular activity against multidrug resistant Mycobacterium tuberculosis clinical isolate 8 by resazurin microtitre assay
Antitubercular activity against multidrug resistant Mycobacterium tuberculosis clinical isolate 9 by resazurin microtitre assay
Antitubercular activity against multidrug resistant Mycobacterium tuberculosis clinical isolate 10 by resazurin microtitre assay
Antitubercular activity against multidrug resistant Mycobacterium tuberculosis clinical isolate 11 by resazurin microtitre assay
Antitubercular activity against extensively drug resistant Mycobacterium tuberculosis KMRC 0 0203-0 0197 by resazurin microtitre assay
Antitubercular activity against extensively drug resistant Mycobacterium tuberculosis clinical isolate 1 by resazurin microtitre assay
Antitubercular activity against extensively drug resistant Mycobacterium tuberculosis clinical isolate 2 by resazurin microtitre assay
Antitubercular activity against extensively drug resistant Mycobacterium tuberculosis clinical isolate 3 by resazurin microtitre assay
Antitubercular activity against extensively drug resistant Mycobacterium tuberculosis clinical isolate 4 by resazurin microtitre assay
Antitubercular activity against extensively drug resistant Mycobacterium tuberculosis clinical isolate 5 by resazurin microtitre assay
Antitubercular activity against extensively drug resistant Mycobacterium tuberculosis clinical isolate 6 by resazurin microtitre assay
Antitubercular activity against extensively drug resistant Mycobacterium tuberculosis clinical isolate 7 by resazurin microtitre assay
Antitubercular activity against extensively drug resistant Mycobacterium tuberculosis clinical isolate 8 by resazurin microtitre assay
Antitubercular activity against extensively drug resistant Mycobacterium tuberculosis clinical isolate 9 by resazurin microtitre assay
Antitubercular activity against extensively drug resistant Mycobacterium tuberculosis clinical isolate 10 by resazurin microtitre assay
Antitubercular activity against extensively drug resistant Mycobacterium tuberculosis clinical isolate 11 by resazurin microtitre assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth by alamar blue assay
Antitubercular activity against multidrug resistant Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth by alamar blue assay
Antitubercular activity against extensively drug resistant Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth by alamar blue assay
Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis H37Rv
Antimycobacterial activity against extensively drug resistant Mycobacterium tuberculosis H37Rv
Antimycobacterial activity against non replicating Mycobacterium tuberculosis by broth dilution method
Antimycobacterial activity against rifampicin resistant Mycobacterium tuberculosis by broth dilution method
Antimycobacterial activity against isoniazid and rifampicin resistant Mycobacterium tuberculosis by broth dilution method
"Antimycobacterial activity against isoniazid, rifampicin, amikacin and moxifloxacin resistant Mycobacterium tuberculosis by broth dilution method"
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial growth by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis STB-FJ05349 assessed as inhibition of bacterial growth by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis STB-FJ05060 assessed as inhibition of bacterial growth by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis MDR-FJ05120 assessed as inhibition of bacterial growth by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis MDR-FJ05189 assessed as inhibition of bacterial growth by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis XDR-FJ05195 assessed as inhibition of bacterial growth by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 2 weeks
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 3 weeks
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 5 weeks
Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 199-00 harboring gyrA QRDR c270t (A90V) mutant and wild type gyrB
Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 581-17 harboring gyrA QRDR c270t (A90V) mutant and wild type gyrB
Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 410-11 harboring wild type and wild type gyrB
Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 742-0 harboring gyrA QRDR a282g (D94G) mutant and wild type gyrB
Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 666-0 harboring wild type gyrA and wild type gyrB
Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 383-0 harboring wild type gyrA and wild type gyrB
Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 152-0 harboring wild type gyrA and wild type gyrB
Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 427-18 harboring gyrA QRDR c270t (A90V) mutant and wild type gyrB
Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 775-0 harboring gyrA QRDR c270t (A90V) mutant and wild type gyrB
Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 124-0 harboring wild type gyrA and wild type gyrB
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv harboring wild type gyrA and wild type gyrB
Antimycobacterial activity against against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as inhibition of microbial growth incubated for 6 days by resazurin based assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv strain assessed as bacterial growth inhibition
Antimycobacterial activity against isoniazid and rifampicin resistant Mycobacterium tuberculosis A8 ATCC 35822 assessed as reduction in bacterial growth after 28 days by serial dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as reduction in bacterial growth after 28 days by serial dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as reduction in bacterial growth after 21 days by serial dilution method
Antitubercular activity against Mycobacterium tuberculosis expressing luxCDABE operon assessed as inhibition of bacterial growth under hypoxic conditions by low oxygen recovery assay
Antibacterial activity against wild type Mycobacterium tuberculosis CDC1551 incubated for 10 days by resazurin dye based microtiter plate assay
Antibacterial activity against Mycobacterium tuberculosis rv0443 knockout strain incubated for 10 days by resazurin dye based microtiter plate assay
Antimycobacterial activity against wild type Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition measured after 21 days by microbroth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis NTB1 harboring DprE1 G387S mutant assessed as inhibition of bacterial growth measured after 21 days by microbroth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis DR1 harboring mmpL3 V681I mutant assessed as inhibition of bacterial growth measured after 21 days by microbroth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis 88.7 harboring pyrG V186G mutant assessed as inhibition of bacterial growth measured after 21 days by microbroth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis 53.3 harboring Rv2466c W28S mutant assessed as inhibition of bacterial growth measured after 21 days by microbroth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis Ty1 harboring Rv3405c C190T mutant assessed as inhibition of bacterial growth measured after 21 days by microbroth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis 81.10 harboring EthA del (1109 to 37 residues) mutant assessed as inhibition of bacterial growth measured after 21 days by microbroth dilution method
"Antimycobacterial activity against streptomycin, isoniazid, rifampicin, ethambutol, pyrazinamide, ethionamide and capreomycin resistant Mycobacterium tuberculosis IC2 assessed as inhibition of bacterial growth measured after 21 days by microbroth dilution method"
Antibacterial activity against Mycobacterium tuberculosis H37Rv by alamar blue method
Antibacterial activity against Mycobacterium tuberculosis H37Rv (ATTCC 27294) by alamar blue based broth dilution assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth
Antimycobacterial activity against Mycobacterium tuberculosis K4 assessed as reduction in bacterial activity
Antibacterial activity against Mycobacterium tuberculosis ATCC 27294 assessed as reduction in bacterial growth by LORA method
Antimycobacterial activity against Mycobacterium tuberculosis assessed as reduction in microbial growth
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra assessed as reduction in bacterial growth by MABA method
Antimycobacterial activity against MDR/XDR Mycobacterium tuberculosis
Antimycobacterial activity against Mycobacterium tuberculosis in presence of isoniazid
Antimycobacterial activity against Mycobacterium tuberculosis in presence of ethambutol
Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis clinical isolates
Antimycobacterial activity against extensively drug resistant Mycobacterium tuberculosis clinical isolates
Antimycobacterial activity against Mycobacterium tuberculosis harbouring katG gene
Antimycobacterial activity against Mycobacterium tuberculosis harbouring inhA gene
Antimycobacterial activity against Mycobacterium tuberculosis harbouring ndh gene
Antimycobacterial activity against Mycobacterium tuberculosis harbouring embCAB gene
Antimycobacterial activity against Mycobacterium tuberculosis harbouring pncA gene
Antimycobacterial activity against Mycobacterium tuberculosis harbouring rpoB gene
Antimycobacterial activity against Mycobacterium tuberculosis Rv0667 harbouring rpoB gene
Antimycobacterial activity against Mycobacterium tuberculosis harbouring rpsL gene
Antimycobacterial activity against Mycobacterium tuberculosis harbouring rrs gene
Antimycobacterial activity against Mycobacterium tuberculosis 000019 harbouring rrs gene
Antimycobacterial activity against Mycobacterium tuberculosis harbouring vph gene
Antimycobacterial activity against Mycobacterium tuberculosis Rv0005 harbouring gyrB gene
Antimycobacterial activity against Mycobacterium tuberculosis Rv0006 harbouring gyrA gene
Antimycobacterial activity against Mycobacterium tuberculosis harbouring thyA gene
Antimycobacterial activity against Mycobacterium tuberculosis Rv1484 harbouring inhA gene
Antimycobacterial activity against Mycobacterium tuberculosis Rv0503c harbouring cmaA2 gene
Antimycobacterial activity against Mycobacterium tuberculosis Rv0701 harbouring rplC gene
Antimycobacterial activity against Mycobacterium tuberculosis Rv2163c harbouring pbpB gene
Antimycobacterial activity against Mycobacterium tuberculosis Rv2068c harbouring blaC gene
Antimycobacterial activity against Mycobacterium tuberculosis Rv0050 harbouring ponA1 gene
Antimycobacterial activity against Mycobacterium tuberculosis Rv2163c harbouring ftsI gene
Antimycobacterial activity against Mycobacterium tuberculosis Rv0706 harbouring rplV gene
Antimycobacterial activity against Mycobacterium tuberculosis rv0678
Antimycobacterial activity against Mycobacterium tuberculosis Rv1305 harbouring atpE gene
Antimycobacterial activity against Mycobacterium tuberculosis Rv3547
Antimycobacterial activity against Mycobacterium tuberculosis Rv0206c harbouring mmpl3 gene
Antimycobacterial activity against Mycobacterium tuberculosis Rv1302 harbouring wecA gene
Antimycobacterial activity against Mycobacterium tuberculosis Rv1302 harbouring rfe gene
Antimycobacterial activity against Mycobacterium tuberculosis Rv2196 harbouring qcrB gene
Antimycobacterial activity against Mycobacterium tuberculosis Rv2156c harbouring mraY gene
Antimycobacterial activity against Mycobacterium tuberculosis Rv3790 harbouring DprE1 gene
Antimycobacterial activity against Mycobacterium tuberculosis harbouring fdxA gene
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC27294 assessed as inhibition of bacterial growth by agar dilution assay
Antitubercular activity against Mycobacterium tuberculosis measured after 5 days by alamar blue dye based analysis
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by MABA method
Antimycobacterial activity against clinically isolated multidrug resistant Mycobacterium tuberculosis assessed as bacterial growth inhibition incubated for 14 days by CLSI protocol based assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition in presence of clavulanate by checkerboard assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition by checkerboard assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 infected in african green monkey Vero cells assessed as bacterial growth inhibition incubated for 6 days by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv TMC102 assessed as bacterial growth inhibition
Antimycobacterial activity against Mycobacterium tuberculosis CIP103471 infected in human U-937 cells assessed as bacterial growth inhibition incubated for 7 days
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition and measured upto 14 days by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 6 days by resazurin based fluorescence assay
Antitubercular activity against multidrug resistant Mycobacterium tuberculosis assessed as bacterial growth inhibition incubated for 6 days by resazurin based fluorescence assay
Antitubercular activity against extensively drug resistant Mycobacterium tuberculosis assessed as bacterial growth inhibition incubated for 6 days by resazurin based fluorescence assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as bacterial growth inhibition for 5 days
Antitubercular activity against Mycobacterium tuberculosis H37Rv overexpressing DprE1 assessed as bacterial growth inhibition
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as extracellular bacterial growth inhibition
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as intracellular bacterial growth inhibition
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition by REMA analysis
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 1 week by resazurin reduction microplate assay
Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis 16833 assessed as bacterial growth inhibition incubated for 7 days by microplate Alamar blue assay
Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis 16995 assessed as bacterial growth inhibition incubated for 7 days by microplate Alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 6 days by resazurin dye based assay
Antimycobacterial activity against BTZ-resistant Mycobacterium tuberculosis NTB1 assessed as bacterial growth inhibition incubated for 6 days by resazurin dye based assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 7 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis Erdman assessed as bacterial growth inhibition incubated for 7 days by microplate alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis ATCC 27294 (H37Rv) assessed as bacterial growth inhibition by agar dilution method
Antitubercular activity against Mycobacterium africanum ATCC 25420 assessed as bacterial growth inhibition by agar dilution method
Antitubercular activity against Mycobacterium tuberculosis assessed as bacterial growth inhibition in 7H9 medium incubated for 5 days by microplate reader analysis
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 7 days by Alamar blue based fluorescence assay
Antitubercular activity against multidrug resistant Mycobacterium tuberculosis clinical isolate assessed as bacterial growth inhibition
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 infected in mouse J774 cells assessed as intracellular bacterial growth inhibition incubated for by resazurin microtiter assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 6 days by resazurin reduction microplate assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 7 days by resazurin reduction microplate assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC25618 assessed as bacterial growth inhibition incubated for 6 days by resazurin based fluorescence analysis
Antitubercular activity against multidrug-resistant clinical isolate Mycobacterium tuberculosis CDCT-27 assessed as bacterial growth inhibition
Antitubercular activity against multidrug-resistant clinical isolate Mycobacterium tuberculosis CDCT-3 assessed as bacterial growth inhibition
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 14 days by agar plate method
Antitubercular activity against Mycobacterium tuberculosis Erdman assessed as bacterial growth inhibition incubated for 14 days by agar plate method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 24 hrs by [14C]-acetate labelling based radiometric analysis
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition by microdilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 6 days by MABA analysis
Antitubercular activity against Mycobacterium tuberculosis H37Rv expressing the luxABCDE operon assessed as bacterial growth inhibition incubated for 28 hrs in aerobic condition by luminescence analysis
Antitubercular activity against Mycobacterium tuberculosis mc2 7000 assessed as bacterial growth inhibition incubated for 6 days by resazurin based fluorescence assay
Antitubercular activity against multidrug resistant Mycobacterium tuberculosis clinical isolates assessed as bacterial growth inhibition incubated for 6 days by resazurin based fluorescence analysis
Antitubercular activity against extensively drug resistant Mycobacterium tuberculosis clinical isolates assessed as bacterial growth inhibition incubated for 6 days by resazurin based fluorescence analysis
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 7 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv mc2 6206 assessed as inhibition of bacterial growth measured after 7 days by visual analysis
Antimycobacterial activity against Mycobacterium tuberculosis harbouring wild-type mmpL3 gene assessed as inhibition of bacterial growth by visual analysis
Antimycobacterial activity against Mycobacterium tuberculosis harbouring mmpL3 S309C mutant gene assessed as inhibition of bacterial growth by visual analysis
Antimycobacterial activity against Mycobacterium tuberculosis harbouring mmpL3 L189R mutant gene assessed as inhibition of bacterial growth by visual analysis
Antimycobacterial activity against Mycobacterium tuberculosis harbouring mmpL3 G253E mutant gene assessed as inhibition of bacterial growth by visual analysis
Antimycobacterial activity against Mycobacterium tuberculosis harbouring mmpL3 S288T mutant gene assessed as inhibition of bacterial growth by visual analysis
Antimycobacterial activity against Mycobacterium tuberculosis harbouring mmpL3 L567P mutant gene assessed as inhibition of bacterial growth by visual analysis
Antimycobacterial activity against Mycobacterium tuberculosis harbouring mmpL3 S591l mutant gene assessed as inhibition of bacterial growth by visual analysis
Antimycobacterial activity against Mycobacterium tuberculosis harbouring mmpL3 F644C mutant gene assessed as inhibition of bacterial growth by visual analysis
Antimycobacterial activity against Mycobacterium tuberculosis harbouring mmpL3 V684G mutant gene assessed as inhibition of bacterial growth by visual analysis
Antimycobacterial activity against Mycobacterium tuberculosis harbouring mmpL3 V684A mutant gene assessed as inhibition of bacterial growth by visual analysis
Antibacterial activity against Mycobacterium tuberculosis ATCC 25177 by resazurin microplate assay
Antimycobacterial activity against Mycobacterium tuberculosis assessed as reduction in bacterial growth
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth dilution method
Antimycobacterial activity against isoniazid-resisitant Mycobacterium tuberculosis ATCC 35822 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth dilution method
Antimycobacterial activity against ethambutol-resisitant Mycobacterium tuberculosis ATCC 35837 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth dilution method
Antimycobacterial activity against streptomycin-resisitant Mycobacterium tuberculosis ATCC 35820 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth dilution method
Antimycobacterial activity against rifampicin-resisitant Mycobacterium tuberculosis ATCC 35838 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth dilution method
Antibacterial activity against Mycobacterium tuberculosis H37Rv incubated for 7 days by alamar blue reagent based fluorescence plate reader analysis
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra transformed with pSMT1 luciferase reporter plasmid incubated for 7 days by luminometric assay
Antimycobacterial activity against replicating Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 7 days by microplate alamar blue assay
Antimycobacterial activity against non-replicating Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 10 days under anaerobic condition followed by treatment under aerobic condition and measured on day 11 by luminescence based low oxygen recovery assay
Antimycobacterial activity against Mycobacterium tuberculosis assessed as reduction in bacterial growth measured after 7 days by fluorescence microplate analysis
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 7 days by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis assessed as inhibition of bacterial growth incubated for 7 days by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 5 days by broth microdilution method
Antimicrobial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth by Alamar Blue fluorescence assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth
Antitubercular activity against Mycobacterium tuberculosis XDR-FJ05195 assessed as inhibition of bacterial growth incubated for 14 days by microplate alamar blue assay
Antitubercular activity against Multi-drug resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth incubated for 14 days by microplate alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by green fluorescent protein microplate assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth incubated for 7 to 14 days by broth microdilution method
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth incubated for 7 to 14 days
Antimycobacterial activity against Mycobacterium tuberculosis assessed as reduction in mycobacterial growth
Antibacterial activity against Mycobacterium tuberculosis Erdman assessed as bacterial growth inhibition
Antimycobacterial activity against clinical isolates Mycobacterium tuberculosis assessed as inhibition of bacterial growth
Antimycobacterial activity against isoniazid resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth
Antimycobacterial activity against rifampin resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra assessed as inhibition of bacterial growth measured after 7 days by resazurin dye based analysis
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition measured after 7 days by resazurin based assay
Antibacterial activity against multi-drug resistant Mycobacterium tuberculosis clinical isolate PT2 assessed as bacterial growth inhibition measured after 7 days by resazurin based assay
Antibacterial activity against multi-drug resistant Mycobacterium tuberculosis clinical isolate PT12 assessed as bacterial growth inhibition measured after 7 days by resazurin based assay
Antibacterial activity against multi-drug resistant Mycobacterium tuberculosis clinical isolate PT20 assessed as bacterial growth inhibition measured after 7 days by resazurin based assay
Antibacterial activity against qcrB-resistant Mycobacterium tuberculosis harbouring T313A mutant assessed as bacterial growth inhibition measured after 7 days by resazurin based assay
Antimicrobial activity against Mycobacterium tuberculosis H37Rv assessed as microbial growth inhibition
Antibacterial activity against Mycobacterium tuberculosis H37Rv mc2 6206 assessed as inhibition of bacterial growth by resazurin dye based assay
Antimycobacterial activity against Mycobacterium tuberculosis Rv0678
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth incubated for 7 days by broth dilution method
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition measured after 7 days by broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis mc2 6230 assessed as inhibition of bacterial growth measured after 7 days by broth dilution method
Antimycobacterial activity against Mycobacterium tuberculosis mc2 6230 harbouring pMV261 plasmid overexpressing inhA assessed as inhibition of bacterial growth measured after 7 days by 7H9 broth based dilution method
Antimycobacterial activity against Mycobacterium tuberculosis mc2 6230 harbouring pMV261 plasmid overexpressing inhA assessed as inhibition of bacterial growth measured after 7 days by 7H10 agar based dilution method
Antibacterial activity against Mycobacterium tuberculosis H37Ra assessed as bacterial growth inhibition incubated 2 to 3 weeks by resazurin dye based assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as MIC of kanamycin A at 100 uM incubated for 24 hrs followed by kanamycin A addition measured after 6 days by alamarblue dye based assay
Antibacterial activity against Mycobacterium tuberculosis K204 assessed as MIC of kanamycin A at 100 uM incubated for 24 hrs followed by kanamycin A addition measured after 6 days by alamarblue dye based assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as MIC of kanamycin A at 8.2 uM incubated for 24 hrs followed by kanamycin A addition measured after 6 days by alamarblue dye based assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as MIC of kanamycin A at 43.8 uM incubated for 24 hrs followed by kanamycin A addition measured after 6 days by alamarblue dye based assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as MIC of kanamycin A at 7.9 uM incubated for 24 hrs followed by kanamycin A addition measured after 6 days by alamarblue dye based assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as MIC of kanamycin A at 5 uM incubated for 24 hrs followed by kanamycin A addition measured after 6 days by alamarblue dye based assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as MIC of kanamycin A at 6.3 uM incubated for 24 hrs followed by kanamycin A addition measured after 6 days by alamarblue dye based assay
Antibacterial activity against Mycobacterium tuberculosis mc2 6230 assessed as bacterial growth inhibition incubated 2 to 3 weeks by resazurin dye based assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition measured after 6 days by alamarblue dye based assay
Antibacterial activity against Mycobacterium tuberculosis mc2 6230 K204 assessed as bacterial growth inhibition measured after 6 days by alamarblue dye based assay
Antimycobacterial activity against wild type Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 7 days by resazurin microplate assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv harboring qcrB deletion mutant assessed as inhibition of bacterial growth incubated for 7 days by resazurin microplate assay
Anti-mycobacterial activity against Mycobacterium tuberculosis H37Ra assessed as reduction in bacterial growth incubated for 24 hrs
Antimycobacterial activity against Mycobacterium tuberculosis H37Ra assessed as reduction in microbial growth
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 7 days by alamar blue assay
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 24 hrs by two-fold dilution method
Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 7 days by Microdilution Alamar Blue assay
Antibacterial activity against autoluminescent Mycobacterium tuberculosis H37Ra by 7H9 broth based assay
Antimycobacterial activity against Mycobacterium tuberculosis H37RV assessed as bacterial growth inhibition
Antimycobacterial activity against Mycobacterium tuberculosis assessed as bacterial growth inhibition measured after 14 to 21 day
Antimycobacterial activity against Mycobacterium tuberculosis My331/88 assessed as bacterial growth inhibition measured after 14 to 21 day
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition by microplate Alamar blue assay
Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition measured after 5 days by microplate Alamar blue assay
Antimycobacterial activity against extensive resistant Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition measured after 5 days by microplate Alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition measured after 5 days by microplate Alamar blue assay
Antimycobacterial activity against Mycobacterium tuberculosis infected in Macrophage cell (unknown origin) assessed as bacterial growth inhibition
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition by agar cup diffusion assay
Antimycobacterial activity against pan sensitive Mycobacterium tuberculosis R2012-123 assessed as bacterial growth inhibition by agar cup diffusion assay
Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis assessed as bacterial growth inhibition by agar cup diffusion assay
Antimycobacterial activity against extensive drug resistant Mycobacterium tuberculosis assessed as bacterial growth inhibition by agar cup diffusion assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition by broth microdilution assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition by LJ slant assay
Antimycobacterial activity against multidrug Mycobacterium tuberculosis assessed as bacterial growth inhibition by LJ slant assay
Antimycobacterial activity against extensive drug Mycobacterium tuberculosis assessed as bacterial growth inhibition by LJ slant assay
Antibacterial activity against multidrug-resistant Mycobacterium tuberculosis clinical isolate CDCT-16 assessed as inhibition of bacterial growth
Antibacterial activity against multidrug-resistant Mycobacterium tuberculosis clinical isolate CDCT-27 assessed as inhibition of bacterial growth
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth by microplate alamar blue assay
Antibacterial activity against isoniazid and rifampicin-resistant Mycobacterium tuberculosis T113/09 assessed as inhibition of bacterial growth
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth by broth microdilution assay
Antibacterial activity against drug susceptible Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth
Antibacterial activity against ethambutol-resistant Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth
Antibacterial activity against streptomycin-resistant Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth
Antibacterial activity against rifampicin-resistant Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth
Antibacterial activity against isoniazid-resistant Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth
Antibacterial activity against Mycobacterium tuberculosis assessed as inhibition of bacterial growth by microplate alamar blue assay
Antibacterial activity against multidrug-resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth by microplate alamar blue assay
Antibacterial activity against extensively drug-resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth by microplate alamar blue assay
Antibacterial activity against drug-sensitive Mycobacterium tuberculosis assessed as inhibition of bacterial growth
Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial growth
Antibacterial activity against wild-type Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth
Antibacterial activity against multidrug-resistant Mycobacterium tuberculosis clinical isolate H37Rv assessed as inhibition of bacterial growth
Antibacterial activity against extensively drug-resistant Mycobacterium tuberculosis clinical isolate H37Rv assessed as inhibition of bacterial growth
Antibacterial activity against multidrug-resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth
Antibacterial activity against extensively drug-resistant Mycobacterium tuberculosis assessed as inhibition of bacterial growth
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial growth cultured in Middlebrook 7H9/ADC/Tween 80 with cydC::aph medium for 2 weeks
Antitubercular activity against Mycobacterium tuberculosis H37RV ATCC 27294 assessed as inhibition of bacterial growth cultured in Middlebrook 7H9/cholesterol/BSA/Tyloxapol medium for 2 weeks
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial growth cultured in Middlebrook 7H9/DPPC/cholesterol/BSA/Tyloxapol medium for 2 weeks
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial growth cultured in Middlebrook 7H9/BSA/Tyloxapol with glucose medium for 2 weeks
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial growth cultured in Middlebrook 7H9/ADC/Tween 80 medium for 2 weeks
Antitubercular activity against ethambutol/D-cycloserine-resistant Mycobacterium tuberculosis NIH_G11R assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against Mycobacterium tuberculosis K10b00DS assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial growth cultured in Middlebrook 7H9/glucose/casitone/tyloxapol medium for 2 weeks
Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against Mycobacterium tuberculosis Erdman assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against Mycobacterium tuberculosis HN878 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against Mycobacterium tuberculosis CDC1551 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against Mycobacterium tuberculosis clinical strain K5072429 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against Mycobacterium tuberculosis K04b00DS assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against Mycobacterium tuberculosis K05b00DS assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against Mycobacterium tuberculosis K07b00DS assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against Mycobacterium tuberculosis K09b00DS assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against ethionamide-resistant Mycobacterium tuberculosis NIH_G145 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against streptomycin/D-cycloserine-resistant Mycobacterium tuberculosis NIH_G169 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/ethionamide/D-cycloserine-resistant Mycobacterium tuberculosis NIH_G17R assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/ofloxacin/prothionamide-resistant Mycobacterium tuberculosis NIH1B127 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/rifampicin/streptomycin-resistant Mycobacterium tuberculosis clinical strain 01291696 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/rifampicin/ethambutol/rifabutin-resistant Mycobacterium tuberculosis K18b01MR assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/rifampicin/ethambutol/streptomycin-resistant Mycobacterium tuberculosis K21b00MR assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/rifampicin/ethambutol/rifabutin-resistant Mycobacterium tuberculosis K22b00MR assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/rifampicin/ethambutol/pyrazinamid/rifabutin/prothionamide-resistant Mycobacterium tuberculosis K25b00MR assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/rifampicin/ethambutol/pyrazinamid/rifabutin-resistant Mycobacterium tuberculosis K26b00MR assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/rifampicin/streptomycin/para-aminosalicylic acid/ofloxacin-resistant Mycobacterium tuberculosis K29b00MR assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/rifampicin/ethambutol/rifabutin-resistant Mycobacterium tuberculosis NIH_G10R assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/rifampicin/ethambutol/streptomycin/D-cycloserine/rifabutin-resistant Mycobacterium tuberculosis NIH_G19R assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/rifampicin/ethambutol/pyrazinamide/streptomycin/kanamycin-resistant Mycobacterium tuberculosis K20b00MR assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/rifampicin/kanamycin/pyrazinamide/capreomycin/amikacin/prothionamide/D-cycloserine-resistant Mycobacterium tuberculosis K32b00MR assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/rifampicin/ethambutol/pyrazinamide/streptomycin/kanamycin/para-aminosalicylic acid/prothionamide-resistant Mycobacterium tuberculosis K33b00MR assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/rifampicin/ethambutol/para-aminosalicylic acid/kanamycin/ofloxacin/prothionamide-resistant Mycobacterium tuberculosis Kb019 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against extensively drug-resistant Mycobacterium tuberculosis 026K111 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against extensively drug-resistant Mycobacterium tuberculosis 028K111 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against extensively drug-resistant Mycobacterium tuberculosis clinical strain 00202293 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against extensively drug-resistant Mycobacterium tuberculosis clinical strain X37b00XR assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against Mycobacterium tuberculosis K11b00DS assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against Mycobacterium tuberculosis K12b00DS assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against Mycobacterium tuberculosis K13b00DS assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against Mycobacterium tuberculosis K14b00DS assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against Mycobacterium tuberculosis K15b00DS assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against Mycobacterium tuberculosis K16b00DS assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against Mycobacterium tuberculosis K17b00DS assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against Mycobacterium tuberculosis K35b00DS assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against Mycobacterium tuberculosis NIH_G12 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/ethionamide-resistant Mycobacterium tuberculosis NIH1B21 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/ethambutol/prothionamide/D-cycloserine/ofloxacin/levofloxacin/pyrazinamide-resistant Mycobacterium tuberculosis NIH1B314 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/prothionamide-resistant Mycobacterium tuberculosis NIHA38 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/prothionamide-resistant Mycobacterium tuberculosis NIHB140 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against rifampicin/isoniazid/streptomycin/prothionamide-resistant Mycobacterium tuberculosis NIHB43 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isonizaid/rifampicin/ethambutol/rifabutin/D-cycloserine-resistant Mycobacterium tuberculosis NIH_G21R assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isonizaid/rifampicin/ethambutol/rifabutin-resistant Mycobacterium tuberculosis NIH_G22R assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isonizaid/rifampicin/ethambutol/rifabutin-resistant Mycobacterium tuberculosis NIH_G269DR assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isonizaid/rifampicin/streptomycin/ethionamide-resistant Mycobacterium tuberculosis NIH_G79 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isonizaid/rifampicin/rifabutin-resistant Mycobacterium tuberculosis NIHA37 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isonizaid/rifampicin/ethionamide/prothionamide-resistant Mycobacterium tuberculosis NIHA48 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/rifampicin/ethambutol/pyrazinamide/rifabutin/prothionamide-resistant Mycobacterium tuberculosis NIHB302 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/rifampicin/para-aminosalicylic acid/ofloxacin/prothionamide-resistant Mycobacterium tuberculosis NIHB67 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/rifampicin/para-aminosalicylic acid/pyrazinamide/prothionamide/rifabutin-resistant Mycobacterium tuberculosis NIHB68 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/rifampicin/moxifloxacin-resistant Mycobacterium tuberculosis NIH_G367DR assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/rifampicin/moxifloxacin-resistant Mycobacterium tuberculosis NIH_G76MR assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/rifampicin/pyrazinamide/prothionamide/rifabutin/ofloxacin/moxifloxacin/levofloxacin-resistant Mycobacterium tuberculosis NIHB188 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against isoniazid/rifampicin/ethambutol/pyrazinamide/prothionamide/ofloxacin/levofloxacin/rifabutin-resistant Mycobacterium tuberculosis NIHB270 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against extensively drug-resistant Mycobacterium tuberculosis NIH1B178 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against extensively drug-resistant Mycobacterium tuberculosis NIH1B250 assessed as inhibition of bacterial growth incubated for 2 weeks
Antitubercular activity against extensively drug-resistant Mycobacterium tuberculosis NIHB13 assessed as inhibition of bacterial growth incubated for 2 weeks
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 8 days by resazurin assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 24 hrs by broth microdilution method
Antibacterial activity against Mycobacterium tuberculosis H37Ra assessed as bacterial growth inhibition incubated for 24 hrs by broth microdilution method
Antitubercular activity against marker free autoluminescent Mycobacterium tuberculosis H37Ra assessed as reduction in relative light unit measured once a day for 6 days
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 6 days by microplate alamar blue assay
Antibacterial activity against Mycobacterium tuberculosis clinical isolate K4 assessed as inhibition of bacterial growth incubated for 6 days by microplate alamar blue assay
Antibacterial activity against Mycobacterium tuberculosis clinical isolate K5 assessed as inhibition of bacterial growth incubated for 6 days by microplate alamar blue assay
Antibacterial activity against Mycobacterium tuberculosis clinical isolate K12 assessed as inhibition of bacterial growth incubated for 6 days by microplate alamar blue assay
Antibacterial activity against Mycobacterium tuberculosis clinical isolate K16 assessed as inhibition of bacterial growth incubated for 6 days by microplate alamar blue assay
Antibacterial activity against pan-sensitive Mycobacterium tuberculosis H37Rv ATCC 27294 measured after 7 days by resazurin dye based assay
Antibacterial activity against MDR Mycobacterium tuberculosis clinical isolate PT2 harboring S94A mutation in inhA coding sequence by resazurin dye based assay
Antibacterial activity against MDR Mycobacterium tuberculosis clinical isolate PT12 harboring S315T mutation in katG gene by resazurin dye based assay
Antibacterial activity against MDR Mycobacterium tuberculosis clinical isolate PT20 harboring S315T mutation in katG gene by resazurin dye based assay
Antibacterial activity against MDR Mycobacterium tuberculosis clinical isolate PE-003 measured after 7 days by resazurin dye based assay
Antibacterial activity against Mycobacterium tuberculosis H37Ra assessed as reduction in bacterial growth incubated for 14 days by CLSI protocol based method
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth incubated for 14 days by CLSI protocol based method
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth by broth microdilution method
Synergistic antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as isoniazid MIC by broth microdilution method
Synergistic antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as ethambutol MIC by broth microdilution method
Synergistic antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as rifampicin MIC by broth microdilution method
Synergistic antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in microbial growth in presence of rifampicin by broth microdilution method
Synergistic antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in microbial growth in presence of isoniazid by broth microdilution method
Synergistic antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in microbial growth in presence of ethambutol by broth microdilution method
Bactericidal activity Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth incubated for 2 days by time kill assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as bacterial growth inhibition incubated for 7 days by resazurin dye based broth microdilution method
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial cell growth incubated for 6 days by Alamar blue staining based assay
Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition by resazurin staining based broth micro-dilution assay
Antibacterial activity against Mycobacterium tuberculosis H37Ra assessed as bacterial growth inhibition incubated for 7 days by broth microdilution method
Antibacterial activity against Bedaquiline- sensitive Mycobacterium tuberculosis H37Ra harboring atpB.K179N_01 mutant incubated for 7 days by resazurin staining based microtiter assay
Antibacterial activity against Bedaquiline- sensitive Mycobacterium tuberculosis H37Ra harboring atpB.K179N_02 mutant incubated for 7 days by resazurin staining based microtiter assay
Antibacterial activity against wild type Mycobacterium tuberculosis H37Ra incubated for 7 days by resazurin staining based microtiter assay
Anti-mycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 7 days by microplate Alamar blue assay
GSK_TB: Minimum inhibitory concentration against H37Rv stain of Mycobacterium tuberculosis using MABA method
GSK_TB: Minimum inhibitory concentration against isoniazid and rifampicin resistant clinical isolates of Mycobacterium tuberculosis
